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Abstract 
A critical global health concern in the last few decades is the widened gap between what we 
recognized scientifically as best practice interventions and what patients actually receive in 
clinical settings. Despite the fact that the past two decades has witnessed a preponderance of 
new and more effective interventions for acute stroke care globally, uptake of such 
interventions is inadequate and remains largely inaccessible to stroke patients. To be specific, 
uptake rates in low-middle income countries (LMICs) is pervasively slow, notwithstanding the 
fact that these countries bear a greater proportion of the global stroke burden. Yet, research on 
the application of contemporary interventions for acute stroke care in these contexts has been 
limited. Contextualizing this from the theoretical standpoints of evidence-based practice and 
knowledge translation, the overall purpose of this thesis was to advance understandings on the 
extent to which proven interventions for acute stroke care are implemented in standard practice 
in Ghanaian hospital settings This thesis aimed to 1) examine hospital-based services for acute 
stroke care and the extent to which such services are consistent with international best practice 
guidelines for acute stroke care; 2) evaluate in-hospital mortality outcomes among acute stroke 
patients in Ghanaian hospitals; and 3) explore acute stroke care professionals’ views on the 
practical barriers to the provision of evidence-based care for acute stroke patients.  
This thesis comprised three separate but interlinked studies. The first was a multi-site, hospital-
based survey conducted in 11 referral hospitals (regional and tertiary/teaching hospitals) in 
Ghana among neurologists, physician specialists and general medical officers. A structured 
questionnaire was used to gather data on available hospital-based acute stroke services, which 
were then analysed descriptively. The second study was a retrospective cohort study which 
evaluated in-hospital mortality outcomes among consecutive acute stroke patients admitted to 
six referral hospitals, comprising a sample of 300 participants selected randomly, representing 
about 50 patients from each site. Both descriptive and inferential statistics were used to conduct 
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the analysis. The final study involved a multisite in-depth, semi-structured interview conducted 
in the retrospective study sites, comprising a purposive sample of 40 acute stroke care 
professionals (neurologists, emergency physician specialist, non-specialist medical doctors, 
nurses, physiotherapists, clinical psychologists and dietitian) to explore potential barriers to 
acute stroke care. Thematic and grounded theory approaches were employed to analyse the 
data. 
Overall, the findings showed the availability of evidence-based services for acute stroke care 
were limited. Only one tertiary-teaching hospital had a stroke unit. Although aspirin therapy 
was administered in all hospitals, none of the hospitals surveyed offered thrombolytic therapy 
(thrombolysis). Although eight study sites reported having a brain computed tomographic (CT) 
scanning, only 7 were functional. Magnetic resonance imaging (MRI scan) services were also 
limited to only 4 hospitals (only functional in three) within the sample hospitals. Acute stroke 
care specialists, especially neurologists, were available in 4 of the study hospitals whilst none 
of the study hospitals had an occupational or speech therapists. The results further highlight 
inadequate health policy priority towards acute stroke care across the sample hospitals. 
Evidence from the retrospective study revealed that the delivery of acute stroke care remained 
variable and patient outcomes, mainly in-hospital mortality, were also higher and varied across 
the study sites by international comparisons. However, patients provided with aspirin recorded 
less in-hospital mortality. There was also insignificant variance in-hospital mortality across 
admitting wards. Hypertension was identified as a significant risk factor for in-hospital 
mortality. The qualitative interviews also identified four key potential barriers impeding the 
implementation of evidence-based acute stroke care. These included barriers at the patient 
(financial constraints, delays, socio-cultural or religious practices, discharge against medical 
advice, denial of stroke), health system (inadequate medical facilities, lack of stroke care 
protocol, limited staff, inadequate staff development opportunities), health professionals (poor 
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collaboration, limited knowledge of stroke care interventions) and broader national health 
policy (lack of political will) levels. Perceived barriers varied across professional disciplines 
and hospitals.  
In summary, the findings highlight evidence of only limited application of contemporary acute 
stroke care interventions, and relatively high in-hospital mortality and morbidity rates, which 
may be due to multiple barriers to provision of acute stroke care. Decisive and critical decisions 
are thus required to increase political support for acute stroke care by developing relevant 
policy to support well-targeted interventions that improve uptake of new treatment options for 
excellent clinical outcomes, with the ultimate goal of closing the current evidence-practice gap 
in Ghana and potentially other LMICs. 
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CHAPTER ONE 
Research Context and Rationale  
1.0 Introduction  
The translation of best practice guidelines and interventions from robust scientific research into 
standard practice has gained intensive academic and health policy interests over the past 
decades. However, a central concern has been the slow and limited implementation of such 
evidence-based interventions in clinical settings for optimal patient outcomes [1-4]. Although 
some attempts have been made to attenuate this problem, progress has been slow and there is 
no ‘one-size-fits all’ method of rapidly routinizing such proven interventions in clinical 
practice. Owing to this, it In general, the translation of research evidence into standard practice, 
that is, the knowledge-to practice gap can take up to 17 years to be bridged [5].   
In the context of acute stroke care, although there has been a proliferation of scholarship on 
evidence-based acute stroke care interventions over the last two decades [6-10], a fundamental 
and a consistent challenge in both high income counties (HICs) and low-middle income 
countries (LMICs) is the slow translation of research evidence into routine clinical practice for 
optimal patient outcomes. Furthermore, a common theme across the international literature 
indicates this specific problem is more pervasive in LMICs, notwithstanding the fact that these 
countries bear a greater proportion of the global stroke disease. Stroke care within such contexts 
is characterised by widespread variations and less likely to conform to international best 
practice recommendations [11, 12]. This challenges global equity in access to evidence-based 
acute stroke care. Importantly, scholarship on the provision of best practice care for stroke 
patients within such contexts has attracted inadequate attention than its imperativeness 
warrants. 
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Against the backdrop of such knowledge gaps, and adopting the theoretical standpoints of 
evidence-based practice and knowledge translation, this thesis examines the extent to which 
proven interventions for acute stroke care are implemented in standard practice. Because 
translating evidence into practice is a complex, unpredictable task, this thesis employed a 
tripartite approach to understanding the extent to which current interventions for evidence-
based acute stroke care are translated in Ghana, a LMIC setting.  
The first approach explored the availability of stroke care services in acute settings and 
consequently evaluated whether such services comply with international best practice 
guidelines for acute stroke care. The second approach investigated the extent to which such 
existing services are effective and improve patient outcomes. Given that the delivery of 
evidence-based stroke care does not occur in isolation, but within a specific context actioned 
by multiple acute stroke care providers, the third approach assessed the underlying practical 
barriers impeding the provision of optimal patient care.  Although these investigations were 
conducted in Ghana, a LMIC according to the World Bank classification [13], regular reference 
is made to other LMICs where this paradoxical situation also exists; regions where the current 
global stroke burden is highest, and also seen with health systems that are highly underfunded, 
yet the uptake of contemporary stroke care interventions remains far from optimal.  
Within this context, this opening chapter sets the stage by presenting an overview of the 
research background that contextualise the study. First, it provides an overview of stroke 
epidemiology, exploring the disease burden as a public health concern within both global and 
the study setting contexts (African region and Ghanaian contexts). Next, the research problem 
is outlined by providing three key rationales underpinning the present thesis. Following this, 
the theoretical and conceptual underpinnings of this thesis and how it is operationalised are 
explored. The subsequent sections in this chapter discuss the overarching study purpose, 
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research questions and study aims. The chapter also summarises the research methodology 
utilised in the study. Definitions of key terms used in the study, the scope and delimitation of 
the thesis are then presented. An outline for the entire thesis is thereafter summarized to 
conclude the chapter.   
1.1 Research Background 
1.1.1 Definition of Stroke 
Stroke is a non-communicable disease of global health importance. It is widely recognised as 
a medical emergency which can result in permanent neurological impairment or immediate 
loss of life [14, 15]. A stroke occurs when blood flow into the brain is slowed or stopped 
abruptly, that is, when there is an interruption or blockage in the supply of blood to the brain 
or bleeding into or around the brain due to a rupture in the artery [16, 17]. According to WHO 
standard clinical definition, a stroke is reported when there is a sudden neurological disorder 
of vascular origin caused by an acute focal injury of the central nervous system lasting more 
than 24 hours or leading to death [18].  
Following this long standing definition by WHO, concerns have been expressed about the 24 
hour limit for such medical symptoms prior to being declared a stroke. As a result, attempts 
have been made to reframe this definition to reflect current understandings of stroke from 
technological advancements in brain imaging. This movement for a new definition led by the 
American Heart/Stroke Association has challenged the 24 hour inclusion criterion for stroke as 
outdated and unreflective of current knowledge [19]. In their view, permanent injury of the 
brain can set in much earlier. Other researchers have further posited that the 24 hour inclusion 
criterion is misleading and undermines the medical urgency required for responding to transient 
ischemic attack, which has similar medical symptoms as stroke but mostly controlled within 
24 hours [20]. Thus, the new proposed definition notes symptoms can be longer than 24 hours 
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or any duration provided a brain scan (CT/MRI) suggest ischemic or haemorrhagic features 
[21]. Despite the exposition of the limitations inherent in the global standardised definition of 
stroke, the WHO definition still remains valid and widely applied in many stroke clinical and 
epidemiological studies to date. 
1.1.2 Classification of Stroke 
Two types of stroke are known globally; ischemic and haemorrhagic [20, 22]. Making a 
distinction between the main stroke subtypes is essential to ensure appropriate treatment is 
provided to acute stroke patients [20]. Specialist skills are required to make such accurate 
distinctions and clinical epidemiological data show that 20% of suspected stroke cases are 
misdiagnosed [17].  
Over the past decades, stroke epidemiological studies have shown consistency in the 
dominance of ischemic stroke subtype which constitute about 80% of all stroke cases, whilst 
the remaining proportion constitute haemorrhagic stroke subtypes [22-24]. However, the 
majority of stroke-associated mortalities and disabilities are of haemorrhagic origin [22, 24]. 
Research suggests that the recurrence of ischemic stroke is 2%  within the first seven days of 
stroke and  29% within the first 5-years after a stroke [25]. Major distinctions exist in case 
fatality rates for ischemic stroke between HICs and LMICs. Evidence from an earlier review 
suggest early case fatality in LMIC is comparatively 25% higher than HIC settings, with the 
differences attributed primarily to improved care for acute stroke [25]. Although the literature 
does not show clear support for any risk factor as a dominant cause of haemorrhage stroke, 
some epidemiologic research has implicated hypertension [26, 27] and high cholesterol levels 
[28, 29]. 
In Africa and other LMIC regions, although ischemic stroke prevalence exceeds that of 
haemorrhagic stroke, the proportion of haemorrhagic strokes is higher compared to most high 
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income regions [22, 30, 31]. For instance, a study reported that whilst the prevalence of 
haemorrhagic stroke in Africa was 34%, high income countries recorded only 9% as 
haemorrhagic strokes [32]. In Ghana however, there is mixed evidence related to which subtype 
is predominant. Whilst some studies reported a higher prevalence of ischemic strokes [33-35], 
others indicated haemorrhagic strokes are more common [36-38]. 
1.1.3 Risk Factors for Stroke  
Global efforts to control or prevent stroke have been hampered by unclear identification of its 
main risk factors. Hence, the need to accurately identify the risk factors and how they contribute 
to the present stroke burden. Stated risk factors for stroke vary [16]. However, evidence from 
the INTER-STROKE provides a wide-ranging overview of the main stroke risk factors [31], 
showing that ten main risk factors contribute to 90% of all stroke cases globally. They include 
hypertension, smoking, obesity, physical inactivity, psychosocial factors, diabetes mellitus, 
excess alcohol intake and apolipoproteins. However, others have argued  that five key risk 
factors are of significant population health interest namely hypertension, diabetes, lack of 
physical exercise, atrial fibrillation and smoking [17, 20]; which collectively contribute to 
about two-thirds of  the global stroke cases [39]. In Ghana and other African countries, common 
identified stroke risk factors comprised hypertension, smoking, diabetes, physical inactivity 
and high cholesterol intake [40]. Among these risk factors, hypertension predominates, 
contributing 60%-70% of stroke cases globally [20, 25, 31]. It is calculated that individuals 
with hypertension are predisposed to stroke by an odds ratio of 2.6 [41]. Yet, few people are 
aware of their hypertensive state  and many remain undiagnosed [42]. This is more common in 
LMICs such as Ghana where recent studies indicate low awareness of hypertension [43, 44].  
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1.1.4 Global Burden of Stroke 
The recent global burden of stroke disease data indicates a considerable increase in stroke-
related deaths by 26% between 1990 to 2010 [45]. The report further documented that about 
6.7 million stroke deaths were reported in 2013, and an additional 25.7 million stroke survivors 
were burdened with multiple disabilities over the same time period. However, it is important 
to emphasise that the current global stroke burden is inequitably distributed as more of this 
burden is disproportionately found in LMICs compared to HICs [25, 45]. In fact, about 80% 
of the stroke burden worldwide resides in LMICs [25, 32, 46, 47]. Furthermore, although HICs 
have witnessed a substantial decrease in stroke incidence of about 42% over the last four 
decades, LMICs recorded over 100% increase over the same time [25]. This inequitable stroke 
burden is further evident in comparing the stroke survival rates in these two regions: that is, 
84% for HICs against 16% for LMICs within the first three years after a stroke [30]. 
Stroke has a major impact on the patient, families and carers, economic development and the 
health care system [48]. Contemporary research suggests that the increasing stroke burden 
globally poses a substantial burden on the economic development of a country [48-51]. A study 
in Sweden estimates that the total excess cost of treating and managing stroke per annum stands 
at 629 million (€69 million) [52]. A study in the USA also reported that the overall cost of 
stroke to the economy stood at $65.5 billion dollars in 2008 [48]. Within the Australian context, 
stroke is ranked as the second highest cause of mortality and disability and cost the government 
about $49.3 billion dollars in 2012 [53]. The impact of stroke is also extended to the carers and 
family members. Carers and other family members of stroke survivors are affected 
psychologically with an increased risk of depression, anxiety and exhaustion [54, 55]. For 
example, in a cohort study of 105 stroke informal carers in a UK community, the investigation 
showed that carers were almost three times more likely to be distressed psychologically relative 
to the non-carers control group [56]. 
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1.1.5 Burden of Stroke in Africa and Ghana 
In Africa, stroke has become a great public health concern over the last two decades [47, 57-
59]. In 2002, the Global Burden of Disease study identified three countries  from the African 
continent (Liberia, Angola and Sierra Leone) as recording some of the highest stroke death 
rates globally [60]. Added to this, more than 90% of stroke-related disorders were associated 
with hypertension complications [61]. Yet the continent is still characterised by low awareness, 
poor diagnosis and poor treatment for hypertensive patients [32, 59, 62, 63], an indication that 
stroke incidence is likely to rise. In Ghana, despite scant reliable data, recent data from some 
hospital-based studies and reports [33, 38, 64, 65] suggest stroke is an increasing public health 
issue. The WHO indicates that cardiovascular diseases contribute to about 18% of the total 
deaths in Ghana [66]. Further, the United States of America Centers for Disease Control and 
Prevention (CDC) rated stroke was the second highest cause of mortality in the country in 2012 
[67], a significant rise from the fourth position in 2010 [68]. Stroke-related mortalities during 
hospital admissions have been reported to be 43%-46% [33, 69]. This is relatively higher 
compared to some HICs such as France, where stroke case fatality  has been reported to be as 
low as 8% [25]. Such disparities in stroke burden have been attributed to HICs’ unrestricted 
access and use of interventions to reduce risk factors and a relatively higher application of 
current best practice therapies [20]. 
There is currently limited evidence on the exact impact of stroke in LMICs. In Togo, research 
suggested that the cost involved for single stroke care is €936 for expenses incurred within 17 
days, which is over 100% of the average annual cost of health expenditure for an average 
Togolese [70]. Furthermore, evidence suggests the burden of stroke, heart disease and diabetes 
was expected to cost Tanzania and Nigeria a total amount of $2.5 billion and $7.6 billion 
respectively [71]. In the Ghanaian context, research on the impact of stroke is underexplored. 
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Only one single study exists on the impact of a stroke [72]. This study reported stigma and 
depression as predominant impacts of stroke on patients. There are also indications that the 
cost of treatment of Non-Communicable Diseases (NCDs) such as a stroke is high. An analysis 
on the cost of treating diabetes in Ghana noted that the daily cost involved is more than the 
average Ghanaian’s monthly salary [73]. In this analysis, the author argued that the cost 
involved in treating diabetes ranges between $106 and $638; whilst cases of complicated 
diabetes treatment cost $1,383. This estimate accordingly, far exceeds the minimum daily wage 
of $2 and average monthly salary of $213 per a civil servant in 2007 when the study was 
reported. Though unknown, from this analysis, it is possible to argue that the health cost 
especially the out-of-pocket payment for acute stroke care will pose a major catastrophic 
financial burden on the patient or family in Ghana.  
Even with the growing burden of stroke in LMICs such as Ghana, and with projections of 
further increases underpinned by the epidemiological transition caused by the aging 
populations, increased rates of unplanned urbanization and modifiable risk factors for stroke 
[74, 75], it stands to reason that more people are likely to experience stroke, as already warned 
by the World Stroke Society (that one in six will experience a stroke in their life ) [76]. In light 
of this, a key public health question is whether the current health systems of LMICs are 
prepared to sufficiently address this problem. It is not known if such countries have the capacity 
to respond to WHO’s recommendation on the need to ensure that quality and standardised 
stroke care is provided to stroke patients in order to moderate the current increasing mortality 
and morbidity burden [77]. Thus, this thesis submits that the current relatively high rates of 
stroke mortality and morbidity in LMICs points to systemic deficiencies in current acute stroke 
care services, exacerbated by inadequate health policy support for evidence-based acute stroke 
care. 
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1.2 Study Rationales  
This research project is based on three key rationales: 
Rationale 1 
The need for clearer understanding of acute stroke care interventions/services in Ghana and 
how these align with global best practice recommendations 
To date, despite great advancements in developing best practice guidelines and interventions 
for acute stroke care to support optimal patient care, research evidence has consistently 
highlighted that the spate of implementation of such interventions in LMICs is very slow, 
compared to HICs [78-81]. The World Stroke Society’s prioritisation of the need for increased 
access to evidence-based stroke care in its 2016 global campaign, underscores the centrality of 
this issue.  
Acute stroke care has witnessed considerable revolution over the past few decades due to 
advancements in medical neurological research and technology. To date, many acute stroke 
care interventions, services and guidelines exist. However, and based on pooled analysis, stroke 
scholars have often recognised four key interventions which have been demonstrated by level 
1 scientific evidence to be most effective in acute settings namely; stroke unit care of all stroke 
sub-types, sex and severity [82], thrombolysis using tissue plasminogen activator (t-PA) within 
4-5 hours of an acute ischemic stroke [9, 83], aspirin within 48 hours of an acute ischemic 
stroke [84] and decompressive surgery within 48 hours of an acute ischemic stroke [8, 85]. In 
recent times, there has been a surge in evidence of optimal patient outcomes using endovascular 
therapy (mechanical thrombectomy to be specific) for acute ischemic stroke [86, 87]. Despite, 
global uptake of the above interventions has been sub-optimal. To illustrate this point, two 
proven interventions for acute stroke care: stroke unit care and thrombolysis for acute ischemic 
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stroke are presented as case examples. Since the publication of the original evidence about the 
efficacy of stroke unit care compared to normal care in general medical wards  in 1993 [6], the 
world has not kept pace in establishing more stroke units to maximise the clinical benefits of 
this service for stroke patients. This research established that those treated in stroke units have 
a 28% increased chance of survival and are generally associated with reduced length of stay, 
dependency and disability. Subsequent trials have consistently reproduced similar results of 
improved patient outcomes [82, 88-90]. As a result, the emergence of stroke units has 
revolutionised modern stroke care services, with some authors regarding it as the ‘core’ of 
modern stroke care services [91]. Stroke unit care is also reported to be cost effective relative 
to other therapies [92-94].  
Notwithstanding such evidence, the published literature still reveals that stroke units are not 
widely prevalent across the world. For instance, the National Stroke Foundation of Australia 
reported that only 58% of patients have access to stroke units in Australia [95]. Interestingly, 
compared to HICs, the uptake of stroke unit care is relatively lower in LMICs [96, 97]. 
Evidence from an earlier study by Langhorne and colleagues suggested stroke units were 
relatively limited in LMICs [81]. However, since then, an extensive literature review found no 
inter-country or intra-country study in any LMIC in recent times to systematically profile the 
availability of stroke unit care and other best practice interventions.  
Beyond stroke unit care, thrombolytic therapy using tissue plasminogen activator (t-PA) to 
treat acute ischemic stroke patients within 4.5 hours is currently the most effective 
pharmacological therapy for acute ischemic stroke [9, 83]. This therapy is proven to 
significantly reduce patients’ mortality and morbidity, compared to conventional care [9, 98]. 
Despite the net health benefits associated with this therapy, global uptake is slow, necessitating 
increased translational research interest to enhance uptake levels [99-101]. A recent worldwide 
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systematic review for example, found that 3% of the studies reported  evidence of t-PA in low-
income countries, 19% in LMICs, 33% in upper-middle-income countries and 50% in HICs 
[78]. Another study by Pandian and other researchers reviewing evidence of the uptake of 
thrombolysis in developing countries reported limited uptake of this intervention [102], further 
highlighting the limited comparative uptake of thrombolysis in LMICs relative to HICs. 
Internationally, published studies on evidence-based acute stroke care services and 
interventions in hospitals are currently reported from HICs as such as Australia [103], UK 
[104], Canada [105] and some western European countries [106, 107]. Conversely, studies to 
specifically clarify the range of these interventions in hospital settings located in most LMICs 
remain limited. This implies that such services remain limited in LMICs, and the nature of 
stroke care in such contexts is suboptimal and less likely to conform to international best 
practice guidelines [11, 80, 96].  
Like many LMICs, there is inadequate data on the nature of acute stroke care in Ghana. Most 
studies on stroke pertain only to its incidence, risk factors, awareness and mortality outcomes 
[33, 36-38, 64, 108]. No attempt has been made to further our understanding of acute stroke 
care, the different acute stroke services in hospitals and how such services align with best 
practice guidelines in Ghana. Such information has the potential to provide the first baseline 
data on acute stroke services and how such services are consistent with global best practice 
guidelines. It further has the potential to identify important intellectual, public health and policy 
gaps for the attention of researchers, practitioners, health managers, consumer advocates and 
policy makers. The gaps identified could also inform the development of context-specific 
interventions to improve uptake of current best practice guidelines/interventions for acute 
stroke care to optimise patient outcomes.  
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Rationale 2 
The need to understand the extent of effectiveness of current acute stroke care interventions 
in Ghana 
 
In addition to the limited evidence on acute stroke care interventions in Ghana and other 
LMICs, it is argued that the low uptake of evidence-based practice results in high case fatality 
rates [77, 109]. This is demonstrated by the fact that stroke patients in HICs have a better 
chance of survival compared to their counterparts in LMICs [25, 47]. Similar evidence of such 
inequity reported a 30 day case fatality rate in Ghana of 43% compared to 8 % in France within 
a similar period [25].  
Previous evidence suggests that patients’ medical history, socio-demographic characteristics, 
economic conditions, severity, complications, and the kinds of care provided following a stroke 
determine stroke patients’ survival [110-113]. Importantly, whilst the stroke literature from 
Ghana and most African countries focus more on the epidemiology of stroke, emphasising the 
burden of the disease, its risk factors, incidence and mortality [32, 36, 37, 60, 64, 114], little 
information is offered on the processes of care or efficacy levels of available acute stroke care 
services to support optimal patient care. This notwithstanding, some efforts have been made to 
illuminate our understanding of the efficacy levels of some acute stroke care interventions in a 
few African countries. Evidence from South Africa and Morocco demonstrates improved 
patient clinical outcomes following a multidisciplinary care in a stroke unit and t-PA [115, 
116]. Yet, there is no research in Ghana which has sought to advance understandings on the 
efficacy of current acute stroke care interventions.  
Arguably, the current knowledge deficit on acute stroke care and clinical outcomes in Ghana 
and most parts of Africa is attributable to the overly focused attention on profiling the 
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prevalence, incidence and stroke risk factors. Due to this, there is uncertainty about the nature 
of in-patient stroke care especially efficacy of the available services used to support in-patient 
care. This thesis intends to address this gap. There is a clear need for such information because 
the paucity of such data limits the opportunity to critically evaluate the effectiveness of the 
acute stroke therapies prevalent in the Ghanaian hospital settings. This information will also 
contribute to the global discourse on the implementation feasibility of contemporary acute 
stroke care interventions and insights on the disparities in stroke outcomes vis-à-vis acute 
stroke care between LIMCs and HICs. Overall, such information could further support the 
formulation of policy and clinical interventions to improve optimal stroke care in Ghana. 
Rationale 3 
Insights on practical barriers that inhibit stroke care professionals’ ability to provide optimal 
patient care  
Globally, the application of best practice guidelines in routine clinical practice is not 
instantaneous or linear. In fact, it is postulated that the gap between research evidence and its 
actual implementation in routine clinical practice can take decades [5]. As a result, it is often 
not the case that clinicians apply current scientific evidence to support clinical practice [117]. 
There are currently no ‘magic bullets’ to narrow this delay. It is therefore overly simplistic to 
assume that the existence of evidence-based treatments such as stroke unit care or t-PA for 
acute stroke care in clinical settings provides adequate grounds to expect concurrent uptake 
and usage by stroke care providers. For instance, despite robust scientific evidence on ways of 
providing optimal diabetes care globally, only 10% of diabetes patients receive evidence-based 
care, despite the fact that the USA continues to spend close to USD132 billion  per annum on 
diabetes care [118]. Although the issue of ensuring that the best research evidence is translated 
into standard care has consistently been a recurrent concern over the past two decades,  the 
importance of this topic has recently gained currency in the wake of the Lancet series on Right 
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Care [119], a movement which seeks to bring to the world’s attention the systemic underuse of 
proven medical interventions for optimal patient benefits. 
For acute stroke care, despite the increases in best practice interventions and guidelines, global 
uptake is less than optimal, and particularly in LMICs [78, 96]. Current research suggests that 
multiple factors influence the low uptake and adherence to these best practice interventions 
including; health-system/organisational identified barriers, physician-identified barriers, 
patient-identified barriers and socio-political barriers [120-124]. Although some evidence 
exists to enhance understandings of these barriers, a more balanced and holistic understanding 
is lacking. I have shown in a recent systematic review that existing scholarship to date only 
presents a one-sided viewpoint on these barriers, solely reported from HICs such as Australia, 
Netherlands and USA, and such evidence is also reported more on the barriers to thrombolysis 
[125]. It is unclear what these barriers are in settings other than HIC settings. Research on these 
barriers from LMICs is important since such settings currently bear a greater proportion of 
global stroke burden and yet, record the poorest uptake of current best practice 
recommendations. Importantly, LMICs also have different geographical, political, social, 
economic and health system contexts and so may have uniquely different barriers compared to 
what is known in HICs. Research to shed light on the barriers to optimal acute stroke care is 
imperative in LMICs for the development of contextualised and well-targeted interventions to 
improve uptake of best practice guidelines by stroke care professionals, hence the rationale for 
this study. 
In order to provide clearer philosophical, epistemological and analytical frameworks to 
contextualise these three rationales and how they interconnect, the next section outlines the 
theoretical and conceptual contexts of the thesis. 
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1.3 Theoretical Contexts of the Study 
Two main theoretical frameworks were employed to operationalise this study: the concepts of 
evidence-based practice and knowledge translation. 
1.3.1  Evidence-based practice 
The concept of evidence-based practice or medicine evolved as a significant facet of delivering 
healthcare following the seminal publication by the renowned Scottish medical physician, 
Archibald L. Cochrane [126]. The evidence-based practice movement was subsequently 
invigorated by researchers at McMaster University, Canada, to reframe the practice of 
medicine and how evidence from medical research could be utilised optimally [127]. Prior to 
this, the provision of clinical care was mainly guided by medical manuals, textbooks and 
guidance from senior medical professionals [128]. However, this process was fraught with 
variations in clinical care, associated with unnecessary health costs, use of ineffective therapies 
and incorrect health management or clinical decisions [129, 130]. Half a century since the 
seminal work by Cochrane, the challenges remain unabated as evident in recent calls on the 
need for evidence-based care in clinical settings [3, 4, 119, 131].  
The most widely acknowledged definition of evidence-based practice is by Sackett et al: ‘the 
conscientious, explicit and judicious use of current best evidence in making decisions about 
the care of individual patients, as well as individual clinical expertise with the best available 
external clinical evidence from systematic research in accordance with the needs and values 
of  the patients’ [130, 132]. The evidence-based practice movement advocates the need for 
health interventions to be backed by unequivocal evidence underpinned by systematic reviews 
from randomised control trials. Despite prominence gained by this movement, critiques remain. 
Some have questioned the evidence-based practice idea and have consequently described it as 
flawed [133],  a paradigm currently saddled in crisis [134, 135],  challenged as dogmatic and 
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merely a tool to limit the autonomy and judgement of clinicians or to control medical spending 
[127, 134] and inadequate to address all clinical or medical problems [136].  
However, a critical issue which characterises contemporary discourses on evidence-based 
practice and remains relevant to the present thesis, is the extent to which evidence-based 
practice should be expected or applied in settings with less developed health systems such as 
those in Africa. Within this context, the evidence-based practice paradigm has further been 
criticised as paying little attention to the processes characterised in clinicians’ uptake of such 
evidence [137]. As will be contended in the next section, the implementation and uptake of 
evidence-based practice and interventions are complex and non-linear, yet this process seems 
to have been ignored by the early postulates of the evidence-based movement, as evidenced by 
widespread variations in medical practice. This unaddressed issue is still an essential topic of 
discussion in medical practice [2, 4] and in research on translating evidence-based interventions 
for stroke care [101]. The limited uptake of such interventions in LMICs has led to questions 
about the relevance of evidence-based practice in LMICs [138].  
Overall, despite the widespread acceptance of the evidence-based practice paradigm (though 
not without challenges and criticisms), a very important aspect is that inadequate attention has 
been given to the translation process of evidence-based practice interventions and guidelines. 
This is regarded as essential to successful implementation of research evidence for improved 
health outcomes [1, 2, 4], as will be discussed next. 
1.3.2 Knowledge Translation 
In recent times, the concept of knowledge translation (implementation science) has gained 
increased interest from practitioners, academics and policy makers. As a consequence, the field 
of knowledge translation has many diverse conceptualisations and understandings [2, 139-
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141]. However, in simple terms, knowledge translation according to the WHO encompasses 
the processes, science and practices aimed at bridging the gap between what we consider as 
best practice or evidence and the actual use of such evidence [142]. Of the many definitions 
and conceptualisations of knowledge translation, what stands out is the emphasis on the actual 
use of the accumulated evidence in standard practice. 
The translation of research evidence in healthcare settings has become a topic of great interest 
in the medical literature. This has consequently attracted widespread scholarship, theoretically 
and conceptually, to discover and explore optimum ways to bridge the current ‘know-do gap’ 
to achieve the goal of rapid translation of best practice guidelines for optimal patient outcomes. 
Yet, the translation of such interventions is still slow, limited, complex and unpredictable [141, 
143]. Hence, a plethora of theoretical conceptualisations, perspectives and frameworks have 
been developed to shed light on the current evidence-practice gap, provide a clearer explanation 
of the translation process, illuminate our understanding of the underlying drivers of  the change 
process in clinical settings and to guide policy efforts in closing this gap [141, 144-150]. 
The earliest work, which has spurred great interest in this subject, is attributed to Rogers’ work 
on the diffusion of innovations in 1962 [149]. According to Rogers, diffusion of innovation is 
a process made possible through different mediums over time within a social context. These 
innovations could take the form of a practice, idea or product. For a successful diffusion of an 
innovation, he posited five factors in knowledge translation namely: the complexity of the 
innovation, trialability, relative advantage, compatibility and observability. 
Firstly, in the perspective of Rogers, for an innovation or acute stroke care intervention, in this 
case, to be widely adopted, such an intervention should be perceived by its users as a better 
option compared to what is currently known and used. This component is perceived within the 
context of its cost-effectiveness, social prestige, and increased satisfaction by users and the 
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convenience of adopting such an intervention. Without a positive perception of an intervention 
within these contexts by the users, uptake could be slow or unpredictable according to Rogers. 
Another element espoused by Rogers was the extent of the ease with its usage. If users perceive 
an intervention to be difficult, complex and cumbersome to apply in routine practice, it is less 
likely to be adopted compared to an innovation perceived to be simple and straightforward to 
use. The third component of Rogers’ theory on the diffusion of innovation talks about the 
triability of an innovation. To this end, an intervention which could easily be rolled out without 
any risk or additional tasks for the users stands the chance of faster adoption. Another element 
emphasised by Rogers is the extent to which an innovation is consistent with or able to integrate 
well with already existing structures, practices, beliefs or values of its users. Any innovation 
which seems to be at odds with any of the above risks low levels of uptake or a complete 
desertion by users. The last element deals with the observability of results of the new 
innovation. Users are likely to welcome and implement new interventions once they are able 
to observe immediate results following its usage in the early stages as this rules out any 
uncertainly about conflicting interests or harms. These five elements postulated by Rogers 
determine the extent to which users of new interventions will potentially welcome, integrate or 
apply a new intervention into their routine works and account for about 49% to 87% of 
variations in new interventions uptake [151]. 
Following Rogers, the field of knowledge diffusion or translation in healthcare has grown 
significantly. As a result, different and diverse terminologies have been used to describe 
knowledge translation. They include; bench-to-bedside research, translational medicine, 
knowledge utilisation, implementation science, implementation research, knowledge transfer, 
knowledge exchange or diffusion of knowledge. In fact, a previous study reported that about 
90 terminologies exist relating to the field of knowledge translation [152]. Despite increased 
interest in and research on translating research evidence into practice, a unified global 
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framework to facilitate a comprehensive understanding of the field is lacking. However, a 
number of frameworks within the field of knowledge translation have been reported [145, 153, 
154].  
For example, the “Promoting Action on Research Implementation in Health Services’’ 
framework is one of the widely recognised works within the knowledge translation literature 
[155, 156]. This framework proposes that efforts to translate evidence into practice in 
healthcare delivery is contingent on the following: the nature of the research evidence 
(suitability to clinicians’ experiences and expectations and patients’ needs), the context of 
clinical settings (organisational support, receptivity of new knowledge, etc.) and how research 
evidence is translated into the clinical setting. The framework acknowledges the role of 
facilitation of research evidence as a key element in assessing and appreciating the extent to 
which effective interventions can be designed to bring about change in routine clinical practice. 
Despite the widespread consideration of this framework, it lacks clarity across its elements, 
pays little attention to the role of context and external factors to influencing change, 
overemphasises the facilitation component of the translation and lacks clarity on what a 
successful translation process represents [157-159]. The above limitations inevitably limit its 
applicability to adequately understand the knowledge translation process and how change 
happens in healthcare settings.  
Another insightful framework relevant for reflections on processes underpinning the translation 
of evidence into routine clinical practice is the ‘framework for improvement' by Cabana et al 
[145]. The framework emerged from a systematic review to provide further understanding on 
why clinicians do not use proven interventions. The review recommended six key drivers of 
paramount importance to health managers and policy makers to understand what influences 
clinical adherence to best practice guidelines or to design interventions to drive change in 
clinical practice for best patient outcomes. The factors consist of physicians’ inadequate 
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knowledge of evidence-based interventions, their agreement with available evidence, their 
level of self-efficacy, the extent of motivation to use the guideline, outcomes expected from an 
intervention and the influence of factors external to the clinical setting[145]. The authors 
emphasised that these factors are context-specific and so cannot be generalised or applied to 
all clinical settings. However, a key limitation of this framework is its exclusive focus on 
physicians, thus questioning its wider applicability to other healthcare professionals, especially 
with stroke where a multidisciplinary care team is recommended. 
However, recognising the limitations of the above and other existing frameworks, this thesis 
draws upon and discusses one framework, considered more applicable and relevant to the 
present research: ‘The comprehensive, integrated checklist of determinants of practice (the 
TICD)’ [146]. This framework explicitly acknowledges the complexities and intricacies which 
characterise the translation of evidence into practice, and incorporates the factors suggested in 
the aforementioned frameworks [145, 153, 154]. This work is unique as it pushes beyond the 
elements outlined in the other frameworks to present an extensive, multi-factored and in-depth 
discussion of the known factors likely to influence change in clinical practice or support the 
uptake of health innovations. Developed from the ‘Tailored Implementation for Chronic 
Diseases Project [160], the framework demonstrates logical consistency and precise 
interconnections embedded in the concepts it proposes. It also potentially plays a key binary 
role of either informing the design of well-targeted interventions to improve clinical practice 
for the best health outcomes or could be used to evaluate any intervention essential to 
improving clinical practice. 
Reflecting most of the drivers reported in other frameworks, seven important domains were 
proposed as essential to understanding what drives change in healthcare practice. As will be 
discussed below, these comprised factors at the guideline level, patient level, individual health 
professional’s levels, professional interaction factors, resources and incentives to make change. 
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The framework also includes the capacity of the health system to activate a change via social, 
political or legal factors. The key factors of this framework are discussed below: 
 First, the guideline factors include the intervention characteristics such as its user-
friendliness, wide applicability, accessibility, cost-effectiveness, evidence of 
effectiveness, its complexity, adaptability and compatibility. The existence of these in 
any intervention could influence uptake levels in real practice. 
 Second is the capacity of the health care system to engineer or adopt a change. The 
authors noted that for change in practice to happen, it is imperative to consider the 
organisation capacity to have policies or structures supportive of change and be 
receptive to changing practice or new innovations. This component also stresses the 
need for a strong organisational leadership, with structures and resources, such as 
guidelines, protocols, adequate staff numbers, infrastructure to support any change 
process or the uptake of any new intervention.  
 Third is the extent and quality of professional interactions within a healthcare setting. 
The existence of quality and positive professional and peer interaction, communication, 
networks and support systems can propel or dispel the use of innovations [146].  
 Fourth is the availability of resources and incentives. This refers to the availability of 
medical facilities to support evidence-uptake. These include CT scan availability, 
specialist stroke nurse or a physician, time, funding issues and availability of incentives 
for staff among others. 
 Fifth in the framework comprised the patient level factors. These include patients’ 
willingness to comply with a particular therapy, patient-health professional 
interactions, ability to pay for an intervention and delays in seeking care. 
 The role of individual health professionals was the sixth factor. This is characterised by 
the knowledge and skill levels of health professionals to use a particular intervention, 
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how their beliefs and values conform to new interventions and the extent to which they 
perceive an intervention to be effective. 
 The seventh in the framework include the social, political and legal contexts within 
which a change or new intervention is to be adopted. This encompasses regulatory and 
legal frameworks or policies supporting or against evidence uptake.  
 
Overall, it is clear that diverse conceptual and theoretical models and frameworks are available 
to further understanding of health professional’s uptake of evidence-based interventions. 
However, most of the key concepts postulated by these frameworks or models overlap with 
some fluidity. It is also evident the frameworks above were considerably inspired by the initial 
work of Rogers on the diffusion of innovation. Nevertheless, the comprehensive integrated 
checklist of determinants of practice (TICD)’ checklist considered in this thesis is more current, 
comprehensive and encapsulates the essential drivers to contextualise healthcare providers’ 
adherence to evidence-based interventions. The framework also has a greater potential of 
informing the design of interventions to improve evidence-uptake or in evaluating the 
usefulness of targeted interventions to improve uptake of evidence-based interventions.  
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1.4 Study Purpose 
The overarching purpose of the thesis is to advance understanding on the extent to which 
evidence-based interventions for acute stroke are translated into optimal clinical outcomes in 
the Ghanaian hospital setting.  
 
1.5 Research Questions 
Following the highlighted knowledge gaps, three thematic questions are put forward for critical 
interrogation:  
1. Which hospital-based services and therapies are available for acute stroke care in 
Ghanaian hospitals and to what extent are these consistent with international best 
practice recommendations? 
2. What is the extent to which acute stroke services and therapies are effective in Ghanaian 
hospitals? 
3. What are the practical barriers identified by stroke care professionals as inhibiting their 
ability to deliver evidence-based care for stroke patients in Ghanaian hospitals? 
 
1.6 Study Aims 
To address these research questions, the following study aims will be contextualised: 
1. To identify hospital-based services for acute stroke care and examine the extent to 
which such services are consistent with international best practice guidelines for acute 
stroke care 
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2. To evaluate in-hospital mortality outcomes among acute stroke patients in Ghanaian 
hospitals  
3. To explore acute stroke care professionals’ views on the practical barriers to the 
provision of evidence-based care for acute stroke patients 
 
1.7 Research Methodology  
This thesis employs three interrelated studies to address the study aims. These comprise a 
survey, a retrospective cohort study and a qualitative study. This approach is inspired by the 
pragmatic epistemological strand which draws from both objective and subjective knowledge, 
using contemporary scientific methods to address the study questions.  
 
1.8 Study Setting 
This study was undertaken in Ghana, West Africa. According to the 2015 data by the World 
Bank [161], Ghana has a population of about 27,409,598 million, with an estimated Gross 
Domestic Product (GDP) of US$ 37.543 billion. The life expectancy at birth for both sexes in 
2014 stood at 61.3 years [161] which is a significant improvement from 46 in 1960 [162]. 
Ghana is ranked as a LMIC with a human development index position of 138th, out of the 187 
countries [163],  an increase from 135 in 2011 [164]. Table 1 presents a summary of selected 
health and economic indicators of Ghana and her neighbours according to the World Bank 
[165] 
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Table 1: Selected health and economic indicators of Ghana and her neighbours  
Indicators                                         Ghana             Cote d’Ivoire            Togo         Burkina-Faso     
World Bank Income Groups (2013)                  LMI                  LMI             LI                    LI 
Population (millions)                                         28.21                    23.70   7.61                  18.65 
Population growth (%)                                       2.2                         2.5   2.5                     2.9 
GNI per capita ($)                                              4,150                    3,610                     1,370                 1,680 
GDP (Billions)        42.69                   36.16                       4.40                  12.12 
GDP growth (annual %)                                      3.6                          8.8                       4.9                      5.9 
Health expenditure, total (% of GDP)                 3.55                       5.71                      5.24                  4.96 
Health spending per capita (current US$)          57.89                    88.37                      33.89                 35.19 
Out-of-pocket health expenditure                       26.84                     50.81                   46.24                  39.09 
(% of total expenditure on health) 
Hospital beds (per 1,000 people) 2011                 0.9                            - 0.7                        - 
Nurses and midwives (per 1,000) 2010              0.926                    0.483                     0.274                0.565 
Physicians (per 1,000 people) 2010                   0.096                    0.144                       0.052               0.047 
Life expectancy                                                    61                          52                         60                       59 
Maternal deaths (2015)                                        2800                      5400                     940                   2700 
Under-5 mortality (per 1,000 live births)             62                          93                         78                      89 
Deaths from NCDs (% of overall deaths)           43.9                       35.9                     36.6                      32.7 
Cardiovascular diseases (18%)                            18                           11                          11                      12 
Prevalence of raised blood pressure 2010 (%)    29.1 30.0                      31.3                   32.9 
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1.8.1 Organisation of healthcare in Ghana 
Similar to other countries, Ghana has a multi-healthcare system which includes formal medical 
services, faith-based health care services and ethno-medical services [40]. However, challenges 
remain to delivering equitable and quality health services, such as low allocation of GDP to 
healthcare expenditure. The World Bank estimates that Ghana allocated 3.5% of GDP to 
healthcare expenditure in 2014, a substantial drop from 5.3 in 2007. The current GDP allocation 
means Ghana is currently failing to meet the minimum 5% GDP allocation set by the UN to 
achieve Universal Health Coverage by 2030 [166]. This is relatively lower compared to her 
immediate neighbouring countries (See table 1) with similar per capita incomes. Also, the 
health expenditure per total GDP of other African countries includes 6.5% in Angola,  9.8% in 
Uganda, 7.5% in Rwanda and 11.1% in Sierra Leone [161]. This corresponds to Ghana having 
fewer hospital beds per capita, compared with other countries with similar per capita incomes 
in Africa [167].          
Government delivery of healthcare services is largely organised and administered through the 
Ministry of Health (MOH) and its main implementing agency, the Ghana Health Service 
(GHS). The latter overseas the delivery of health care services whilst the former is responsible 
for health policy-making, funding and oversight of all health care implementation by the GHS. 
The main providers of health care services under the administration of the GHS comprise 
Health Centres and Clinics, District Hospitals, Regional Hospitals and Tertiary Hospitals [167]. 
The GHS has three levels: national, regional and district. At the national level, the GHS is 
headed by the Director General, whilst the MOH is led by the State Minister for Health. 
According to GHS, there are about  2,441 health facilities comprising 358 hospitals and 2,083 
health centres and clinics [168]. Community-based health planning and services facilities 
(CHPS compounds) provide health services in the most deprived areas of Ghana. The CHPS 
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compound policy, inspired by the Alma Atta Declaration, was introduced to improve access to 
health services by the rural populace and to ensure services corresponds to the needs, values 
and preferences of the communities [169]. On the other hand, the public healthcare system is 
decentralised into 10 regions (See Figure 1 below). 
Figure 1: Map of Ghana showing the ten administrative regions 
 
Ghana has five specialists care centres or tertiary hospitals; the Korle Bu Teaching Hospital in 
the capital of Ghana, Accra, Cape Coast Teaching Hospital and the Komfo Anokye Teaching 
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Hospital in Kumasi and the Tamale Teaching Hospital located in Tamale, northern Ghana. 
There is also a military/tertiary hospital located in the national capital. The tertiary-teaching 
hospitals dispense specialist care with adequately equipped state of the art healthcare 
infrastructure and specialists.   
The healthcare system is also characterised by a long-standing development gap between the 
northern regions and the rest of Ghana. This gap tends to pattern the availability and 
distribution of health resources and infrastructure. As a result, the hospitals in the northern 
regions tend to be less endowed compared to their counterparts in southern Ghana. Such 
disparities translate into poorer clinical and health outcomes [167, 170-172]. 
On healthcare financing, Ghana has a social health insurance policy called the National Health 
Insurance Scheme (NHIS). This was established in 2003 in response to calls by the World 
Bank, Civil Society Organisations (CSOs) and WHO to replace the cash and carry system with 
the aim of working towards universal health care coverage [173, 174]. The NHIS introduction 
was widely acclaimed by many as a financial relief on individual healthcare expenditure. 
However, although the scheme’s implementation has significantly improved access to 
healthcare [175, 176], it is currently challenged by widespread mismanagement, moral hazards, 
the high cost of premiums and low subscription rates [177-181].  As a result, out of pocket 
payment for healthcare is still common. Due to the current challenges of the scheme, the World 
Bank and some Civil Society Organisations have expressed doubt about its sustainability [173, 
181]. In addition, despite the existence of the NHIS, there remain significant disparities in 
healthcare access and equitable health care resource distribution [182, 183]. This has led to 
recent policy discourses on alternative health financing options such as the capitation model of 
health financing to sustain the current scheme [184]. 
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In terms of disease burden in Ghana, communicable diseases remain highly prevalent [185]. 
Associated with the problem of communicable diseases, NCDs such as stroke are increasing 
and have also become a growing public health and policy concern [73]. NCDs account for 
about 42% of total deaths in the country, of which cardiovascular diseases alone represent about 
18%, which is higher than most African countries [66]. As reported previously, stroke, an 
important category of cardiovascular disease, was ranked the second highest cause of death in 
Ghana in 2012 [67]. There is evidence to suggest stroke incidence is increasing in Ghana [36, 
38]. The main risk factor for stroke in Ghana is hypertension, which is also rising consistently. 
It is estimated that hypertension prevalence among adults 15 years and above was 3.5million 
in 2008 [43]. Regardless, like many LMIC, Ghana has limited evidence-based guidelines or 
protocols to manage stroke and other major NCDs [167, 185]. This raises questions about the 
country’s level of preparedness to respond to the growing prevalence of stroke and other NCDs. 
 
1.9 Definition of key terms 
The following are certain key fundamental terms used in this thesis. 
Stroke: A sudden neurological disorder caused by an acute focal injury of the central nervous 
system lasting more than 24 hours or leading to death and of vascular origin [18].  
High Income Countries, Low-Income Countries and Middle-Income Countries: For the 
purpose of this study and per the World Bank classifications [186], low-income countries 
represent countries with a Gross National Income (GNI) per capita of $1,025 or less; counties 
with economies between $1,026 and $4,035 of GNI per capita are categorized as LMICs. HICs 
consist of those with $12,476 or more as GNI per capita. 
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Evidence-based medicine: Also described as evidence-based practice according to Sackett et 
al. refers to 'the conscientious, explicit, and judicious use of current best evidence in making 
decisions about the care of individual patients’’ [132]. 
Evidence-based acute stroke care interventions: Refer to ‘those interventions which are guided 
by sound scientific evidence, are consistent with the clinical judgment and expertise of the 
individual clinician and meet the needs of patients for improved clinical outcomes’ [97]. 
Stroke unit: Refers to a designated medical ward or physical space where care is routinely 
provided  exclusively to stroke patients by a coordinated multidisciplinary medical team of 
doctors, nurses and therapists with a specialty in stroke care [187].  
Thrombolysis: A term used interchangeably with thrombolytic therapy, t-PA, or alteplase is a 
blood thinning, clot busting or dissolving treatment injected into the blood vessels or arteries 
to facilitate the flow of blood.  The removal of the clots can be facilitated by an intravenous 
(IV) line which transports the drugs directly to the location of the clot [10].  
Aspirin: Also called Acetylsalicylic Acid refers to a medication which prevents blood clots 
from forming or dissolves formed blood clots following a stroke or heart attack [188]. 
Decompressive surgery: A surgical procedure where  a portion of the human skull is removed 
to create sufficient space for a swelling brain from being suppressed, control intracranial 
pressure and prevent further damage to the brain tissues [189].  
 
1.10 Scope and Delimitation 
First, although this thesis explores the continuum of care for stroke patients, it is limited to care 
at the acute stage and not long term and out-patient rehabilitation. This implies care provided 
in the early hours, days and weeks of acute stroke during in-patient care. The focus of 
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investigating acute stroke care services comprises hospital-based services, which support the 
diagnosis and treatment of acute stroke patients.  
Additionally, the practical barriers faced by acute stroke care professionals only focuses on 
those barriers encountered during the delivery of acute care. The efficacy levels of the 
hospitals-based interventions for stroke care were evaluated following review of patient clinical 
data during hospitalization of first index stroke and this excludes data from recurrent stroke 
patients and outpatient care.  
The health system in Ghana is pluralistic comprising both public and private sectors, traditional 
herbal practice and faith-based or religious health systems. However, the present research was 
conducted across only public regional and tertiary hospitals in all administrative regions. 
District, sub-district hospitals and private non-state owned hospitals were not enlisted. 
 
1.11 Thesis Outline 
This thesis is structured into five separate chapters. 
The First Chapter presents a general overview and a roadmap for the entire thesis. This chapter 
situates the study within the context of the stroke disease burden (the main public health issue 
under investigation) extending from a global to the study context perspectives. The key 
rationales for the thesis are presented. The chapter also explores the theoretical and conceptual 
frameworks in the literature related to evidence-based practice and knowledge translation. The 
study questions and key aims framing the present thesis, the research methodology and study 
design employed, the scope and delimitation of the study are also discussed. Lastly, a general 
overview of the study setting, the nature and organization of the healthcare delivery within 
which the thesis was conducted is presented. 
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Chapter Two comprised two sections; both based on systematic reviews of the evidence on the 
uptake of evidence-based interventions/services for acute stroke care. The first section 
specifically evaluated the current evidence on evidence-based acute stroke care interventions 
and their level of efficacy within the African region. The extent of efficacy of such 
interventions was measured based on patients’ morbidity and mortality outcomes. The second 
section reports a systematic review from a global perspective, and explores the barriers and 
enablers inhibiting stroke care professionals’ ability to provide evidence-based acute stroke 
care. This section highlights the main barriers or enablers to the currently low uptake levels of 
such interventions. Through these two systematic reviews and syntheses of the evidence, the 
essential gaps necessitating the present thesis were highlighted. 
Chapter Three describes the research methodology and design. The Chapter commences with 
the ontological and epistemological paradigms of the research approaches employed in the 
thesis. A rationale for the choice of the epistemological paradigms used, the study designs, 
settings, target participants, sampling approaches, participants’ recruitment, data collection, 
quality control approaches and the types of analytical approaches employed are also reported. 
Chapter Four presents results from the empirical fieldwork component of the thesis. This is 
presented in three separate manuscripts. The first reports findings of a descriptive survey on 
hospital services for acute stroke care. The data on such interventions were then mapped against 
the World Stroke Organization guidelines on best practice recommendations for acute stroke 
care. In reporting the findings, the chapter highlighted the existing gaps in evidence-uptake and 
key considerations for health policy makers towards the improvement of patient care. The 
second manuscript quantitatively evaluates the efficacy levels of current care for acute stroke 
patients in Ghana. This was done through a multi-site retrospective cohort study to show how 
patient mortality outcomes correlate with different processes of care and admitting wards. In 
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the third manuscript, findings from a qualitative study on the perceived practical barriers 
inhibiting acute stroke care professionals from providing optimal care are reported. Such 
findings contextualise the extent to which evidence-based acute stroke care is provided in 
Ghana. By this, possible reasons why acute stroke care professionals fall short of providing 
optimal care for patients are proffered and also provide a plausible explanation underlying the 
prevailing mortality rates as shown in the second manuscript. 
The final chapter integrates and presents the overall thesis findings into a single scientific body 
of evidence. It first presents an overall synthesis of the thesis findings, specifically, an outline 
of the key findings comparable to pre-existing literature, their implications for clinical and 
public health practice, health policy and future research agendas. Key recommendations for the 
translation of current evidence-based interventions for acute stroke care for health policy 
consideration within the Ghanaian context were made. The main strengths and limitations of 
the study are also reported here. Following this is a conclusion which comprises an overall 
summary of the key findings, gaps for future research, clinical and public health implications 
of the study findings and areas for the attention of health managers and policy makers towards 
evidence-based acute stroke care in LMICs such as Ghana. 
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CHAPTER TWO 
Literature Review 
 
2.0 Introduction 
This section frames the thesis within the context of earlier academic scholarships on the 
translation of evidence-based interventions for acute stroke care, patient clinical outcomes 
associated with the provision of acute stroke care and the factors underpinning the provision 
of optimal acute stroke care. The section expands the scope of the three key study rationales 
reported in chapter one which necessitated the present research. This chapter is made up of two 
sections, each constituting a systematic review manuscript. The findings of the first review is 
submitted to BMC Systematic Reviews and has been accepted with minor revisions currently 
under review. This is reported in Section A of this chapter. The second systematic review on 
the other hand has been published in BMC Implementation Science as presented in Section B 
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2.1.1 Overview and rationale 
This first section reports a systematic review of the evidence on key evidence-based acute 
stroke care interventions for the management of acute stroke care and their extent of efficacy 
on patient clinical outcomes within the African region where a growing body of evidence 
indicate that there is inadequate uptake of evidence-based stroke care interventions. The paper 
provides a background for the first and second study aims and subsequently the conduct of 
study one and two as will be reported in chapter four of this thesis. Overall, the paper sought 
to examine the scope of implementation of contemporary interventions for acute stroke care 
and their extent of clinical efficacy. First, the findings points largely to a dearth of knowledge 
on the implementation of the four recommended interventions for acute stroke care. Despite, 
the few identified studies showed improved patient outcomes highlighting the need to expand 
the current uptake of these interventions. The dearth of knowledge in the implementation of 
contemporary acute stroke care interventions and notable methodological gaps (e.g. small 
sample sizes and with limited provisions to control the effect of confounding factors) in the 
eligible studies which limited definitive conclusions about the efficacy of the acute stroke care 
interventions, thus advanced the case for the first two studies of this thesis. Given the limited 
evidence, this review highlights the need for future studies to comprehensively report on the 
kinds of acute stroke care interventions currently available in the hospital settings of Africa 
and other LMICs. It also emphasized the need for robustly designed studies to clarify the 
efficacy levels of current acute stroke care interventions across Ghana and other resource poor 
settings in Africa. As shown in the ensuing section, the manuscript in Section A of this chapter 
presents the findings of this study. 
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Abstract 
Background 
The past decades have witnessed a rapid evolution of research on evidence-based acute stroke 
care interventions worldwide. Nonetheless, the evidence-to-practice gap in acute stroke care 
remains variable with slow and inconsistent uptake in low-middle income countries (LMIC). 
This review aims to identify and compare evidence-based acute stroke management 
interventions with alternative care on overall patient mortality and morbidity outcomes, 
functional independence and length of hospital stay across Africa.  
Methods  
This review was conducted according to the preferred reporting items for systematic reviews 
and meta-analyses (PRISMA) guideline. An electronic search was conducted in six databases 
comprising Medline, Embase, Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), Web of Science, Academic Search Complete and Cochrane Library for 
experimental and non-experimental studies. Eligible studies were abstracted into evidence 
tables and their methodological quality appraised using the Joanna Briggs Institute checklist. 
Data were analysed and presented narratively with reference to observed differences in patient 
outcomes, reporting p-values and confidence intervals for any possible relationship.  
Results 
Initially, 1896 articles were identified and 37 fully screened. Four non-experimental studies 
(three cohort and one case series studies) were included in the final review. One study focused 
on the clinical efficacy of a stroke unit whilst the remaining three reported on thrombolytic 
therapy. The results demonstrated a reduction in patient deaths attributed to stroke unit care 
and thrombolytic therapy. Thrombolytic therapy was also associated with reductions in 
Symptomatic IntraCerebral Haemorrhage (SICH). However, the limited eligible studies and 
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methodological limitations compromised definitive conclusions on the extent of and level of 
efficacy of evidence-based acute stroke care interventions across Africa.   
Conclusion 
Evidence from this review confirms the widespread assertion of low applicability and uptake 
of evidence-based acute stroke care in LMICs. Despite the limited eligible studies, the overall 
positive patient outcomes following such interventions demonstrate the applicability and value 
of evidence-based acute stroke care interventions in Africa. Health policy attention is thus 
required to ensure widespread applicability of such interventions for improved patients’ 
outcomes. The review findings also emphasises the need for further research to unravel the 
reasons for low-uptake.  
Systematic Review registration: PROSPERO 2016: CRD42016051566 
Keywords: Stroke, Organised care, Stroke Service, Africa, Evidence-Based Practice, 
Implementation 
 
 
 
 
 
 
 
 
67
6 
 
Background 
Stroke is a major public health concern worldwide. Despite major advances in medical research 
and technology for acute stroke care treatment and management, in 2013, it accounted for about  
6.5 million deaths and 25.7 million stroke survivors were burdened with multiple debilitating 
impairments worldwide [1]. However, the distribution of the global burden of stroke is uneven, 
with low-middle income countries (LMICs), especially those in Africa being 
disproportionately affected. In Africa, this burden is further accentuated by the increasing 
prevalence of hypertension [2-5]. This notwithstanding,  the nature of acute stroke care is often 
poor due to the fact that the application of evidence-based acute stroke care interventions for 
optimal patient outcomes in such countries remain inadequate [6-9]. Evidence-based acute 
stroke care interventions in this context applies to all scientifically proven therapies, treatment 
procedures or service intervention for the provision of acute stroke care  in clinical settings for 
optimal patient outcomes. In the context of Africa, the health systems are highly underfunded 
and as a result, there is low allocation to the national health budgets [10]. Compounded to this 
is the fact that the African continent is currently facing an epidemiological transition where 
rapid unplanned urbanization, aging population and increasing modifiable risk factors for non-
communicable diseases [11]. Yet prioritising the delivery of standardized care for acute stroke 
and other non-communicable diseases (NCDs) remain low in Africa and most resource poor 
regions [12, 13]. This makes it extremely difficult for most healthcare systems to provide 
standardised care. 
Internationally, amongst the range of diverse acute stroke care interventions and services, four 
are recommended by most stroke experts as the most effective front-line interventions to 
significantly reduce stroke-related mortality and morbidity [14, 15]. These interventions 
comprise having a specialised stroke unit care [16, 17], thrombolytic therapy through tissue 
plasminogen activator (t-PA) for acute ischemic stroke care within 4.5 hours of a stroke [18-
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21], aspirin therapy for ischemic acute ischemic stroke within 48hours of a stroke [22] and 
decompressive surgery within 48 hours of an acute stroke [23]. In recent times, endovascular 
therapy has also shown promise for improved neurological outcomes following a stroke [24]. 
The stroke unit care, for example, has been distinguished as a core component of modern stroke 
services given its proven benefits to stroke patients in general [17], and the cost-effectiveness 
of such care [25-27]. A stroke unit is a designated ward where a multidisciplinary team 
specialised in stroke treatment and management provides exclusive care for acute stroke 
patients [17]. The multidisciplinary team include medical, nursing and therapy/allied health 
staff, comprising specifically of physiotherapists, speech therapists, occupational therapists, 
pharmacist, dietitians, radiologists, clinical psychologists, and social workers [28]. 
More importantly, existing evidence uptake of such interventions is much lower in LMIC such 
as Africa [7, 9, 29], despite such countries bearing much of the global stroke burden. It has 
been suggested that the provision of care for stroke patients within such resource poor settings 
is often poor and fragmented [30-32] and less likely to follow evidence-based 
recommendations due to limited resources [33]. For example, a recent review on the global 
uptake of thrombolytic therapy revealed only 19% uptake in LMIC compared to 50% HIC [7]. 
Evidence from the UK estimated 82% patients receive care in a stroke unit [24] and another 
86% in Sweden [25]. Such disparities in uptake apparently warrants global policy actions to 
ameliorate this situation given that LMICs bear a larger share of the global burden of stroke 
and yet have limited access to the best interventions for optimal patient care. Previous research 
has reported that barriers such as limited health policy priority, patient, health professionals’ 
and other organizational context factors potentially underpin the currently low uptake of 
evidence-based interventions for acute stroke care in Africa [34] . 
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Given indications of  variable  and poor nature of acute stroke services in Africa, evidently 
manifested in high case fatality rates of about 40% in Ghana [35, 36] and 70% in Mozambique 
[37], it is important to understand the exact nature of acute stroke care interventions in this 
particular region of the world. However, the extent to which evidence-based acute stroke 
management interventions are used within the African region specifically is not well 
understood and so there is insufficient knowledge on the forms of acute stroke care 
interventions and whether such interventions result in optimal patient outcomes. Although 
some reviews have been conducted on the use of these acute stroke care interventions in LMICs 
[7, 32], this work did not focus exclusively on Africa. This study aims to identify and compare 
four recommended acute stroke management interventions (stroke unit, thrombolytic therapy, 
aspirin and decompressive surgery) with alternative care on overall patient mortality and 
morbidity outcomes, functional independence and length of hospital stay across hospital 
settings in Africa. A synthesis of this evidence will address the current knowledge gap on 
application of evidence-based acute stroke management and potentially help formulate 
strategies to strengthen the clinical capacity of the current healthcare system to improve uptake 
of current interventions in Africa.  
Methods 
This review was guided by the standardised Preferred Reporting Items for Systematic reviews 
and Meta-Analyses (PRISMA) approach [38]. The review protocol was registered 
(PROSPERO 2016:CRD42016051566). 
Eligibility Criteria  
Study Design 
Studies for this review comprised randomised control trials (RCTs), quasi-randomised trials, 
non-randomised clinical studies, quasi-experimental studies and reporting on acute stroke care. 
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To ensure inclusion of all relevant potential studies, prospective and retrospective cohort 
studies, case-control studies, before-and-after studies and analytical cross sectional studies 
were also considered. Included studies also reported patient outcomes after in-patient stroke 
treatment and management intervention. To qualify for inclusion, eligible studies reported 
patients’ baseline characteristics and duration of follow-up. Editorials or opinion pieces related 
to the subject of the review were excluded.  
Participants 
This review considered studies on adult stroke patients 18 years and older, of either sex. Studies 
reporting patients diagnosed and treated for transient ischemic attack were excluded. Studies 
which included a mix of patients with stroke and other health conditions were also excluded.  
Interventions  
Studies evaluating the efficacy of acute stroke care interventions were included. The 
interventions of interest included the use of aspirin, thrombolytic therapy and hemicraniectomy 
or decompressive surgery. Studies which reported on acute stroke outcomes following 
multidisciplinary stroke team care in a stroke unit were also included. Additionally, secondary 
interventions of interest such as endovascular therapy were included. The comparators of 
interest included normal care, conventional care or no other treatment.  
Outcome Measures 
Study outcomes were categorised into two; primary and secondary. The primary outcomes of 
interest were interventions reporting on in-patient deaths (mortality outcomes), length of 
hospital stay, functional independence and morbidity outcomes such as asymptomatic 
intracranial haemorrhage and extracranial haemorrhage. Secondary outcomes included patient 
access to the following acute stroke care services: magnetic resonance imaging, computed 
tomographic scan, electrocardiogram (ECG) and Carotid Doppler services.  
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Search Strategy and Selection Criteria 
An electronic search of six databases comprising Medline, Embase, CINAHL, Academic 
Search Complete, Web of Science and Cochrane Library was conducted. All databases were 
searched individually to ensure all relevant studies were considered. Other sources such as 
Google Scholar, African Journals Online and African Index Medicus were also searched. In 
addition, reference lists and bibliographies from eligible studies were screened manually for 
further eligible studies. The year limit for searches was opened up to November 2016 and only 
studies published in English or French were considered. Finally, studies had to be conducted 
in an African country hospital setting. For search terms, an initial scoping of literature was 
undertaken to identify key words, subject specific terms or MeSH terms related to stroke and 
the acute stroke care interventions. An example of the search strategy in Medline database 
employed in the search process is provided (Supplementary File 1). 
Study Selection and Data Extraction 
Selection and extraction of potential studies was conducted through a four-step process. First, 
one author (LB) screened and retrieved all potential studies and consequently imported them 
into a reference manager (Endnote) which helped organise the entire data and supported in the 
removal of duplicates. In the second stage, the remaining studies were screened by two authors 
(LB and SS) for eligibility on the basis of title and abstract relevance. The third stage involved 
cross-checking of studies eligible for full text screening by a third author (AS) in order to 
minimise selection bias. The final stage involved full text screening to select studies meeting 
the inclusion criteria or considered potentially relevant by one author (LB) and this was double 
checked by another author (SS). Using a standardised pre-designed data extraction form, all 
eligible studies were extracted according to author (s), year of publication, country of study 
origin, study aim, population characteristics and sample size, level of evidence, intervention 
type, comparator, study duration, outcomes of interest and key findings.  
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Assessment of Methodological Quality 
To minimise bias and improve the strength of evidence, the quality of each included study was 
first assessed independently by one author (LB) applying the Joanna Briggs Institute quality 
appraisal tool for assessing risk of bias in observational cohort studies and case series [39]. 
This was verified by other authors (CC and SS). A joint discussion was conducted to achieve 
consensus where differences emerged during quality assessment. Assessment of study quality 
for risk of bias was conducted based on how participants were selected, sampling approach, 
representativeness of sample, study design, assessment of exposure, adequacy of case 
definition and selection of controls exposure for all study types. In classifying the evidence 
levels for each of the eligible studies, the Oxford Centre for Evidence-based Management 
framework was employed [40]. This is an established and widely applied framework in 
classifying the evidence levels of clinical experimental and non-experimental study designs 
based on the best available scientific evidence. 
Data Synthesis  
This review followed the narrative synthesis framework by Popay et al [41] in conducting the 
data synthesis in systematic reviews. To minimise heterogeneity effects resulting from the 
diverse reported study designs, extracted data were managed and reported separately according 
to the particular form of in-patient stroke care. The main outcomes of interest were also 
analysed and presented in text form according to the various forms of in-patient care 
interventions and services. Information such as the effect of acute stroke management 
interventions on key patient outcomes such as in- 
patient mortality, morbidity and length of hospital stay as well as other variables of interests 
were assessed. Results were reported in simple statistical or descriptive format comparing 
patient outcomes across eligible studies. Differences and similarities across interventions were 
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also discussed. In addition, key conclusions of each study were summarised and reported in the 
evidence table. However, the limited number of included studies, small sample sizes and the 
heterogeneity of the study outcomes measured made it impossible to conduct a meta-analysis. 
As a result, the general results were reported as a narrative summary. 
Results  
Overall, the search yielded 1896 studies (Medline = 498, CINAHL= 284, Embase =293, World 
of Science =15, Cochrane Library = 147, Academic Search Complete = 648 and 11 from other 
sources). Of these, 11 studies were from other sources. A total number of 625 duplicates were 
removed. Another 1234 studies were removed after title and abstract screening for relevance. 
Consequently, a full text article screening for eligibility was conducted for 37 studies. The full 
text assessment excluded another 33 as they did not meet the eligibility criteria. Finally, a total 
of four studies met the eligibility criteria for this review. The search results are presented in 
Figure 1.  
Characteristics of Included Studies 
A total number of 700 participants were included in this review. Studies were published 
between 2009 and 2016. Of the four eligible studies, there was no experimental studies, two 
were retrospective cohort studies [42, 43], a prospective cohort study [44] and a case series 
study [45]. Three of the studies reported on thrombolytic therapy using recombinant tissue 
plasminogen activator [43-45] and the remaining study focused on stroke unit care [42]. Three 
of the eligible studies were conducted in South Africa [42-44] and the other in Morocco [45]. 
The characteristics of the four eligible studies are summarised in Table 1. 
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Figure 1: PRISMA 2009 Flow Diagram 
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Quality and strength of evidence  
On the basis of evidence classification, the three eligible cohort studies were classified as levels 
3 whereas the case series study fell under level  4 per the Oxford Centre for Evidence-Based 
Management (OCEBM) levels of evidence for effectiveness [46]. Despite evidence of the 
efficacy of thrombolytic therapy using t-PA and stroke unit care, the quality of the eligible 
studies comprised the strength of the evidence. The lack of experimental studies, inadequate 
measures to account for confounding covariates and absence of randomisation showed a low 
level of evidence to unequivocally support the effectiveness of thrombolysis and 
multidisciplinary stroke unit care on clinical outcomes. For the cohort studies, the sampling 
procedure was only moderately conducted despite those studies employing a clearly defined 
selection criteria and had reliably measured and analysed patient outcomes.  
Despite accounting for confounding factors in cohort studies, only one study [43] accounted 
for it in the analysis. Also, the retrospective nature of two of the cohort studies [42, 43], where 
outcomes were reportedly based on a chart review of medical records, could bias the results by 
potentially underestimating or overestimating the final outcomes. All included studies 
contained small and unrepresentative patient samples which limited their generalisability. 
Methodologically, the case series study, on the other hand, scored highly on the quality 
appraisal checklist. Nonetheless, it lacked important baseline information, limiting 
generalizability. On this basis, the overall quality of the cohort studies provide only limited 
support for efficacy of such interventions. Quality assessment of included studies is shown in 
Table 2. 
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Table 2: Risk and Quality Assessment of Eligible Studies 
  
Appraisal questions for cohort studies 
Bryer & 
Wasserman, 
2012 
Villiers et 
al, 2009 
Klemperer 
et al, 2014 
1 Were the groups similar and recruited from the same 
population? 
Yes Yes Yes 
2 Were the exposures measured similarly to assign people to 
both exposed and unexposed groups? 
Yes Yes Yes 
3 Was the exposure measured in a valid and reliable way? Yes Yes Yes 
4 Were confounding factors identified? Yes Yes Yes 
5 Were strategies to deal with confounding factors stated? No No Yes 
6 Were the groups/participants free of the outcome at the start 
of the study (or at the moment of exposure)? 
Yes Yes Yes 
7 Were the outcomes measured in a valid and reliable way? Yes Yes Yes 
8 Was the follow up time reported and sufficient to belong 
enough for outcomes to occur? 
Yes No Yes 
9 Was follow-up complete, and if not, were the reasons to loss 
to follow-up described and explored? 
NA NA NA 
10 Were strategies to address incomplete follow-up utilized? NA NA NA 
11 Was appropriate statistical analysis used? Yes Yes Yes   
 Critical Appraisal Questions for Case Series Study 
Naima 
Chtaou et al., 
2016 
 
 
1 
Were there clear criteria for inclusion in the case series?  
Yes - - 
2 Was the condition measured in a standard, reliable way for 
all participants included in the case series? 
Yes - - 
3 Were valid methods used for identification of the condition 
for all participants included in the case series? 
Yes - - 
4 Did the case series have consecutive inclusion of 
participants?  
Yes - - 
5 Did the case series have complete inclusion of participants? Yes - - 
6 Was there clear reporting of the demographics of the 
participants in the study? 
Yes - - 
7 Was there clear reporting of clinical information of the 
participants? 
Yes - - 
8 Were the outcomes or follow up results of cases clearly 
reported?  
Yes - - 
9 Was there clear reporting of the presenting site(s)/clinic(s) 
demographic information? 
No - - 
10 
Was statistical analysis appropriate?  
Yes - - 
11 
Were there clear criteria for inclusion in the case series?  
Yes - - 
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Table 1. Characteristics of studies on interventions for acute stroke care 
Lead 
Author  
Year & 
Country 
Study Aim Study 
Design 
Intervention Level of 
Evidence 
Duration Population  
sample 
Outcome 
measures 
Key Results 
Villiers et al, 
2009 
 
South Africa 
Examine the impact 
of multidisciplinary 
stroke care on in-
hospital mortality, 
resource utilization, 
and access to 
inpatient 
rehabilitation 
facilities for stroke 
patients admitted to 
the stroke unit  
Retrospective 
study 
 
 
Stroke unit Level 3 December 
2001 -
February 
2002 
 
March 
2002 - May 
2002 
195 
patients 
 
Mean age = 
58.8  
 
60% were 
female 
length of hospital 
stay  
inpatient death 
transfer to a 
tertiary 
hospital 
number of 
patients who 
accessed CT brain 
In-hospital mortality was 31 (33%) in general 
ward compared to 16 (16%) in the stroke unit 
(P=0.005) 
Mean length of hospital stay before stroke 
unit was 5.1 (6.5, 3.8–6.4) days compared 
with 6.8 (4.5, 5.9–7.6) days after stroke unit 
care (P=0.01) 
Access to CT brain scans increased from 13% 
(12) to 16% (16) 
Referrals to the tertiary academic hospital 7% 
(n=7) vs. 4% (n=4) did not change 
significantly 
Wasserman 
and Bryer, 
2012 
 
South Africa 
 
To evaluate early 
outcomes and safety 
of stroke 
thrombolysis in a 
South African 
setting 
Prospective 
study 
Thrombolytic 
therapy 
Level 3 January 
2000 - 
February 
2011 
42 patients early neurological 
recovery 
functional 
independence at 
discharge  
rate of 
symptomatic 
intracranial 
haemorrhage 
(SICH) 
death 
Mean time to t-PA infusion was 160 mins 
(SD 50; range 60 to 270). 72·5% patients 
were thrombolysed within 180 mins  
Median NIHSS score fell to 7·5 (IQR 1 to 15) 
by the time of discharge 
67% of patients achieved significant 
neurological improvement after thrombolysis 
40.5% were functionally independent 
2 (4·8%) patients suffered SICH  
3 (7·1%) patients died at discharge 
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Klemperer et 
al, 2014 
 
South Africa 
To evaluate the 
performance of 
SITS-SICH and 
SEDAN scores in 
predicting the risk of 
SICH after 
thrombolysis  
Retrospective 
Study 
Thrombolytic 
therapy 
Level 3  2000-2012 41 patients bleeding 
complications 
 
SICH risk 
2 (4.9%) patients experienced SICH, (95% 
CI: 0–11.5%); SITS-SICH (5.1%) and 
SEDAN (6.5%) cohorts 
23 patients accessed CT brain scan 
 
Naima 
Chtaou et al., 
2016 
 
Morocco 
 
To report the case 
series of all patients 
who were treated 
with rt-PA in a 
stroke unit of 
HASSAN II 
University hospital 
between 2010 and 
2013 
 
Case series 
 
Thrombolytic 
therapy 
 
Level 4 
 
2010-2013 
 
52 patients  
 
Mean age = 
63 years  
 
 
 
 
 17 patients (32.7%) were treated within a 3 
hours window of stroke onset and 35 (67.3%) 
within 3-4.5 hours 
25 patients (48%) had significant early 
improvements within 24 hours, 21 (40.3%) 
had good outcomes at 3 months and 15 (29%) 
died  
Mean door-to-needle time was 75 min and 
mean onset-to treatment was 212mins 
3 asymptomatic ICH  and 4 symptomatic 
ICHs were reported 
2 of the 4 symptomatic ICHs were fatal 
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Efficacy of the Acute Stroke Care Interventions 
Stroke Unit 
Two studies were identified which reported multidisciplinary team care in stroke unit [42]. 
This was a retrospective study to evaluate patient outcomes following multidisciplinary care in 
a South African stroke unit and a general medical ward among 195 patients. The study 
outcomes comprised inpatient deaths, patient access to CT brain scan, length of hospital stay 
and transfer to a tertiary hospital. Overall,  the study showed less deaths (16%) in patients 
treated in the stroke unit compared to the general ward (33%); (p<0.005). The mean length of 
hospital stay prior to the stroke unit was 5.1 days in the general wards, compared to 6.8 days 
when the stroke unit care was introduced (p<0.01). Stroke patient referrals at discharge to 
inpatient rehabilitation also increased from 5% to 19% (p<0.04) after introducing the stroke 
unit. In contrast, only 3 patients (5%) were referred at discharge for further in-patient 
rehabilitation in the general wards before the advent of the stroke unit care. Additionally, there 
was disparity in access to brain scanning services between the two admitting wards. Patient 
access to CT brain scan was 12 (13%) in the general medical ward but this increased to 16 
(16%) following the introduction of the stroke unit. The difference in access to brain CT scan 
between the two patient cohorts was not significant. 
Thrombolytic Therapy 
Three studies reported on thrombolytic therapy for acute stroke care; two in South Africa [43, 
44] and another in Morocco [45]. The first study evaluated outcomes and safety of thrombolysis 
among 42 patients thrombolysed using t-PA in a tertiary academic hospital [44]. The outcome 
measures included in-patient deaths, early neurological recovery and rate of symptomatic 
intracranial haemorrhage (SICH). The results showed 17 (40.5%) of participants being were 
functionally independent at discharge. Risk of bleeding and other complications such as SICH 
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is associated with thrombolysis use globally [18]. This study also found 2 (4.8%) patients 
experienced SICH whilst 3 (7.1%) patients died following thrombolysis.  
The second South African study examined the risk outcomes associated with thrombolysis 
using t-PA among 41 patients [43]. The study outcomes included SICH, deaths, asymptomatic 
intracranial haemorrhage (AIH), and extracranial haemorrhage (EH). Two instruments were 
used to predict risk of SICH; SEDAN and Safe Implementation of Treatment in Stroke (SITS) 
scores. Overall, the study showed 2 (4.9%) patients experienced SICH, (95% CI: 0–11.5%) 
representing 5.1% for SITS-SICH and 6.5% for the SEDAN cohorts. One patient (2.4%) died 
as a result of SICH following thrombolysis. Evidence of AIH was found in 8 Eight (19.5%) 
patients reported evidence of AIH and another two 2 (4.9%) patients of EH. Of the 41 
participants, 23 (56.0%) had access to Computed Tomography brain (CT) scan prior to the 
intervention. 
The third study, which was a case series, examined patient outcomes following the use of 
thrombolytic therapy in a stroke unit [45]. Study outcomes measured in this study are deaths, 
early clinical improvement, clinical morbidities including SICH. The evidence showed that 25 
(48%) patients had significant early clinical improvements within 24 hours, 21 (40.3%) at 3 
months and 15 (29%) in-patient mortality cases. The early National and NIHSS score was more 
severe in the first patient cohort (NIHSS >15 in 58% of the patients) compared to the second 
patient cohort (NIHSS > 15 in 28% of the sub-patient group). The study also noted 3 (5.7%) 
asymptomatic intracerebral haemorrhage and 4 (7.7%) SICH complications. Two of the SICH 
cases were also fatal.  
Discussion 
This study set out to systematically identify the best available evidence on the application of 
interventions for acute stroke care across hospital settings in Africa. To our knowledge, this 
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review represents the first systematic synthesis of key interventions for acute stroke care and 
evaluation of patient clinical outcomes in hospital settings across Africa. Overall, despite 
global advancements in best practice interventions for acute stroke care, the evidence base in 
the African context remains limited. As demonstrated in this review, only four studies were 
eligible; one evaluating clinical outcomes following stroke unit care and the remaining three 
on outcomes following thrombolytic therapy. This limited number that met the inclusion 
criteria highlights the paucity of work on this topic to date. Nonetheless, this limited literature 
demonstrates improved patient clinical outcomes within the African context. The studies report 
similar results of improved patient outcomes compared to those studies conducted in other 
LMIC and HIC settings. Although the limited number of eligible studies, their non-
experimental nature, and methodological quality preclude more definite conclusions, the 
evidence reported in this review still provides valuable insight towards health policy 
formulation and future research to optimise clinical management of stroke patients. 
Comparison with previous evidence  
Studies that have examined evidence-based acute stroke care interventions in LMIC are scarce. 
An earlier review on the uptake of thrombolysis in developing countries also found very few 
studies [29]. A systematic review undertaken by Berkowitz et al, to estimate thrombolytic 
therapy uptake globally found the use of thrombolytic therapy was 19% in LMICs such as those 
in Africa [47]. In contrast, uptake was about 50% in HICs. Hence, this current review confirms 
the previously described paucity of evidence-based acute stroke care interventions in resource 
poor settings such as Africa [48-50].  
The reviewed studies confirm previously identified improved patient outcomes in other settings 
following stroke unit care [17, 51, 52] and thrombolytic therapy [18, 53-55]. This efficacy 
seems consistent across various country contexts. For example, a reduction of in-patient 
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mortality following stroke unit care in the South African study [42] corroborates with an Indian 
study which also found positive patient outcomes following admission in a stroke unit [51]. 
Further, a Canadian study also found favourable patient outcomes following stroke unit care 
[56]. This retrospective study compared two community hospitals, and found a significant 
reduction in in-patient deaths (17.1% to 8.3%). This study also found a significant reduction in 
length of hospital stay from 12 to 8 days. Comparable to the results of the Cochrane review on 
in-patient care in a stroke unit [17], the present review confirmed lower in-patient deaths in the 
stroke unit but no reduction in length of hospital stay in the stroke unit.  
In this review, three studies reported improved patient outcomes following thrombolytic 
therapy. The study by de Bryer et al [44] demonstrated a relatively lower SICH and deaths 
following thrombolytic therapy, consistent with studies in India [57, 58] and Vietnam [53], as 
well as some HICs including Western Europe [59] and Australia [60, 61]. Similar positive 
findings have been reported previously in randomised control trials [18, 19]. In combination, 
such findings show that thrombolytic therapy can generate optimal patient outcomes in Africa. 
It is thus imperative for policy makers to increase efforts to upscale the use of thrombolytic 
therapy in hospital settings to reduce the current disproportionately high stroke burden in 
Africa. Previous work has identified some potential barriers to the use of thrombolysis in Africa 
and developing countries in general. According to some authors [34, 62], potential barriers 
such as patient late arrival for care in a hospital setting, lack of specialist stroke care 
professionals and inadequate medical facilities such as CT brain scanning services provide 
specific targets for policy makers. 
Althought this review did not find studies on aspirin therapy, its low cost and ease of 
administration [62-64] are likely drivers for its widespread use for acute ischemic stroke care 
across hospital settings in Africa. The present review did not find any eligible study on the use 
of decompressive surgery in the region. However, studies in Nigeria which were excluded 
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because the cases were non-stroke patients did report such intervention [65, 66], suggesting 
that such interventions may be routine in Africa for acute stroke care but not yet reported in 
the literature .  
Implications for practice, policy and future research 
Stroke is a major public health problem in Africa and current evidence suggest its incidence 
will rise further. It is therefore important to ensure unimpeded access to standardised acute 
stroke care in hospital settings. The evidence from this review suggests a likely limited 
availability of ‘best practice’ interventions for acute stroke care across Africa. The current 
scarcity of evidence may be due to relatively increased attention on stroke prevention rather 
than treatment. 
As noted previously, although multiple barriers such as limited stroke care specialists, patient 
delay in seeking care or limited access to brain scanning services may account for the low 
application of evidence-based acute stroke interventions such as thrombolysis, the most 
important barrier may be its cost [50]. This has been demonstrated by a study in Congo where 
eligible stroke patients could not afford the treatment [67]. Additionally, a feasibility study on 
thrombolysis provision has been conducted in Senegal [68], suggesting acute stroke patients 
can be treated with standard acute stroke care in Africa. However, factors such as limited health 
resources and cost need to be considered.  
As there is an urgent global need to translate research evidence to community uptake and policy 
reform [69], the limited evidence evaluating the effectiveness of  stroke unit care in this review 
requires policy attention. This relatively lower uptake in LMIC compared to HIC [49] may be 
a function the limited resources characteristic of most health systems in resource poor settings. 
One study in Africa which was excluded on the basis of lack of access to a full text reported 
improved clinical outcomes following multidisciplinary stroke team care in a Nigerian stroke 
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unit [70]. The study reported consistent reductions in annual mortality since the introduction 
of the stroke unit, thus demonstrating that if more policy support is provided for intervention 
uptake, improved patient outcomes could be realised.  
This review also revealed three studies which confirmed the safety and efficacy of thrombolytic 
therapy (t-PA). Despite persistent questions about its safety, thrombolytic therapy is recognised 
internationally as a highly effective pharmacological therapy for acute ischemic stroke cases. 
Yet, this review indicated that uptake was limited. Within the context of Africa where resources 
to support the health system are often inadequate, affecting access to t-PA which requires 
administration by specialised stroke physicians and nurses. Patient inability to pay for t-PA 
[62, 71] and late patient arrival are other major barriers to accessing t-PA [62, 72]. The 
availability of dedicated stroke units and brain CT scan services facilitate the administration of 
t-PA and thus are integral to ensuring optimal delivery of t-PA. The availability of decision-
making tools, such as the SITS-SICH and SEDAN scores for assessing SICH [43] can support 
healthcare staff in evaluating the risk-benefit in relation to the selection of eligible patients for 
t-PA. 
Overall, the paucity of studies identified in this review suggests a wide evidence-practice gap 
within the context of acute stroke treatment and management across the African region. 
Although a recent study illuminated the potential reasons for such under-utilization, it is 
important to review this within the broader context of the existing constraints to optimal 
healthcare delivery in Africa. The widespread development and provision of stroke unit care 
across Africa requires major health policy, with consequent budgetary requirements. Within 
this context, this review emphasises the need to review the applicability and context-
appropriateness of current interventions for acute stroke care. This is necessary because the 
clinical trials which concluded on the efficacy of the current interventions were predominantly 
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from HICs and thus, their applicability to African settings remain unclear. This situation 
necessitates further research on potential adaptation of best practice for resource-poor settings.  
Increased patient access to brain imaging services such as CT and MRI scans could optimise 
the benefits of aspirin towards the treatment of acute stroke and prevention of recurrent stroke. 
In Africa, access to brain scanning services is limited due to service availability and cost to 
patients [34]. Subsidies addressing these issues are a potential policy pathway to enhance 
access and availability. Centralisation of standard acute stroke care services may also be 
feasible in LMIC as a short term measure. Centralised stroke care services involve rerouting 
and transferring suspected stroke cases to a specialist referral centre, often a tertiary hospital 
and well-equipped to provide specialist care. This will replace the current practice of 
transporting and admitting stroke suspected cases to the nearest hospital. This is important 
given the under-funded nature of the existing healthcare systems to be able to resource most 
hospitals with adequate facilities to provide standard acute stroke care. Research in HIC 
suggests that this method can improve access to standard care for acute stroke patients resulting 
in reduction in mortality and length of hospital stay [73-76]. Low cost acute stroke 
interventions such as tenectoplase may be a potential alternative and could also be explored 
due to the high cost of thrombolysis. Although more evidence on the safety and efficacy of 
tenectoplase is needed, advocating for the use of such cost-effective and low-level evidence 
interventions could contribute to strategies to minimise the current rise in the global stroke 
burden in Africa and other LMIC regions.  
The limited eligible studies and low methodological quality of the eligible studies in this review 
indicates a need for further research, particularly for prospective studies such as randomised 
control studies, to provide a clearer understanding of the effects of current interventions for 
acute stroke management on patient outcomes. The limited funds to support such research 
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studies in LMICs such as those in Africa could impede such efforts. In particular, there is a 
need for information on the factors influencing the low application of such acute stroke care 
interventions in resource poor settings such as Africa, particularly from the perspectives of 
stroke care practitioners, patients, health managers or from health policy makers. 
Study Limitations and Strengths  
The limited number of eligible studies in this review provide only a small evidential base. This 
may reflect the limited research on evidence-based acute stroke care interventions in Africa. It 
seems likely that informative research, yet unpublished, is underway currently, for example in 
Ghana [6], Congo [71], Morocco [45], Nigeria [77] and Egypt [78], indicating further emerging 
evidence of the availability of stroke unit care in hospital settings. Further, the quality of 
evidence from the included studies is low as the studies were non-experimental, non-
randomised and did not control for confounding covariates. The low ranking of studies in the 
evidence classification also limited the strength of evidence. Another limitation worth noting 
is the small sample size in each of the eligible studies.  This inherently compromises the 
statistical power of the studies to report accurate and precise differences and effects between 
acute stroke care interventions. Finally, it is possible the evidence reported in this review may 
have suffered from publication bias, arising from the publication of only significant results. 
Despite the above limitations, to our knowledge, this represents the first systematic review on 
evidence-based acute stroke interventions and their effects on patient outcomes in the African 
region. Thus, the findings provide information with the potential to inform health policy makers 
in developing interventions in the future to optimise patient outcomes.  
Conclusion 
Despite the limited studies on current evidence-based acute stroke care interventions in Africa, 
this review highlights improved patient outcomes, hence the need for policy support to 
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routinize current best practice interventions for acute stroke care. However, because eligible 
studies were limited and had some methodological weakness, more definitive conclusions 
require further research which focuses on strong methodological procedures, primarily 
randomised control trials, to better understand the efficacy of contemporary acute stroke care 
interventions in the African region.  
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Supplementary File 1: Medline Search Strategy 
Search Query 
1 
(Stroke) OR (Acute Stroke) OR (Cerebrovascular Disease) OR (Cerebrovascular Accident) OR (CVA) OR 
(Brain Attack) OR (Cerebral Infarction) OR (Lacunar ) OR (Chronic Stroke ) OR (Neurological Disorder) 
OR (Brain Tumour) OR (Brain Accident) OR (Brain Vascular Accident) OR (Cerebral Vascular Accident) 
OR ( Cerebrovascular Trauma) OR  (Cerebrovascular Injury ) OR (Cerebral Infarction) 
2 
(Stroke unit) OR (Organised Stroke Care) OR (Stroke Ward) OR (Organised In-patient care) OR (Organized 
Stroke Care) OR (Organised Care) OR (Comprehensive stroke unit) OR (Stroke Service) OR (Rehabilitation 
Stroke Unit) OR (Multidisciplinary Stroke Care) OR (Multidisciplinary Stroke Team) OR (Stroke Treatment 
Team) OR (Stroke Management Team) 
3 
(Aspirin) OR (Antiplatelet) OR (Fibrinolytic Agents) OR (Acetylsalicylic Acid) OR  (Antithrombocytic 
Agent) 
4 
(Thrombolytic Therapy) OR (Intravenous fibrinolysis) OR (Tissue Plasminogen Activator) OR (t-PA) OR 
(rt-PA) OR (Alteplase ) OR (Thrombolysis) OR (Intravenous IV thrombolysis) OR (Blood Clot Lysis) OR  
(Fibrinolytic Therapy) 
5 
 (Decompressive Hemicraniectomy) OR (Craniectomy) OR (Decompressive Surgery) OR (Neuroprotective 
therapy) OR (Vascular Surgery) OR (Neurosurgery) OR (Decompression Surgery) 
6 
(Endovascular Therapy) OR (Endovascular) OR (Thrombectomy) OR (Stent Retriever Thrombectomy) OR 
(Tenecteplase) OR (Interventional Acute Treatment) OR (Neuro-interventional Management)  OR (Brain 
Treatment ) OR (Brain Management) OR (Acute Stroke Treatment) OR (Stroke Treatment ) OR (Stroke 
Management) OR (Acute Stroke Management) 
7 
(Developing countr*) OR (Low income countr*) OR (Low-middle income countr*) OR (Middle income 
countr*) OR (Africa) OR (Africa South of the Sahara) OR (Sub-Saharan Africa ) OR (Central Africa) OR 
(Southern Africa) OR (Northern Africa) OR (Eastern Africa ) OR (Western Sahara) OR (East Africa ) OR 
(Central African Republic ) OR (West Africa ) OR (Morocco) OR (Libya) OR (Cameroon) OR (Chad) OR 
(Algeria) OR (Congo) OR (Democratic Republic of Congo) OR (Congo, Demographic Republic) OR 
(Congo, Republic) OR (Equatorial Guinea) OR (Gabon) OR (Burundi) OR (Djibouti) OR (Eritrea ) OR 
(Ethiopia ) OR (Egypt) OR (Kenya) OR (Rwanda) OR (Somalia) OR (Sudan) OR (Tanzania) OR (Tunisia) 
OR (Uganda) OR (Angola) OR (Botswana) OR (Lesotho) OR (Malawi) OR (Mozambique) OR (Namibia) 
OR (Swaziland) OR (Zambia) OR (Zimbabwe) OR (Benin) OR (Burkina Faso) OR (Cape Verde) OR (Cote 
D'ivoire) OR (Gambia) OR (Gambia, The) OR (Ghana) OR (Guinea) OR (Guinea-Bissau) OR (Liberia) OR 
(Mali) OR (Mauritania) OR (Niger) OR (Nigeria) OR (Senegal) OR (Sierra Leone) OR (Togo) OR (South 
Sudan) OR (Madagascar) OR (Comoros) OR (Mauritius) OR (Sao Tome and Principe) OR (Seychelles) OR 
(South Africa) 
8 2 OR 3 OR 4 OR 5 OR 6 
9 1 AND 7 AND 8 
Limiters 
Full Text 
English  and French Languages 
Academic Journals 
Humans  
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2.2 Overview and rationale 
In order to put in context the potential reasons underpinning the limited application of 
evidence-based interventions for acute stroke care, the second systematic review which took a 
global scope, explored the barriers and enablers inhibiting stroke care professionals’ ability to 
provide evidence-based acute stroke care interventions and therapies (aspirin, thrombolysis 
using t-PA, multidisciplinary care in a stroke unit and decompressive surgery). Overall, this 
review shed light on multiple barriers inhibiting the provision of evidence-based care for acute 
stroke patients. However, the studies predominantly revealed barriers militating against the 
uptake of thrombolysis. In addition, this review did not locate any relevant studies within the 
context of LMICs, Ghana in this context, to help clarify the main reasons for the inadequate 
and much lower uptake levels of such best practice interventions/services for acute stroke care. 
Evidence of these barriers were reported from only HICs thus, leaving a gap in our 
understanding of the factors accounting for the low uptake of these interventions in Ghana and 
most of LMICs.  Section B of this chapter thus reports the findings of this review. 
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Background: Adoption of contemporary evidence-based guidelines for acute stroke management is often delayed
due to a range of key enablers and barriers. Recent reviews on such barriers focus mainly on specific acute stroke
therapies or generalised stroke care guidelines. This review examined the overall barriers and enablers, as perceived
by health professionals which affect how evidence-based practice guidelines (stroke unit care, thrombolysis
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countries are needed to understand the barriers and enablers in such settings.
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Background
Translation of research evidence into clinical practice is
a major imperative for health professionals in policy,
management and research, worldwide. It is almost half a
century since Cochrane challenged conventional health
care practices which consequently paved the way for the
present day evidence-based practice movement in medi-
cine and health care [1]. Nonetheless, routine clinical
practice still lags behind contemporary research evi-
dence [2–4], despite international calls for research
evidence to guide healthcare delivery [5]. Globally, there
is no single solution to closing this knowledge to prac-
tice gap [4, 6, 7]. In general, it has been estimated to
take about 17 years for research evidence to be trans-
lated into clinical practice [8]. Delays in the adoption of
evidence-based practice could be attributed to a multi-
plicity of barriers [9–12] underpinned by a plethora of
theoretical and conceptual perspectives [2, 3, 13, 14],
which have emerged to shed light on these barriers or
enablers.
Stroke is caused by an interruption or blockage in
blood supply or arterial bleeding into or around the
brain [15, 16]. The early stages (first 48 h) of an acute
stroke are a critical time-window for appropriate inter-
ventions to either stop or slow down brain tissue decay
and minimise mortality and morbidity [17]. To provide
acute stroke care in the early stages, current recommen-
dations from Level-1 evidence for best practice include
(1) stroke care in a specialist stroke unit [18, 19], (2)
thrombolytic therapy with intravenous tissue plasmino-
gen activator (t-PA) within 4.5 h of an acute ischemic
stroke [20–22], (3) aspirin administration within 48 h of
acute ischemic stroke onset [23–25] and (4) decom-
pressive surgery if required within 48 h of stroke onset
[26, 27]. The use of t-PA for example is the most effect-
ive pharmacological therapy for acute ischemic stroke
despite the persistence of controversies surrounding its
usage. First reported by the National Institute of Neuro-
logical Disorders and Stroke (NINDS) trials with a treat-
ment window of 3 h [22], a later trial extended the
treatment time to 4.5 h upon acute ischemic stroke [21].
Given such evidence consistently showed sound clinical
outcomes over time, clinical guidelines have been devel-
oped and continually updated to support the application
of these interventions for improved patient outcomes
[28–34]. However, despite this scientific evidence and in-
creased support for their usage, translation into clinical
practice is slow, and this is greatest in low–middle in-
come countries [35–37]. For example, despite the net
benefits associated with thrombolytic therapy for acute
ischemic stroke, global uptake in low-income countries
is about 3% compared to 50% in high-income countries
[35]. A recent survey of acute stroke services in eleven
major referral hospitals in Ghana also revealed the lack
of use of t-PA for acute ischemic stroke care and the
availability of only one stroke unit [38].
The reasons for the slow uptake remains poorly under-
stood. Some studies have however attempted to shed light
on such barriers, and these comprised inadequate medical
facilities for acute stroke care, health professionals’ un-
willingness for change, unawareness of evidence-based
therapies, lack of health professionals’ competence to
apply evidence-based therapies, limited staff capacity
and decision-makers’ values and preferences could be
attributed for the slow uptake [39–46]. Such barriers
have resulted in the underutilisation of best practice in-
terventions towards positive clinical outcomes. The re-
cent Lancet series on Right Care [47], which seeks
among others, to highlight the chronic underutilization
of evidence-based interventions further underscores the
centrality of this review.
To date, no study has attempted to systematically ana-
lyse published primary studies on the barriers and en-
ablers perceived by health care professionals to influence
the adoption of these four highly recommended acute
stroke therapies or services. Prior studies on this topic
were either limited in focus by only unilaterally explor-
ing barriers related to the use of t-PA [41, 42, 44], neu-
roprotective therapy [45] or generalised acute stroke
care guidelines [40]. A recent study by Craig et al. has
also attempted to examine some of these barriers and
enablers [48], though an important contribution, a dif-
ferent theoretical framework was used, and focused
more on clinical behavioural components.
Our aim in this review was to identify health profes-
sionals’ views on the barriers and enablers to their use of
the above recommended evidence-based acute stroke
care interventions. An understanding of these barriers
and enablers is important towards closing the current
knowledge to practice gap in stroke clinical practice.
With the increasing stroke burden in low–middle income
regions in recent times [49–51] and where uptake levels
of such interventions are presently lowest, a clearer under-
standing of barriers and enablers, primarily from such re-
gions may also be essential in developing context-specific
strategies to optimise uptake of evidence-based acute
stroke care recommendations in clinical practice to
improve patient outcomes.
Methods
This review was conducted according to the Preferred
Reporting Item for Systematic Reviews and Meta-
Analysis (PRISMA) systematic review approach [52], as
outlined in Additional file 1. The review protocol was
registered in the international prospective register of
systematic reviews, PROSPERO 2015 (Registration
Number: CRD42015023481).
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Eligibility criteria
Studies based on the views of stroke specialists, medical
doctors, nurses and allied health professionals were
considered. Other health professionals including health
managers, health planners, health policy-makers or any
health executives’ about barriers or enablers to the up-
take of evidence-based acute stroke care were included.
For inclusion, interventions for evidence-based acute
stroke care were restricted to barriers or enablers in re-
lation to the provision of care in a stroke unit, thrombo-
lytic therapy, the use of aspirin and decompressive
surgery. Peer-reviewed articles of any study design were
considered. Barriers and enablers based on database re-
cords were excluded. Included studies were based only on
the views, opinions and experiences of the health profes-
sionals. Non-original research such as letters, commentar-
ies, guidelines, magazines and editorials were excluded.
Research studies with non-human components were also
not considered.
Search strategy
A systematic search of the literature was conducted
electronically using MEDLINE, CINAHL, Embase, Psy-
cINFO, Cochrane Library and AMED. Reference lists
and bibliographies from eligible studies published from
1990 to 2016 were also considered for inclusion. The
review considered studies published within this time
duration to correspond with the period when evidence-
based medicine movement and scholarship enjoyed
renewed interest and acknowledgement [53]. This was
also done to ensure included studies reflect current evi-
dence of health professionals’ views on what acts as a
barrier or an enabler to their uptake or adherence to
evidence-based practice for acute stroke care. Due to
lack of resources for language translation, all included
studies were limited to studies published in English lan-
guage. Search strings were designed to reflect related
Medical Subject Heading (MeSH) terms, key terms
and phrases from the selected databases related to
the review aim. Details of the search terms used are
presented in Additional file 2.
Study selection
Results were downloaded and imported into EndNote
for screening to first remove duplicates by one author
(LB). The next stage involved the screening of the
remaining studies based on the relevance of study titles
and abstracts to the review aim. When articles had in-
sufficient information in the title and abstract to support
this screening, a full-text reading was conducted. This
was followed by the selection of all potentially eligible
studies in full text. A second author (SS) reviewed the
selected full-text articles to ensure they met the eligibil-
ity criteria. Results of the full text were also shared with
the remaining authors to validate, and none of the
authors raised questions about their eligibility. Articles
which met the inclusion criteria following full-text
screening by two authors (LB and SS) were selected for
the final analysis.
Data extraction
A standardised data extraction tool (evidence table) was
used to extract information relevant to the study aim by
one author (LB). As shown in Table 1, the information
extracted include the authors and year of publication,
country of study, intervention, study aim, design, partici-
pants/sample, data collection methods and key findings
on the barriers and enablers to uptake of acute stroke
care interventions. This was systematically done to en-
sure extracted data characteristics from the eligible stud-
ies were consistent. The key findings and conclusions of
the eligible studies which were reported as either bar-
riers, enablers or barriers and enablers were identified by
one author (LB). These findings were shared with the
remaining reviewers to ensure consistency with the
primary studies.
Data synthesis
Data analysis involved a thematic analysis of the results
from the eligible studies. Based on the Tailored Imple-
mentation for Chronic Diseases project [54], a pre-
existing framework of seven domains developed by
implementation science researchers to examine what in-
forms change in clinical practice [55] was followed to
categorise the themes of barriers and enablers. The
checklist of seven domains comprised guideline factors,
individual health professionals’ factors, patient factors,
professional interactions, incentives and resources, cap-
acity for organisational change, and social, political and
legal affairs. Additional file 3 provides further explan-
ation of each domain. This process was done by one re-
viewer (LB) who is experienced in categorising themes
using pre-existing frameworks. This was done with con-
stant reference to the content of the pre-existing frame-
work and identified barriers and enablers from the
articles to ensure appropriate classification. Another re-
viewer (SS) validated the classification of the barriers
and enablers (See Table 2), and one disagreement was
recorded during this stage but was quickly resolved in
consultation with another author (AdGA). One author
(LB) consequently weighted each domain of barriers/en-
ablers in a tabular form (See Table 3) according to the
frequency of each barrier or enabler as reported in the
articles.
Assessment of methodological quality
To capture the unique reporting differences within
qualitative and quantitative studies, two separate quality
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reporting assessment tools were used. The checklist by
the Joanna Briggs Institute for assessing qualitative stud-
ies was used for the qualitative studies [56], while the
guidelines suggested by the Centre for Evidence-Based
Management to appraise surveys was also used for the
quantitative studies [57]. These checklists were used be-
cause they have comprehensively clear score sheets and
instructions which enabled the authors to assess the
relevance and rigour of all included studies. Given that
there is still lack of consensus on the criteria for asses-
sing the quality of qualitative studies in systematic re-
views [58, 59]; included qualitative studies were not
based on their quality scoring but on the basis of their
overall contribution to the synthesis rigour. One re-
viewer (LB) appraised the quality of included studies.
Another reviewer (SS) carried out a separate rating and
slight variations were observed. However, these differ-
ences were quickly addressed by the two reviewers.
Results
Study selection
The electronic search yielded 9832 studies [MEDLINE=2518,
CINAHL = 458, AMED = 221, PscINFO = 1229, Embase
= 873, Cochrane Library = 4507 and 26 additional stud-
ies retrieved from other sources]. After removing 1386
duplicates, 8446 studies remained. Screening based on
title and abstract relevance excluded 8263 and 81arti-
cles, respectively. Studies excluded at this stage were
either due to the fact that they were not primary
studies, had irrelevant topics, that is, not focused on
barriers and enablers to the four recommended evidence-
based stroke care interventions. Other reasons for exclu-
sion include duplicate studies, letters and editorials. A
full-text screening of the remaining 102 potentially eligible
studies led to further exclusions of 92 studies as they were
deemed irrelevant to the study aim, focused on different
population of interest, included review papers, guidelines
and case reports. Overall, 10 studies met the inclusion
criteria (See Fig. 1).
Study characteristics
Three qualitative [60–62] and seven quantitative studies
[63–69] were included. Quantitative studies employed
online and postal surveys while the qualitative studies
used semi-structured interviews and focus group
methods. Whereas analysis of the quantitative studies
was conducted using predominantly descriptive statis-
tics, thematic analysis guided the analyses of the qualita-
tive studies. The total number of included participants
was 1692, and these comprised nurses, general medical
doctors, neurologists, emergency department physicians,
allied health staff and health managers. Included studies
were published between 2004 and 2015. Four studies
were conducted in Australia [62, 64, 66, 69], three in the
USA [60, 63, 65], two in Sweden [61, 67], and one each
in Norway [67], Denmark [67] and the Netherlands [68].
Most of the barriers or enablers identified in the quanti-
tative studies were also found in the qualitative studies.
Studies predominantly examined the barriers or enablers
to the use of thrombolysis [60, 61, 63–65, 67, 69]. One
study focused exclusively on barriers related to the estab-
lishment of a stroke unit [66], another on the uptake of
both aspirin and thrombolysis [68] and the remaining on
stroke unit and thrombolysis [62]. Although most of the
eligible studies focused on barriers related to the use of
evidence-based care for acute stroke, all included studies
reported on three or more related barriers or enablers
(See Table 1 for additional information).
Table 2 Domain of barriers or enablers to evidence uptake
Author and year Stroke therapy
or intervention
Guideline
factors
Individual health
professionals
Patient
factors
Professional
interactions
Incentives and
resources
Capacity for
organisational
change
Social, political
and legal factors
O’Rourke (2013) [66] Stroke unit x x x x
Grady (2014) [64] Thrombolysis x x x
William (2013) [69] Thrombolysis x x x x
Van Der (2004) [68] Aspirin and thrombolysis x x x x x
Slot (2009) [67] Thrombolysis x x x x x
Meurer (2011) [60] Thrombolysis x x x x x
Purvis (2014) [62] Stroke unit and
thrombolysis
x x x x x x
Stecksén (2013) [61] x x x x x
Hargis (2015) [65] Thrombolysis x x x x x x
Chan (2005) [63] Thrombolysis x x x x
X indicates a particular thematic barrier or enabler reported by the author (s)
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Quality assessment
The overall quality of the quantitative studies was
moderate given that certain methodological limita-
tions were found in the eligible studies. Only one
study described in detail the sampling of study sub-
jects and employed sampling techniques to minimise
selection bias [69]. However, the rest of the cross sec-
tional studies did not include substantive information
on sampling techniques used to minimise selection
bias. Three of the eligible studies reported high re-
sponse rates of 91 [63], 92 [67] and 95.8% [66]. Con-
versely, low response rates of 13 [64] and 26% [69]
were also noted. Details of quality of reporting evalu-
ations are presented in Table 4.
On the other hand, none one of the eligible qualitative
studies reported on theoretical or philosophical bases for
methodological choice, limiting the ability to situate and
assess methodological relevance. However, there was a
common approach to the reporting of specific data col-
lection and the analysis process. However, none of the
studies reported on how the philosophical paradigm in-
fluenced data analysis and interpretation. All qualitative
studies adequately described how interviews were
conducted, although no assessment data trustworthiness
through triangulation or member checking was reported.
Finally, two of the qualitative studies [48, 62] addressed
the issue of reflexivity, that is, potential reporting bias
related to the researcher’s professional background or
areas of interest.
Synthesis of results
Summary of evidence: main barriers and enablers to
evidence uptake
Overall, four studies reported on both barriers and en-
ablers to uptake of evidence-based acute stroke therapies
[61, 62, 66, 69] whilst five reported on only barriers to
evidence uptake [60, 63, 65, 67, 67] and one study had
an explicit focus on enablers to uptake of evidence-
based care for acute stroke [63]. Despite some studies
reporting on both barriers and enablers, studies which
focused only on barriers often made reference to or
inferred enablers as the opposite of the barriers, an ap-
proach that has been adopted in the present review.
Thus, barriers and enablers were analysed and discussed
collectively. As reported below, Table 3 shows the
Fig. 1 Flow chart on selection and screening process for eligible studies using the PRISMA methods
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distribution and weighted frequency of each barrier
which provides information on the potential significance
of each barrier and enabler to the uptake of the four rec-
ommended acute stroke care interventions.
Capacity for organisational change
This category of barriers/enablers was the most highly
cited by participants in all the eligible studies. According
to the health professionals, the use of evidence-based
care could be challenged by lack of institutional support
[61]. They further highlighted limited health staff cap-
acity especially lack of a stroke nurse or specialist [60,
62, 65] and inadequate funding opportunities for staff
professional development [62, 64]. For example, partici-
pants reported that some hospitals were unable to
provide or formalise acute stroke care guidelines to
facilitate health staff use of evidence-based therapies
[60, 69]. Additionally, instances were cited where
there was limited or no executive support for professional
development or upgrading to deliver current therapies for
acute stroke according to best scientific evidence [62]. Of
the varied barriers reported under this category, workload
demands were also commonly cited as a key hindrance to
the implementation of evidence-based acute stroke care
[60, 62, 67]. In one study [69], 71% of participants indi-
cated lack of protocols and pathways. The study by Van
der Weijden et al. identified organisational level barriers
as the most significant barriers to uptake of evidence-
based practice [68].
Individual health professionals
Individual health professionals’ factors were reported by
participants as important barriers/enablers from the eli-
gible studies. This domain of barriers was found in nine
included studies [60–65, 67–69]. In the views of most
participants, uptake of evidence-based interventions
such as thrombolytic therapy is slow or not happening
due to health professional’s lack of awareness of a
particular intervention [60, 61, 68, 69], lack of skills or
self-efficacy to apply the intervention [60, 61, 68] or low
motivation to implement an evidence-based therapy
[60]. For example, in one study, 50% of participants indi-
cated their lack of knowledge on the use of thrombolytic
therapy hampered uptake in their routine clinical
practice [60]. They also outlined barriers such as old-
fashioned views about some specific acute stroke therap-
ies [61]. Further, one study [63] reported that some
neurologists disapprove of the use of thrombolytic ther-
apy, which was agreed by (33%) of respondents.
Resources and incentives
This was another major domain of barriers or enablers
to evidence uptake for acute stroke care. A total of eight
of ten eligible studies identified resources and incentives
related barriers/enablers as crucial to evidence uptake
[60–63, 65–68]. Some of the common barriers/enablers
comprised limited physical space to establish stroke
units [66], lack of CT scans [63], lack of financial re-
sources [61, 62, 66, 68], limited time [61, 66], limited
stroke beds [62, 66] and limited staff capacity [61–63,
66, 68]. These factors were common in both qualitative
and quantitative studies in this review.
Guidelines factors
The present review has shown the nature and character-
istics of specific evidence-based therapies for acute
stroke could influence their levels of uptake. Nine of ten
eligible studies reported barriers related to the character-
istics or the nature of evidence related to the stroke
intervention or guidelines [60–63, 65–69]. Views related
more to health professionals’ misconceptions about the
level of effectiveness of some acute stroke care therapies
such as thrombolysis. For example, despite evidence that
the benefits of thrombolysis outweigh potential associ-
ated side effects, participants expressed doubts in the
effectiveness of this therapy because they were con-
cerned about severe bleeding and other complications.
In one study [69], 73% of respondents indicated risk of
symptomatic intracerebral haemorrhage as a key barrier
to administering thrombolysis. In another study [63],
33% of the participants expressed uncertainty about the
evidence of using thrombolytic therapy for acute ische-
mic stroke and recommended the need for further
studies for definitive evidence of its efficacy before they
would use it for patient care. Disagreement on the rec-
ommended dosage for aspirin was also highlighted by
participants in one study [68].
Patient factors
Within this domain of barriers and enablers, six studies
highlighted factors such as late arrival to seek care, pa-
tients’ or relatives’ lack of awareness of early stroke
symptoms or patients’ decision for other acute care in-
terventions outside the standardised recommendation
Table 3 Barriers and enablers to evidence-based acute stroke
care
Domain of barriers and enablers Frequency (%)
Guideline factors 16 (10.38%)
Individual health professionals 39 (25.32%)
Patient factors 15 (9.74%)
Professional interactions 10 (6.49%)
Incentives and resources 17 (11.03%)
Capacity for organisational change 57 (37.01%)
Social, political and legal factors 0 (0.0%)
Note: The weighted frequency was calculated based on the number of times a
particular barrier or enabler was reported in the eligible studies
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[60, 62, 66, 67–69]. The most frequently reported
patient-related barrier was patients’ late arrival in emer-
gency departments to receive thrombolysis. For example,
one study [69] reported that 91% of respondents
indicated patients’ late arrival for acute care as the major
barrier. Another study ranked delayed patient
presentation for care as the major barrier to the use of
thrombolytic therapy [65] due to the patients’ failure to
recognise stroke symptoms. Another key barrier was
patients’ preference for the non-use of thrombolysis as
a therapeutic option due to perceived side-effects of
this treatment option [67].
Table 4 Critical appraisal of eligible studies
Appraisal questions for survey O’Rourke
(2013) [66]
William
(2013) [69]
Van Der Weijden
(2004) [67]
Grady
(2014) [64]
Hargis
(2015) [65]
Chan
(2005) [63]
Slot
(2009)
[67]
1 Did the study address a clearly focused question/issue? Y Y Y Y Y Y Y
2 Is the research method (study design) appropriate for
answering the research question?
Y Y Y Y Y Y Y
3 Is the method of selection of the subjects (employees,
teams, divisions, organisations) clearly described?
U Y Y Y Y N Y
4 Could the way the sample was obtained introduce
(selection) bias?
N N N N U N N
5 Was the sample of subjects representative with regard
to the population to which the findings will be referred?
N N N Y N N Y
6 Was the sample size based on pre-study considerations
of statistical power?
N Y Y N N N N
7 Was a satisfactory response rate achieved? Y N N N Y Y Y
8 Are the measurements (questionnaires) likely to be
valid and reliable?
N Y N Y N N N
9 Was the statistical significance assessed? N N N Y N N N
10 Are confidence intervals given for the main results? N N Y N N N N
11 Could there be confounding factors that haven’t
been accounted for?
N N N N N N U
12 Can the results be applied to your organisation? N U U N N N Y
Yes (Y), Can’t Tell (U) and NO (N)
Critical Appraisal Questions for Qualitative Studies Meurer
(2011) [60]
Purvis
(2014) [62]
Stecksén (2013)
[61]
1 Is there a congruity between the stated philosophical
perspective and the research methodology?
N N N
2 Is there a congruity between the research methodology
and the research question or objectives?
Y Y Y
3 Is there a congruity between the research methodology
and the methods used to collect the data?
Y Y Y
4 Is there a congruity between the research methodology
and the representation and analysis of data?
Y Y Y
5 Is there a congruity between the research methodology
and the interpretation of results?
Y Y Y
6 Is there a statement locating the researcher culturally
or theoretically?
Y Y N
7 Is the influence of the researcher on the research and
vice versa addressed?
U Y U
8 Are participants, and their voices, adequately
represented?
Y Y N
9 Is the research ethical according to current criteria or, for
recent studies, is there evidence of ethical approval by
an appropriate body?
Y Y Y
10 Do the conclusions drawn in the research report flow
from the analysis, or interpretation, of the data?
Y Y Y
Yes (Y) No (N) Unclear (U) Not Applicable (NA)
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Professional interactions
The uptake of evidence-based care for acute stroke can
also be influenced by the form and nature of interactions
among health professionals, especially engagement with
clinical leaders. Five studies showed evidence of this do-
main of barriers/enablers [61, 62, 64–66]. The present
review found this as among the least described barriers/
enablers in the included studies. Barriers suggested by
participants included: inadequate communication espe-
cially among clinical staff [65], lack of clinical leadership
or support from senior clinicians [62]. As an example,
Hargis et al. reported that 14% of respondents cited poor
communication between emergency department staff,
and the neurology team affected the use of thrombolytic
therapy [65].
Discussion
This review aimed to explore the main barriers/enablers
underlying adoption of evidence-based therapies for
treatment and management of acute stroke. To date,
prior studies have focused largely on barriers or enablers
to generalised acute stroke guidelines or thrombolysis spe-
cifically. This review addressed a knowledge gap on the
main barriers or enablers to the uptake of the four recom-
mended evidence-based therapies/service for acute stroke,
namely, stroke unit care, thrombolytic therapy, aspirin
and decompressive surgery.
The specific innovations of this review are its primary
focus on the four recommended evidence-based therap-
ies for acute stroke care and the inclusion of both quan-
titative and qualitative study designs, both of which add
depth to the analysis. Although this review was limited
to ten eligible studies, there seems to be a saturation of
potential determinants given the commonality and re-
currence of barriers and enablers revealed between stud-
ies. There was also a significant overlap in the reported
barriers or enablers, although these characterisations
differed between health professionals. Findings from
prior reviews on barriers to thrombolysis uptake [41, 44,
45, 70], other studies on the barriers and enablers to
triaging, treatment and patients’ transfer in emergency
departments (ED) [48] and adherence to general stroke
clinical guidelines [40], corroborated with majority of
the barriers/enablers identified in this review.
On the most important barriers or enablers from the
present review, organisational context or structural level
factors were the most cited barriers or enablers to uptake
of evidence-based care for acute stroke by health profes-
sionals. This finding substantiates the results of earlier
works [9, 41, 70]. Given the importance attached to this
category of barriers and as reflected in earlier works, a
greater effort to address these barriers should be prioritise
by health managers and planners for optimal uptake of
evidence-based practice. Further, consistent with the
literature [9, 40, 41, 45, 71], the barriers related to the in-
dividual health professional and guideline level barriers,
availability of adequate health resources and medical facil-
ities were also predominant in this review.
The barriers/enablers associated with social, political
and legal factors were not reported by any of the eligible
studies, thus leaving a gap in our understanding of
whether such thematic barriers or enablers play any im-
portant role in evidence-based care uptake. It is plausible
that their influence on evidence-uptake is negligible and
may not warrant immediate attention of health policy-
makers and health managers. The absence of evidence for
this domain of barriers/enablers in this review was also
evident in the checklist employed to contextualise the dis-
cussion in this review. In that review [55], which promul-
gated the checklist, this particular domain attracted the
least eligible studies.
Importantly, the eligible studies were all conducted in
high-income countries and so the findings may not be dir-
ectly relevant to those in low–middle income countries.
The inadequacy of medical facilities, limited health staff
capacity and other health resource constraints charac-
terised in low- and middle-income countries may emerge
as the most important barrier since health systems in
these contexts always have fewer resources overall com-
pared to high-income countries.
This review has also underscored the need for increased
attention on patient level barriers. Specifically, patients’
late arrival in ED settings for care because of lack of rec-
ognition of early stroke symptoms was notable. To ad-
dress the low awareness or lack of early recognition of
stroke symptoms, we recommend the need for increased
public health campaigns and research emphasising the ur-
gent need to seek care at stroke symptom onset, as
highlighted by the ‘time is brain’ research study [72] and
the ‘FAST’ stroke awareness campaign messages in the
UK [73, 74]. The UK FAST stroke awareness campaign
strategy could be a unique exemplar for low- and middle-
income countries where evidence [75–77] suggest low
awareness of stroke symptoms is a major obstacle to care.
With the exception of thrombolytic therapy, the barriers
or enablers on the remaining three evidence-based recom-
mendations were less explored. No studies explored
decompression surgery, although an earlier review sug-
gested patient level barriers as more essential [45]. Other
researchers have cited limited access to computed tomo-
graphic (CT) brain scans in low-middle income as the
most important factors to address to improve uptake of
aspirin therapy [78].
Implications
The analysis from this review may inform the circum-
stances in which health professionals are able to provide
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evidence-based care for acute stroke patients. Despite
the increased scholarship and policy recommendations
for this, the reported barriers or enablers persist, conse-
quently depriving patients of sound and effective therap-
ies. Given that previous evidence suggest, overall, a
significant number of patients receive clinical care with-
out sound scientific evidence [2, 10, 79], these findings
have the potential to contribute to present efforts aimed
at ensuring stroke patients receive effective care.
Increasingly, reports of the rising incidence and mor-
tality rates from stroke in low- and middle-income
countries continue to attract the attention of global
health authorities. Nonetheless, studies thus far have in-
dicated a low uptake of evidence-based care for acute
stroke in Africa and other low/middle income regions
[35, 36]. However, no eligible studies were found in low-
and middle-income countries to improve understanding
about the factors accounting for this apparent gap. It is
essential to explore the barriers or enablers in the
context of Africa and other low- and middle-income
regions to develop context-specific interventions to en-
hance uptake of evidence-based care for acute stroke.
Various health professionals play major primary roles
as acute caregivers and consequently have unique chal-
lenges that deserve attention in future studies since this
review was unable to separate determinants according to
specific health professionals. Future research should en-
deavour to explore the barriers or enablers unique to
stroke specialists, medical doctors, nurses and allied
health staff. As emphasised earlier, identifying the views
of stroke patients and carers on the barriers and enablers
to stroke care should be part of future research efforts.
Strengths and limitations
An important strength of this review is its primary focus
on the four recommended evidence-based care interven-
tions. The inclusion of both quantitative and qualitative
study designs further adds to the analytical breadth and
depth of this review. Nonetheless, this review has some
limitations. First, we acknowledge that since this study
was limited to studies published in English language, there
remains a possibility other relevant studies and insights
from LMIC were missed. Also, the screening process for
eligible studies was conducted by a single author, and this
may have affected the accuracy, reliability and transpar-
ency of the process. Additionally, the search for relevant
studies was limited to only peer-reviewed journals thus
potentially relevant theses, conference presentations and
book chapters were excluded. Although, the reasons for
the lack of studies from low- and middle-income coun-
tries remains unclear, this could be explained by the
prevailing situation of limited international literature on
the uptake of evidence-based acute stroke care interven-
tions from such settings.
The limited number of eligible studies made it impos-
sible to draw definitive conclusions about the primary bar-
riers or enablers to evidence uptake for acute stroke care.
Also, although the present study attempted to rank the
importance of the barriers and enablers based on their
weighted frequencies, this is not optimal. This field is less
developed with currently no time-tested approaches to
qualitatively rate the importance of such drivers to change
in healthcare. Approaches such as the GRADE-CERQual
framework to measure the confidence of synthesised evi-
dence [80] could be explored in similar reviews in future.
As we used a pre-designed taxonomy of barriers and en-
ablers to contextualise our findings, it is possible other
relevant barriers and enablers considered unfit to the
framework were inadvertently missed out.
Conclusions
The reported barriers or enablers mapped well with the
previously proposed taxonomy of barriers or enablers.
Our findings are consistent with previous studies [9, 40]
where lack of adherence to or inadequate use of evidence-
based care was attributed to organisational level factors,
professionals’ lack of awareness and familiarity to a par-
ticular evidence-based care, financial constraints, lack of
confidence in a particular therapy, fear of adverse effects,
personal beliefs, patient delays, lack of time to implement
evidence-based treatment guidelines and preferences or
values about the use of evidence-based care.
Despite considerable effective therapeutic options for
acute stroke care, poor understanding of barriers or en-
ablers and lack of a clear evidence-based health policy to
ensure their uptake render such therapeutic services
underutilised. In light of this, efforts by health managers
and policy-makers to formulate context-specific policies
and design interventions to enhance uptake of evidence-
based care should be informed by these barriers and
enablers. Following this review, we are also proposing
research studies be conducted in low-middle income
countries to enhance our understanding of the key bar-
riers accounting for the currently low uptake levels of
evidence-based acute stroke care interventions.
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CHAPTER THREE 
RESEARCH METHODOLOGY AND DESIGN  
3.0 Introduction 
This section presents an overview of the methodology employed for the thesis. It examines the 
epistemological and philosophical rationales underpinning the different study designs used in 
the thesis. The underlying rationales for the study settings, sampling approaches, participant 
recruitment, data collection and analysis are also described. The section also discusses the 
strengths and limitations of the selected methods used. Overall, this thesis employed three 
different, stand-alone, single but interlinked study designs, a design described by Creswell and 
colleagues as a nested or an embedded mixed methods design [190]. According to Wisdom et 
al [191], this is an advanced form of  a mixed methods research design commonly employed 
in implementation, translation or  dissemination health research projects, hence its application 
in this thesis. The studies comprise: a survey, a retrospective cohort and a qualitative interview 
study. As will be illustrated further below, these study designs draw knowledge from both 
quantitative and qualitative research philosophical paradigms. 
3.1 Philosophical Paradigms in Research  
3.1.1 Quantitative Approach 
According to the quantitative research approach, which is based on the positivist paradigm, the 
main underlying philosophy for quantitative research is the generation of valid knowledge 
subject to  rigorous testing, measurement and replication [192-194]. Postulates of this view 
believe in the existence of objective reality which can be generated, predicted or controlled 
through standardised procedures [193]. The proponents argue for objectivity in the entire 
research process to minimise bias. In this paradigm, knowledge gained from individual’s 
subjective experiences, opinions, interpretation are less appreciated, often described as external 
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and not purely objective [193, 195]. However, in recent times, this paradigm has begun to 
appreciate the value of data from qualitative research inquiry in the testing or generation of 
hypotheses, designing large scale surveys or in researching a topic of which very little 
information is available [196]. Overall, the focus of the quantitative paradigm is situated within 
the context of the natural world [193], unlike the social world of the qualitative research 
approaches.  
3.1.2 Qualitative Approach 
On the other hand, the constructivist paradigm, also known as the interpretivist or naturalist 
paradigm, aligns with qualitative research approaches. Advocates of this paradigm refute the 
existence of total objective knowledge, the supposedly unproblematic nature of reality [193, 
195, 197, 198]. Proponents of this approach believe in the existence of multiple realities and 
argue that the positivist research ideologies are idealistic, explaining that natural science is a 
social process controlled by human beings whose values, subjectivity and biases are not 
detachable from their everyday activities [197-200]. The qualitative research approach 
emphasises the generation of knowledge through negotiation, interpretation of human 
subjective views, and values of individuals [195, 201, 202]. Hence, this provides a contextually 
rich knowledge detached of hard, predictive and objective facts. In fact, the qualitative research 
approach has been increasingly recognised in contributing to the understanding of health and 
health outcomes [192, 203]. This is particularly the case in contemporary public health practice, 
a discipline within which the present thesis is contextualised. 
3.1.3 A Pragmatic Paradigm 
Regardless of which philosophical, epistemological, or methodological standpoints are 
employed in any form of research inquiry, a renewed focus in recent research approaches tend 
to support multiple methods and data sources [204-206]. Indeed, the use of diverse 
methodological approaches in the collection of data for empirical research has been 
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increasingly recognised over the past decade due to the practicality and value-laden nature of 
such an approach [205, 207]. Drawing on the core tenets of quantitative and qualitative 
approaches, the pragmatic approach or pragmatism has now become popular [196]. This 
approach advocates for the use of multiple theories, approaches, methods and data most 
suitable to answer the research questions under investigation [196, 208]. Sale et al [209] argues 
that, despite the diverse epistemological, ontological and methodological standpoints and 
origins of research, in health research, the two traditional research approaches can be 
practically combined to complement each other to optimally and adequately address a 
particular phenomenon of inquiry using different methods to examine different but related 
issues 
Overall, proponents of the pragmatic approach argue that the conduct of research and the 
strategy to employ should not be dogmatically hinged on quantitative or qualitative approaches 
but rather on the basis of the nature and scope of the research, and the data required to 
adequately answer the specific research question(s). This line of thinking resonates with the 
view of Flyvbjerg, that the conduct of research should be underpinned primarily by the research 
problem and not the methodology [210]. This thesis is thus contextualised within the 
epistemological and philosophical standpoints of both quantitative and qualitative research 
methods, known as pragmatism or the pragmatic approach. Therefore, using the, 
complementarity principle in the pragmatic approach, this thesis employed both quantitative 
and qualitative methods to investigate the uptake of evidence-based acute stroke care within 
the Ghanaian context.   
To address the first and second research questions, two quantitative approaches were utilised 
to examine the range of acute stroke care services in the major referral hospitals across Ghana, 
and the extent to which such stroke services translate into optimal clinical outcomes. The 
qualitative aspect on the other hand, sought to explore the practical barriers associated with the 
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provision of acute stroke care. The qualitative approach provided an in-depth understanding of 
the barriers to evidence-based acute stroke care, a phenomenon which cannot be studied 
adequately using only quantitative approaches. In sum, this study was conducted within a 
pragmatic philosophy to provide a more contextualised and complete understanding of the 
knowledge-translation problem. Closely consistent with the recommendation of research 
methodologists on the stages of the research design and processes [193], Figure 1 presents the 
overall research approach showing how the research was conducted. In summary, it describes 
the main stages from planning and design of the study, review of literature, formulation of 
research questions/aims, the selection of study sites, the instrumentation process, data 
collection and analysis. The remaining stage entailed discussion/interpretation of the research 
findings and the writing up of the entire research project/thesis where conclusions and 
recommendations are finally made. 
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Figure 1: Flow chart showing the research process/stages for the thesis 
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3.2 Ethical Considerations 
This research was conducted in accordance with the Helsinki declaration for medical research 
[211]. The following ethical and institutional review committees granted approval for the 
research: Australian Catholic University Human Research Ethics Committee (2015-154H), 
Institutional Review Board of the 37 Military Hospital (37MH-IRB IPN 035/2015) and the 
Ghana Health Service Ethical Review Committee on Research Involving Human Subjects 
(GHS-ERC:11/07/15). Ethical clearance was also obtained from the Committee on Human 
Research Publications and Ethics of the School of Medical Sciences of the Kwame Nkrumah 
University of Science and Technology and the Komfo Anokye Teaching Hospital 
(CHRPE/AP/141/16). All data from the research were reported in an aggregated form to 
guarantee confidentiality and anonymity of participants and hospitals.  
Written consent was obtained from all participants prior to data collection. Two signed copies 
of the consent form was obtained, one for the participant, and the other for the researcher. In 
addition, all participants were provided with the research information sheet which outlined the 
main study purpose, associated benefits and risks, issues of confidentiality and anonymity in 
relation to their participation. The form also provided information about the researcher, 
supervisor and also contact information of the key ethics committee contact person they could 
reach when necessary. All ethical approval letters supporting the conduct of this study are 
found in appendix 3. 
3.3 Scientific rigor in the study 
Scientific rigor is an essential component in evaluating the scientific value of any research. 
Central to the evaluation of scientific rigor in both quantitative and qualitative studies are the 
components of reliability, validity, bias, comparability, reflexivity and transparency [193, 212-
215]. In recognition of this, a number of strategies were adopted to enhance scientific rigor: 
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standardized and scientific guidelines were followed in the design, data collection analysis, 
reporting and interpretation processes. These included the survey reporting guidelines by 
Bennett and associates [216], the RECORD Statement for reporting observational studies from 
routinely collected hospital data [217] and the guidelines by Tong et al for qualitative 
interviews [218]. Table 1 below summarized the steps and measures undertaken to enhance 
the scientific rigor of the research: 
Table 1: Measures to enhance scientific rigor 
Study         Strategies used to enhance scientific rigor 
Survey 
 
 Pre-test of research instrument 
 Representative sample 
 Comparability of findings with previous studies 
 Results comprehensively reported 
 Adequate reporting of background and context 
information 
 Validation of preliminary results by study sites 
Retrospective cohort study 
 
 Pre-test research instrument 
 Representative sample 
 Comparability of findings with previous studies 
 Results comprehensively reported 
 Adequate reporting of background and context 
information 
Qualitative in-depth 
interviews 
 
 Pre-test of interview guide 
 Ensure saturation of findings 
 Clear descriptions of methods  
 Comprehensive records for data collection analysis. e.g. 
field notes and audio recording of interviews  
 Member validation/cross checking of results 
 Results comprehensively recorded 
 Adequate reporting of background and context 
information 
 Compare findings with previous studies 
 Role of researcher clearly explained (Reflexivity) 
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3.4 Methods for quantitative data collection 
This section outlines the methods employed in collecting quantitative data derived from the 
survey and the retrospective cohort studies. To this end, the ensuing sections describe the study 
designs, settings, target population, sampling and recruitment of research participants, data 
collection and the analytical approaches adopted. Further details of the methods are reported 
in chapter 4.  
3.4.1 Study 1: Survey of acute stroke care services and therapies 
The aim of the survey was to provide information on the kinds of acute stroke services or 
therapies available to support the treatment and management of acute stroke patients in 
Ghanaian hospital settings. Consequently, the data were evaluated to establish the extent to 
which available acute stroke services were consistent with best practice recommendations, 
using the World Stroke Organisation action guidelines [219], as a reference for providing 
evidence-based stroke care. This study presents the first baseline information on evidence-
based acute stroke care services available from the public major referral hospitals in Ghana. 
The findings also support the identification of gaps in the current health system capacity of 
these hospitals to deliver evidence-based acute stroke care and makes recommendations 
thereof, for health policy action to improve stroke care. 
Study Design  
The study implemented a survey across all the study sites because of the advantage of collecting 
several variables of interest, in this case, different stroke care interventions and services without 
additional time and cost [192, 193, 220-222]. The choice of other methods, like qualitative 
interviews, could have been used but this would have limited the study ability to capture as 
many acute stroke services across the main referral hospitals in Ghana, and more importantly 
would have limited the study ability to report an objective, subjective-free data on availability 
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of acute stroke care services. Generalisation of study findings is one of the strengths of the 
survey method [221], and as such, using this method to gather research evidence from the main 
referral hospitals or where the highest level of acute stroke care is provided in each 
administrative region in Ghana gives a strong basis for the study findings to be generalised. 
The survey design further stood out as the more appropriate approach as it has previously been 
used successfully to gather similar data in Australia [103], the UK [223] and some European 
countries [106, 107]. In addition, in Ghana, the survey design is a popular approach used 
consistently to report the availability and accessibility of healthcare services [171, 172]. On the 
basis of this context, the survey design was concluded to be the most suitable approach to 
collate evidence on the range of acute stroke care services in Ghana. 
Study Settings 
The survey was conducted in eleven referral hospitals in Ghana (4 tertiary-teaching and 7 
regional hospitals). Although there are more than 300 public and private hospitals, the selected 
hospitals are among the main referral public hospitals where the highest level of clinical care 
is provided in each of the ten administrative regions of the country [167]. In the Ghanaian 
setting, more medical admissions with conditions, such as a stroke, are greater in the public 
regional and teaching hospitals compared to private hospitals, district or sub-district hospitals. 
The clinical capacities of the selected public hospitals differ according to their categorisation 
as a teaching or a regional hospital. In contrast to the seven regional hospitals, the tertiary-
teaching hospitals serve as larger referral centres and are well-resourced with diagnostic and 
therapeutic facilities. They are also semi-autonomous and serve as tertiary academic centres 
offering training in a range of highly specialised medical or clinical options. The remaining 
seven regional hospitals on the other hand have the capacities to deliver clinical care for acute 
stroke but with less clinical capacity compared to the tertiary-teaching hospitals. In Ghana, 
there also exists Municipal, District and Sub-District hospitals but these were excluded from 
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this study because they have limited clinical capacity to support acute stroke care compared to 
the regional and tertiary referral hospitals. As a result, these are less likely to provide evidence-
based care for health conditions such as acute stroke. This formed the basis for the selection of 
the study sites, representing at least one major public referral hospital in each administrative 
region of the Ghana. A detailed description of the healthcare organisation in Ghana is outlined 
in chapter 1. Table 2 shows the study hospitals based on their status, bed capacity and stroke 
admissions for 2014. 
Study Participants  
The target respondents included senior hospital staff in charge of the provision and supervision 
of acute stroke care in the study hospitals. The choice for this category of health care staff 
stemmed from the fact that they play central roles in the provision of healthcare in hospitals 
including but not limited to supervising the delivery of acute stroke care, making strategic 
decisions in the hospitals’ operations such as procurement of stroke services and organisation 
of clinical care. Participants included in the study had served in the post for at least one year. 
Resident doctors or doctors in training were not eligible. Table 2 below presents the distribution 
of the participants, their ranks and the settings. 
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Table 2:  Characteristics of study hospitals 
Hospital status 2014 stroke admissions Hospital bed capacity 
Teaching Hospital 1 
1500 653 
Teaching Hospital 2 
1000 650 
Teaching Hospital 3 
118 500 
Teaching Hospital 4 
125 400 
Regional Hospital 1 
409 194 
Regional Hospital 2 
313 358 
Regional Hospital 3 
- 250 
Regional Hospital 4 
520 235 
Regional Hospital 5 
71 400 
Regional Hospital 6 
39 226 
Regional Hospital 7 
49 200 
 
Sampling Procedure 
This study adopted a non-probabilistic purposive sampling technique to recruit participants. 
This method of sampling targets participants based on their specialised and informed 
knowledge of the study topic [193, 197, 224]. Thus, this study sampled only participants who 
worked in the study hospitals purposively or primarily to provide direct acute stroke care to 
patients or acting as supervisor for the delivery of acute stroke care. This was essential as the 
present study focused exclusively on staff clinically qualified to provide acute stroke care 
directly to stroke patients in acute hospital settings. Overall, one respondent (i.e. 11 in total) 
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was selected from each study hospital deemed appropriate and knowledgeable based on their 
job titles and roles.  
 
Table 3: Characteristics of survey respondents and study hospitals 
 
Respondents Regional Hospital Tertiary-Teaching Hospital Overall Total 
Years of professional experience 
     1 -5 
 
     6-10 
 
     11-20 
 
     21+ 
 
4 
 
1 
 
1 
 
1 
 
1 
 
2 
 
1 
 
- 
 
5 
 
3 
 
2 
 
1 
Sex 
    Male 
    Female 
 
5 
2 
 
2 
2 
 
7 
4 
Rank/Post in the Hospital    
     Neurologist Consultant - 1 1 
     Neurologist - 1 1 
     Physician Specialist 2 1 3 
     Clinical Care Coordinator 1 - 1 
     Senior Medical Officer 3 - 3 
     Medical Officer 2 1 3 
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Recruitment  
The recruitment process involved five stages. First, following ethics approval for the study, all 
study hospitals were formally contacted and invited to participate in the study. The invitation 
letter included a detailed study protocol which outlined the study purpose and the criteria for 
eligibility. In addition, copies of all ethics approval documents were included in order to 
showcase the credibility of the study.  
Second, in order to further give credibility to this study, an introductory / supporting letter for 
the study was also sought from the Director General of the Ghana Health Service. The Director 
General oversee the delivery of healthcare in all public and non-teaching hospitals, and as well 
oversee the implementation of all national health policies and interventions. This letter was 
included in all the invitation letters sent out to the study hospitals. 
Following responses from hospitals confirming their participation in the survey, and through 
personal visits and telephone calls to the appropriate Unit/Department heads, Human Resource 
Managers or Hospital Administrators of the hospitals, an eligible respondent from each hospital 
was selected. Subsequently, arrangements were made to meet the survey respondent, where 
they were briefed about the study, then discussed and agreed on a date, a place and time for the 
survey to be completed.  
Survey Instrument 
The survey tool (See Appendix 3) was adapted from a well-established survey instrument 
developed by the National Stroke Foundation of Australia to audit acute stroke services [225]. 
The content of the tool was also informed by other key documents [219, 226-228]. The survey 
instrument was a paper-written structured questionnaire designed with 80-question items 
requiring respondents to provide responses on the range of hospital-based services provided to 
stroke patients. Questions were mainly closed ended, with a minority being open-ended. The 
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questionnaire was written and administered in the English language. Questions in the 
instrument were categorised into nine sections covering the following domains: direct 
questions on respondents’ demographic and hospital data, data on services and hospital 
arrangements to support early presentation of acute stroke patients. Information on diagnosis, 
assessment services and stroke clinical guidelines covered the next section. In the next section, 
data were collected on available clinical management plans/guidelines, neuro-imaging 
facilities (CT and MRI scans), acute stroke services and treatments as well as stroke 
rehabilitation services. Data were then gathered on stroke care workforce, acute stroke services 
and therapies. Finally, data were collected on the extent of health / hospital policy initiatives 
and interventions to support acute stroke care. 
Data collection 
An interviewer-administered approach was employed where the questionnaires were 
administered to respondents in their offices, clinic rooms and hospital wards. The interviewer-
administered approach was considered for three important reasons: to guarantee the solicitation 
of complete and appropriate responses (49, 51-53), to enhance response and compliance rates, 
allow the opportunity for certain concepts or questions to be clarified and to guarantee complete 
appropriate responses were elicited [220, 222, 229]. This approach to data collection is the 
most prominent, widely used and accepted approach of collecting survey data  in Ghanaian 
settings, e.g. [171, 230]. On average, each survey questionnaire took about 45-minutes to 
complete. 
Quality Control 
Given the diversity on many fronts between Australia and Ghana (country of study), the survey 
tool had to be pre-tested in Ghana prior to data collection in non-study public hospitals (with 
similar features to a regional hospital) to test for suitability and relevance to the test population. 
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In addition, the pre-test was conducted to ensure questions were clear, understandable, and 
appropriate within the study context and served as an opportunity to assess response category 
adequacy [203, 220, 222]. Feedback from the pilot exercise was used to modify the survey 
prior to the actual data collection. In addition, the raw data from the survey were shared/sent 
back to each study hospital to validate whether the reports from the survey were consistent with 
their earlier responses about stroke services availability in their respective hospitals. This 
afforded hospitals the opportunity to address any potential errors prior to the final analysis. 
Data Analysis 
Descriptive statistical analysis were conducted using SPSS Version 22.0. Data from this 
analyses were graphically displayed in frequencies, percentages, and proportions using tables 
to show the types of stroke care services available in each study site. The data analysis also 
showed potential inequities and discrepancies in the availability of stroke services in the study 
sites. Finally, in order to evaluate the extent to which available services align with global best 
practice recommendations for acute stroke services, the World Stroke Society stroke service 
guideline was adopted. 
3.4.2 Study 2: Retrospective cohort study on in-hospital mortality outcomes 
This study aimed to evaluate in-hospital mortality outcomes among acute stroke patients 
admitted in Ghana. Whilst elucidating the extent to which available acute stroke care services 
in the study hospitals are effective, the study findings also potentially offer new insights with 
the potential to contribute valuable data towards decisions and development of interventions to 
minimise preventable deaths for future acute stroke patients and promote standardise care for 
acute stroke patients.                                                                                                 
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Study Design 
This was a multi-site, hospital-based retrospective cohort study that aimed to evaluate any 
possible relationship between available acute stroke care services / process of care for acute 
stroke care and in-hospital mortality outcomes in six major referral hospitals in Ghana between 
November 2015 and April 2016. The six hospitals were part of the 11 discussed in the first 
study. Retrospective studies are commonly and preferably used in health research to investigate 
several variables of interest  at a lesser cost and time compared to a prospective cohort study 
or a randomised control trial [231, 232]. Such studies, often based on data routinely collected 
in hospitals for administrative purposes, have been growing in health research over the past 
decades [217]. However, retrospective studies sometimes involve incomplete classification and 
documentation of patient records. A prospective study design may have provided a better 
quality and standard data to address the study aim. To control for these potential limitations, a 
strict eligibility criterion was applied in the data collection process to ensure the collection of 
objective, complete and accurate data. As reported in the data analysis section, other 
methodological considerations were made to minimise potential compromise of the data 
quality.  
Study Setting 
Due to time and resource constraints, the retrospective cohort study was conducted using the 
medical records units of three teaching hospitals and three non-teaching hospitals. The study 
sites (See table 4) comprised two hospitals each from the southern, middle and northern belts 
of Ghana, in order to take account of the geo-spatial and socio-economic contrasts among the 
administrative regions of the country. Additional information about the regional and tertiary 
teaching hospitals are outlined in chapter one. 
 
130
Table 4: Characteristics of study hospitals 
Hospital 2014 stroke admissions Hospital bed   capacity 
 
TH1 1500 653  
TH2 1000 650  
TH3 118 500  
RH4 409 194  
RH5 520 235  
RH6 49 200  
 
TH =Tertiary (Teaching) Hospital,  
RH= Regional Hospital 
 
Study Population 
Stroke patients (aged ≥ 18) admitted to the hospital for their first acute stroke between January 
and December 2014 were eligible to participate. The study reviewed medical records of stroke 
patients based on index admissions, that is, admissions for which acute stroke was treated. 
Patients were excluded if they had recurrent strokes, if they were diagnosed with transient 
ischemic attacks or any neurological deficits arising from a non-cerebrovascular cause or non-
stroke diagnosis, or if clinical records were incomplete via limited clinical information to 
address the study aims. Table 5 shows the demographic and clinical characteristics of the 
patient cohort. 
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Table 5: Patient demographic and clinical characteristics according to hospital status 
 
Participants Regional Hospital Tertiary-Teaching 
Hospital 
Total 
Sex 
      Male                             
      Female           
Age 
      15-30  
      31-45 
      46-60 
      61 and above 
Stroke subtype 
      Ischemic 
      Haemorrhagic 
      Undocumented 
Risk Factors 
      Hypertension 
      Obesity 
      Diabetes 
      Smoking 
      Alcohol intake 
      Asthma 
      Atrial Fibrillation 
      Family history 
 
64 (44.1%) 
86 (55.5%) 
 
8 (72.7%) 
22 (47.8%) 
48 (45.2%) 
82 (51.6%) 
 
27 (36.0%) 
17 (26.2%) 
106 (66.3%) 
 
87 (46.3%) 
29 (61.7%) 
51 (45.9%) 
16 (32.7%) 
11 (40.7%) 
6 (27.3%) 
27 (45.8% ) 
15 (48.4%) 
 
81 (55.9%) 
69 (44.5%) 
 
3 (27.3%) 
24 (52.2%) 
46 (54.8%) 
77 (48.4%) 
 
48 (64.0%) 
48 (73.8%) 
54 (33.8%) 
 
101 (53.7) 
18 (38.3%) 
60 (54.15) 
33 (67.3%) 
16 (59.3%) 
16 (72.7%) 
32 (54.2%) 
16 (51.6%) 
 
145 (48.3%) 
155 (51.7%) 
 
11 (3.7%) 
46 (15.3%) 
84 (28.0%) 
159 (53.0%) 
 
75 (25%) 
65 (21.7%) 
160 (53.3%) 
 
188 (69.9%) 
47(17.5%) 
111 (41.3%) 
49 (18.2%) 
27 (10.0%) 
22 (8.2%) 
59 (21.9%) 
31 (11.5%) 
Access to brain (CT scan) 
Status at discharge 
      Dead                           
      Alive 
43 (35.5%) 
 
40 (26.7%) 
110 (73.3) 
77 (64.2%) 
 
55 (36.7%) 
95 (63.3%) 
120 (40.0%) 
 
95 (31.7%) 
205 (68.3) 
 
Sampling and Sample size 
Although multiple study outcomes were sought, the main study outcome was in-hospital 
mortality, based on which the overall retrospective cohort study sample was estimated.  
Sample size calculation was based on an African study which found that 16% of those treated 
in a stroke ward died compared to 33% in medical wards [109]. Using a two-sided alpha of 
0.05, power of 0.8, ratio of treatment of groups of 3:1, and proportions described above, the 
study needed a total of 284 patients with 71 being treated in specialised acute wards.  
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Using the admission and discharge medical logbooks as the sampling frame, past-hospitalised 
stroke patients in the study hospitals from January to December 2014 were selected from each 
site using a sex-stratified systematic probabilistic random sampling technique. The sampling 
procedure involved a four-stage process: First, all stroke cases treated between January to 
December 2014 in the study sites were identified. Next, patients were stratified according to 
their sex in each of the study hospital. The third stage involved a random selection of every 
fifth individual enlisted in the admission and discharge logbooks as having an acute stroke and 
their identification numbers noted. In the final stage, based on the unique patient IDs in the 
hospital files, patients’ medical folders were subsequently retrieved manually by health 
information personnel from each of the medical records unit of the study hospitals. Where 
retrieved patient medical records had limited information to address the study aim, or in 
situations where a patient folder was irretrievable, random sampling of patient medical records 
continued according to the above protocol until the required sample was reached. However, in 
order to account for possible methodological challenges which could arise (such as missing 
data), a sample of 50 stroke patient medical records was reviewed in each hospital, resulting in 
an overall total of 300 stroke patients’ medical records, that is, 50 past stroke cases from each 
study hospital, within equal sex distribution.   
Chart Review  
A paper-based structured medical extraction form was used for the chart review. The patient 
medical records extraction form was trialled in each study hospital on a single acute stroke case 
and revisions made where necessary. The content of the form was adapted from relevant 
literature such as the National Stroke Foundation Clinical Audit tool [95]. The instrument 
collected data on the following: patient demographic data (age, gender, etc.), patient admission 
and discharge information, (admission and discharge dates, length of stay, destination at 
discharge). Data were also collected on the process of care indicators such as information on 
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whether the patient was admitted and treated in a stroke unit, general ward or an intensive care 
unit, treatment using t-PA or aspirin for an ischemic stroke, attended to by a therapist  and 
having access to a brain scanning service. Finally, the instrument also made provision for data 
collection on medical diagnoses of stroke type and other relevant stroke patient health 
characteristics. 
Following the sampling procedure, data on index admissions of stroke cases in the study 
hospitals were extracted from the hospital morbidity and mortality logbooks, admissions and 
discharge records logbooks and other available records (patient folders, electronic storage, 
etc.). The admission and discharge record books and logbooks are prospective registers of all 
consecutive patients with a wide range of health conditions admitted to hospitals for clinical 
care. Primarily, the information collected in these logbooks includes date and time of admission 
and discharge, patient demographic information (age, sex, occupation, date of birth, hometown, 
marital status, etc.) and some clinical information (diagnosed health condition, co-
morbidities/risk factors, discharged alive, deceased). The collection and storage of patients’ 
medical records is often supervised by skilled health information officers in each hospital. All 
extracted data were de-identified and codes were applied to ensure data anonymity.  
Patient Outcome Measures 
Outcomes of relevance relate to all-cause in-hospital mortality from all first time stroke 
admissions in the study sites. Also of interest in this study was patient length of stay, measured 
as the date of admission to discharge or death. The overall outcome was to measure the efficacy 
levels of treatments and the process of care procedure. The process of care indicators included 
type of admitting wards, access to CT scan, aspirin, t-PA, and care provided by allied health 
staff (physiotherapist, dietitian, etc.) 
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Data Analysis 
Descriptive and inferential statistical analyses were conducted using SPSS version 22.0. 
Descriptive statistics were conducted on patient demographics, patient health outcomes (death 
or alive) at discharge, stroke therapies and use of brain imaging services, patients’ 
characteristics (stroke types, sex and gender distribution). On the other hand, inferential 
statistics involved the use of Pearson chi-square and Fisher exact tests to make comparisons in 
outcomes across the study sites and other variables of interests. The mean differences between 
the various groups were also evaluated using Student’s t-test or one-way ANOVA. The non-
parametric Mann-Whitney U-Wilcoxon test was used for variables that did not show a normal 
distribution. Normality of distribution was determined by standard diagnostic tests such as 
normal probability plot and Shapiro-Wilk test. Statistical significance was set at a p-value of 
<0.05 (two-sided). In addition, a multivariate regression analysis was conducted to investigate 
patient factors associated with all-cause in-hospital mortality outcomes while accounting for 
confounding variables such as age, gender, stroke risk factors (hypertension, obesity, diabetes, 
atrial fibrillation, asthma, family history and alcohol intake) or type of admitting ward (stroke 
unit, medical emergency and general medical wards). Similarly, the probability of dying was 
plotted and illustrated in Kaplan-Meier curves and differences in outcome variables were 
compared using the log-rank test.   
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3.5 Methods for qualitative data collection 
This section describes the qualitative data collection and analysis process for the research. 
Further details of the qualitative study approach are reported in chapter 4. 
3.5.1 Study Three: In-depth interviews of barriers to acute stroke care 
This study aimed to provide context to the survey and retrospective cohort study data by 
exploring stroke care professionals’ views on barriers to providing evidence-based care for 
acute stroke patients in the study hospitals. Thus, insights from this study illuminated our 
understanding of the practicalities associated with the implementation of current evidence-
based interventions for acute stroke. In other words, the data broadened our understanding of 
why health professionals, especially from LMICs, often provide care unlikely to meet best 
practice guidelines. A better understanding of these barriers may be instrumental in designing 
well-targeted policy interventions to enhance uptake of evidence-based therapies for acute 
stroke care.  
Study Design 
A qualitative study design was employed to explore the barriers faced by stroke care 
professional in providing evidence-based care for better patient outcomes. In providing context 
to the previous two studies as reported in the preceding sections, the qualitative study provided 
an important source of data to understand the possible rationales behind limited utilization of 
evidence-based acute stroke care services/interventions as well as the variable/less optimal 
patient outcomes (relatively high in-patient mortality outcomes) in the admitting hospitals. Few 
efforts have been made to understand the implementation processes of evidence-based 
interventions and underlying factors for effective translation[137]. Hence, the use of qualitative 
research has increasingly been recognised in contemporary works as an important data source 
in understanding the evidence implementation process and the underlying factors behind 
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evidence uptake [233]. First, this is suggested as the most preferred data collection technique 
to understand views on barriers to healthcare delivery in hospital settings [234]. Second, in 
studying gaps between policy and practice, qualitative research has been highly recommended 
as the best technique to explore nuances associated with why policy recommendations do not 
often translate fruitfully in practice [134, 235]. Another key attribute of this method, 
influencing its choice, is its suitability in generating contextually rich data through the capture 
of ‘taken for granted knowledge’, questions of ‘why’ and ‘how’ from participants subjective 
lived experiences and construction of reality [236, 237]. In terms of methodological feasibility, 
a previous systematic review as part of this thesis (see chapter two) suggests that previous 
studies resorted to both quantitative (surveys) and qualitative studies in reporting the barriers 
to acute stroke care [125]. Nonetheless, the aforementioned comparative advantages of the 
qualitative in-depth interviews distinguishes and underscores the centrality of a qualitative 
study design as the more suitable option for gathering relevant data to contextualise an in-depth 
evaluation of the knowledge-practice gap in acute stroke care in Ghana. 
Study Settings  
The qualitative in-depth interviews were conducted in three tertiary (teaching) and three 
regional hospitals that were selected to account for the geographical, political, socio-economic 
diversity of the three regional belts in Ghana (northern, middle and southern). The selected 
hospitals are major referral points in Ghana, representing six of the ten administrative regions. 
Although all hospitals have the clinical capacity to provide a comprehensive service for acute 
stroke care, the tertiary-teaching hospitals are much better resourced with modern medical 
technology and diagnostic equipment. Table 6 shows the selected study hospitals, the annual 
stroke admissions for 2014 and the hospital-bed capacity at the time of the study. 
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Table 6: Characteristics of study hospitals 
Hospital 2014 stroke admissions Hospital bed-capacity 
 
TH1 1500 653  
TH2 1000 650  
TH3 118 500  
RH4 409 194  
RH5 520 235  
RH6 49 200  
 
TH =Tertiary (Teaching) Hospital,  
RH= Regional Hospital 
 
Study Participants  
Participants were either key hospital staff primarily involved in the delivery or the supervision 
of acute care including stroke (See Table 7). To maximise the diversity of responses, 
participants recruited comprised males and females, had different expertise and core roles in 
the provision of acute stroke care in the hospital and with varying years of professional 
experiences. These various categories of health professionals are regarded as the core 
multidisciplinary team for stroke care [238], and thus their inclusion maximised the chance all 
relevant responses relating to the subject under study being elicited. However, health 
professionals not involved in acute stroke care were not eligible. Table 7 shows the distribution 
of participants across study sites. 
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Table 7: Characteristics of respondent sample for qualitative data collection 
Participants Tertiary/teaching hospitals Regional hospitals Total 
Nurses 11 9 20 
Neurologist consultant 
Neurologist 
Emergency Physician   specialist 
Senior Medical Officer 
Medical Officer 
1 
1 
1 
1 
2 
- 
- 
- 
1 
5 
1 
1 
1 
2 
7 
Clinical psychologist 1 1 2 
Physiotherapist 2 3 5 
Dietitian 0 1 1 
Total 20 20 40 
 
Sampling Procedure 
A purposive sampling technique was employed to select the study sites, comprising three 
tertiary-teaching and three regional hospitals. These hospitals were strategically selected 
because of their diversity in clinical capacities and geographical locations, to support analytical 
examination of views on these barriers in hospitals from the three main geographical areas in 
Ghana; the northern, middle and southern belts. Participants were enlisted using a purposive 
sampling technique. As a non-probability sampling technique, this method is a judgemental 
selection of respondents based on their specialised knowledge related to the study [192, 196, 
197]. As a result, only participants with primary roles related to the delivery or supervision of 
acute stroke care were recruited. 
In respect of the sample size for this study, the theoretical sampling technique was utilised 
where recruitment for more participants ended when newly recruited participants added no new 
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insights to earlier views from participants [192, 198, 234]. Notwithstanding this, there is no 
current evident to suggest the existence of a unified position among qualitative researchers as 
to how many participants are sufficient for a complete qualitative study. Whilst some posit that 
fifteen interviews are adequate to reach saturation [239, 240], or that the number of participants 
should be based on the quality of the responses in obtaining the requisite information [241], 
others are of the view a single interview could even be sufficient, provided the study purpose 
is to provide a rich and contextualised account of a particular issue or  the aim is to help 
establish the feasibility of an intervention [242, 243]. In addition, it is argued that if the study 
purpose is to support comparison or the identification of common grounds among different 
study groups or settings, a much larger sample is suggested [242, 244]. Given the current 
absence of a unified perspective about the required number pf participants in qualitative 
interviews, and in the light of uncertainty of sufficient sample, and guided by the data saturation 
principle as mentioned earlier, a sample of 40 participants was recruited and interviewed to 
provide in-depth coverage and diversity of responses. On average, six participants were 
interviewed in each hospital. Ideally, interviews should have been conducted per hospital until 
saturation was reached but this study was constrained by time and resources to do this and so 
an overall saturation was sought instead. 
Recruitment of Participants  
The recruitment process involved several stages. First, following formal correspondence with 
respective study hospitals to solicit their participation, and subsequent approval, a series of 
meetings was held with key gatekeepers1 in the hospitals. The gatekeepers included nurses in-
charge, health services administrators, human resource managers, in-service training and 
research coordinators, and heads of department or units within the hospitals. The study 
                                                          
1Gatekeepers in the study context refer to the guardians of hospitals, units, departments or the person who can grant 
arbitrary approval to the research study or access to study participants. 
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strategically prioritised such meetings to promote the study adequately and as an opportunity 
to identify suitable participants. This was because of their ease of access to potential study 
participants and given that research participants readily trust gatekeepers and are more willing 
to participate in a research process brokered by a gatekeeper [245]. Prospective participants 
(interviewees) were recommended during such meetings. Secondly, follow up visits and calls 
were made to the wards, consulting rooms and individual officers of the participants to discuss 
the study, where dates, times and venue for the interviews were fixed. Due to time and 
workload restrictions, three participants declined to participate in the study. The number of 
participants enrolled into the study was determined by data saturation as discussed in the 
preceding section. 
Interview Guide 
A semi-structured interview guide (see appendix 3) was prepared to systematically direct and 
facilitate the interview process. Questions were open-ended to minimise imposition of the 
researcher’s viewpoints on research participants. The tool was developed and trialled in non-
study hospitals before being used in the actual data collection process. To ensure content 
validity, the guide was designed following an extensive analysis of relevant literature related 
to stroke care professional views on barriers and enablers to acute stroke clinical care. Overall, 
the questions resonated with the recent systematic review on the seven thematic factors which 
enable or inhibit improved practice in healthcare settings [146].  
The interview guide comprised of a series of exploratory interview questions focused on how 
participants provided clinical care for stroke patients, their professional practice, exploring 
their knowledge, attitudes and familiarity with current evidence-based therapies or clinical 
guidelines, considerations in adopting evidence-based therapies and services. The other set of 
questions asked participants about their perceptions or views on possible barriers to evidence-
based stroke clinical care. The last set of questions sought to elicit participants’ views on what 
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they recommend as the best strategies/measures to improve the delivery of acute stroke care in 
their respective hospital settings. 
Data Collection  
To address the issue of reflexivity, my professional background, position as a PhD research 
student with no formal association with the Ghana Health Service, the Ministry of Health or 
their hospital authorities, was first revealed prior to all interviews. This action is recommended 
to ensure no inherent bias/or perceived conflict of interest influenced the interview process, or 
the potential to restrict the extent of interviewee openness and responses to questions during 
the interview process [212].  
A face-to-face in-depth interview with the participants using an interview guide was conducted. 
Data collection occurred in the general and emergency wards, patient consulting rooms, 
physiotherapy departments, conference rooms within the hospitals and participants’ office 
rooms during their work shift periods. The questioning approach was unstructured, whilst 
prompts and follow up questions were frequently used to gain greater insights into the 
responses and to clarify responses from the interviewees. Throughout the data collection 
process, the interview guide was revised where necessary based on the outcomes and the 
interview process as it progressed from one interviewee to the next, a strategy which supported 
the elicitation of new insights from the subsequent interviews. 
Prior to all interviews, written consent were obtained from participants for their participation 
and the overall interview process was audio-recorded. With participants’ consent, all interviews 
were audio-recorded and transcribed verbatim. At the same time, detailed field notes were 
taken during and after every interview to note participants’ expressions, reactions of feelings 
during the interview process, as well as other observed events. The average duration per 
interview was about 45 minutes.  
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Trustworthiness and Quality Control 
To increase data trustworthiness, the interview guide was pre-tested among selected clinicians 
from non-participatory study sites. The guide was subsequently revised to ensure all questions 
were context relevant and appropriate, adequate and well structured. To further enhance data 
confidence, iterative questioning and probes characterised the entire data collection process, as 
this potentially minimises or uncovers deliberate falsehoods from participants [246]. Lastly, 
cross-checking of transcripts from a sample of participants was done in order to seek 
corroboration and ensure records on transcripts matched the intended responses, a measure to 
further enhance the validity of the results from the interviews [193]. Hence, selected transcripts 
from interviews were shared with selected participants to cross-check and ensure the content 
aptly represented their views as expressed during the interview process. 
Data Management and Analysis   
Despite the existence of multiple approaches to analysing qualitative research data, this study 
employed two known approaches for qualitative data management and analysis; thematic data 
analysis and grounded theory approaches. Due to the abundance of research on the drivers of 
evidence uptake in healthcare settings [145, 146, 148], a thematic analysis method employing 
pre-existing categories of themes relevant to the study was utilised over the grounded theory 
approach. Thematic data analysis involves identifying, analysing and reporting themes 
emerging from empirical data [247-249]. This method is flexible and has the advantage of 
capturing data content for comprehensive appraisal [249]. Themes were identified based on 
their recurrence and how they interconnected with the literature on barriers or enablers to 
uptake of evidence-based care for stroke. This framework is considered as the conventional 
analytical framework widely used in qualitative research [193, 250]. According Braun and 
Clarke [249], the role of thematic analysis in qualitative research remains central and thus 
cannot be narrowed to any theoretical or epistemological research paradigm.  
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The grounded theory approach on the other hand, involves the identification of concepts, 
themes, latent patterns or categories which emerged from the data and not based on a pre-
existing category of themes [251, 252]. This approach took an inductive approach to ensure all 
essential emergent themes, concepts or patterns from the codes not included in the deductive 
pre-existing code list of barriers were adequately captured. In other words, this approach is not 
guided by a pre-conceived framework, and is rather more analytic and supports comparative 
inquiry of knowledge [253, 254]. The study found the need to utilise a second data analysis 
approach in order to ensure all relevant accounts of barriers to optimal patient care were 
identified and analysed within the appropriate context. To this, the framework analysis 
technique [255, 256] was followed. This data analysis guideline proposed a seven-staged 
process to qualitative data analysis: 
First, all qualitative in-depth interviews from the field data collection were audio-recorded and 
transcribed verbatim. Secondly, data from the interview transcripts were familiarised through 
constant line-by-line reading and re-reading. As encouraged by qualitative researchers [255],  
re-listening of audio recordings and reading of field notes was further undertaken during this 
stage to enhance familiarity with the data. Third, coding and taking of notes to categorise 
emergent key concepts and patterns was then conducted. The NVivo version 10.0 [257] 
supported the coding process, which was predominantly deductive given the large body of 
evidence on barriers to evidence-uptake in healthcare settings. An initial codebook based on 
prior codes was developed and subsequently modified with the addition of new emergent 
themes after a line-by-line reading and re-reading of seven transcripts across different stroke 
care professionals. The remaining transcripts were coded and themes identified through 
repeated line-by-line reading of transcripts, and in some instances, listening to audio-recordings 
and reviewing field notes. An open-coding process was also conducted using an inductive 
approach to capture all essential elements that were potentially missed during the deductive 
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coding process. In the fourth step, an analytical framework was established based on the 
categorisation of the initial codes. This process was done iteratively to explore emerging 
themes in the subsequent interviews with new study participants. Fifth, new codes were 
indexed into the framework based on coding and categorisation from additional transcripts 
from the interview until all transcripts were coded and indexed into the analytical framework. 
The sixth step involved the charting process where all codes from the data were summarised 
into categories based on each transcript. As part of this step in data analysis, themes were 
supported by illustrative quotes from participants to highlight a particular theme of a barrier 
with the aim of supporting analytical generalisation, a unique feature in qualitative research 
[193]. 
The final step involved interpretation of the data through constant comparison for common or 
diverse codes/themes. This was done to support the identification of key thematic barriers or 
patterns relevant to the uptake of evidence-based therapies for acute stroke. For analytical 
purposes, using the constant comparison approach, common to grounded theory data analysis 
techniques [258-260], cross-sectional analysis of both emergent and prior themes was 
conducted between study sites and from different stroke care professional groups. This enabled 
points of convergence and divergence on barriers to evidence-based stroke care to be identified. 
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CHAPTER FOUR 
RESULTS 
 
4.0 Introduction 
The chapter presents the empirical results for the thesis. This is categorized into three sections, 
comprising findings from a survey, retrospective cohort study and a qualitative interview study. 
The first section (study one) reports results from a survey on hospital-based strokes for acute 
stroke care in Ghana. The second section (study two) evaluates in-hospital mortality from acute 
stroke patients who received care in three different admitting wards. The final section (study 
three) reports results from a qualitative study on the barriers to providing evidence-based acute 
stroke care. 
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4.1.1 Overview and rationale 
The first section reports findings from a survey which was conducted in 11 major public referral 
hospitals in Ghana to identify acute stroke care interventions and services for acute stroke care 
and evaluate the extent to which such services align with international best practice guidelines. 
This study was conducted based on the paucity of information on the range of acute stroke care 
services and interventions provided to acute stroke patients within the context of LMICs, 
especially Africa. The was established based on the findings of a systematic review reported in 
chapter two which highlighted the limited nature of information on acute stroke care 
interventions across the African region. Importantly, findings from this review showed none of 
the eligible studies were not reported from Ghana, leaving a gap in our understanding of the 
availability of evidence-based acute stroke care interventions in Ghana. It highlighted the need 
for future studies to comprehensively report on the kinds of acute stroke care interventions 
currently available in the hospital settings of Africa. This thus provided a rationale and 
scientific bases for the conduct of this study in Ghana. 
Overall, the findings from this survey highlight limited and variable evidence-based acute 
stroke care services. It also points to inequitable availability to these services across of the 
study sites. Using the World Stroke Organization guidelines for stroke services in hospital 
settings, the availability of contemporary services and interventions for acute stroke care were 
lacking although the tertiary hospitals expectedly had better services compared to the regional 
non-tertiary hospitals. The findings also emphasized a deficit in health policy imperative for 
acute stroke care. On the basis of this, gaps in evidence-uptake were highlighted and key 
considerations for health managers and policy makers to improve patient made. The published 
article arising from this study is reported in the next section. 
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Abstract
Background: Stroke and other non-communicable diseases are important emerging public health concerns in
sub-Saharan Africa where stroke-related mortality and morbidity are higher compared to other parts of the world.
Despite the availability of evidence-based acute stroke interventions globally, uptake in low-middle income countries
(LMIC) such as Ghana is uncertain. This study aimed to identify and evaluate available acute stroke services in Ghana
and the extent to which these services align with global best practice.
Methods: A multi-site, hospital-based survey was conducted in 11 major referral hospitals (regional and tertiary - teaching
hospitals) in Ghana from November 2015 to April 2016. Respondents included neurologists, physician specialists
and medical officers (general physicians). A pre-tested, structured questionnaire was used to gather data on available
hospital-based acute stroke services in the study sites, using The World Stroke Organisation Global Stroke Services
Guideline as a reference for global standards.
Results: Availability of evidence-based services for acute stroke care in the study hospitals were varied and limited. The
results showed one tertiary-teaching hospital had a stroke unit. However, thrombolytic therapy (thrombolysis) using
recombinant tissue plasminogen activator for acute ischemic stroke care was not available in any of the study
hospitals. Aspirin therapy was administered in all the 11 study hospitals. Although eight study sites reported
having a brain computed tomographic (CT) scan, only 7 (63.6%) were functional at the time of the study.
Magnetic resonance imaging (MRI scan) services were also limited to only 4 (36.4%) hospitals (only functional in three).
Acute stroke care by specialists, especially neurologists, was found in 36.4% (4) of the study hospitals whilst none of the
study hospitals had an occupational or a speech pathologist to support in the provision of acute stroke care.
Conclusion: This study confirms previous reports of limited and variable provision of evidence based stroke services
and the low priority for stroke care in resource poor settings. Health policy initiatives to enhance uptake of evidence-
based acute stroke services is required to reduce stroke-related mortality and morbidity in countries such as Ghana.
Keywords: Stroke, Hospital services, Organised care, Evidence-based care, Health policy, Ghana
Background
Stroke remains the second leading cause of deaths
globally, recording a 26% increase in stroke deaths
between 1990 and 2010 [1]. According to the World
Stroke Society campaign highlights, one in six people
in the world will suffer a stroke in their life time [2].
In Africa and other LMIC, stroke and other non-
communicable diseases have become a great public
health concern as current evidence suggests such set-
tings are disproportionately affected by the overall
global burden of stroke [3–5]. For example, of the es-
timated 5.9 million deaths linked to stroke worldwide
in 2010, 71% were from LMIC settings [1]. Re-
searchers further suggested that whereas high-income
countries (HIC) show significant reductions in stroke
incidence of about 42% over the last 40 years, a 100%
increase in stroke incidence occurred in LMIC over
the same period [6].
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In Ghana, several studies have also confirmed an in-
creasing stroke burden, with one month in-hospital case
fatality as high as 41–43% [7–10]. For example, one of
such studies examined a total of 12,233 stroke admis-
sions over a 30 years period (1983–2013) and found that
28 day mortality during the study period was 41.1% [8].
In addition, the US Centres for Disease Control and Pre-
vention (CDC) has reported that stroke is the fourth
cause of mortality in Ghana [11]. These relatively high
rates of in-hospital mortality raise important questions
about the nature of acute stroke services in Ghana.
Based on the current epidemiological transition attrib-
uted to aging populations, urbanization and modifiable
stroke risk factors [12, 13] the future burden of stroke is
substantial in LMIC [14], and inevitably, there will be an
increased demand for acute stroke care interventions.
The World Health Organisation (WHO) has previously
asserted that the current stroke mortality burden in
LMIC such as Ghana can be attenuated by the provision
of quality and standardised stroke care [15], highlighting
the need to ensure increased uptake to evidence-based
stroke care interventions in such settings.
Despite the concept of evidence-based medicine is
highly contested and has been diversely conceptualised
[16, 17], the definition by Sackett et al. is widely acclaimed
and accepted among medical researchers and practitioners
[18]. The authors defined evidence-based medicine as ‘the
conscientious, explicit, and judicious use of current best
evidence in making decisions about the care of individual
patients as well as integrating individual clinical expertise
with the best available external clinical evidence from sys-
tematic research’. Thus, evidence-based acute stroke care
interventions in this context refer to those interventions
which are guided by sound scientific evidence, are well
consistent with the clinical judgement and expertise of the
individual clinician and meet the needs of patients for im-
proved clinical outcomes.
Internationally, there is consistent body of evidence
that stroke patients treated a) in a stroke unit by a multi-
disciplinary care team [19], b) using thrombolytic ther-
apy through tissue plasminogen activator (t-PA) for
acute ischemic stroke care patients within 4.5 h of stroke
onset [20, 21], c) administering of aspirin for ischemic
acute ischemic stroke patients within 48 h of a stroke
[22], and d) decompressive surgery within 48 h of an
acute stroke [23, 24] have reduced stroke-related mortal-
ity and morbidity. To support health systems worldwide
especially of poor resource settings with high stroke bur-
den to be able to consistently provide standard care for
improved patient outcomes, a stroke services guideline
by the World Stroke Organisation was developed [25].
Despite clear demonstration of the effectiveness of
these evidence-based interventions for acute stroke care,
there is widespread variation and limited uptake globally
and this is substantially lower in LMIC such as Ghana
[26–28]. The World Stroke Society has consequently
prioritised access to evidence-based stroke care as a key
theme in their 2016 global campaign, emphasizing the
importance of this study. The slow uptake of evidence-
based stroke care interventions is underpinned by multi-
factorial barriers at the health system, patient, health
care providers and nature of acute stroke interventions
levels [29–31].
To date, research on the availability of evidence-based
acute stroke care interventions in hospital settings globally
has been limited to high income countries. The UK,
Australia, Canada and some European countries are ex-
emplars [32–35]. Conversely, there is little information on
evidence-based acute stroke services in Africa and other
resource-poor settings. From the few studies available, the
use of evidence-based acute stroke care services in LMIC
settings is often asserted to be limited, poor and less likely
to follow best practice guidelines [26–28, 36, 37]. An im-
mediate question of public health interest will be to what
extent are evidence-based acute stroke care interventions
provided to acute stroke patients in the hospitals of LMIC
such as Ghana? Addressing this question has the potential
to provide baseline information on available evidence-
based acute stroke care interventions and as well identify
gaps in current stroke services which could support the
development of future interventions seeking to stand-
ardise and improve acute stroke care services for opti-
mal patient outcomes. This study therefore aims to
identify available acute stroke services in Ghana and to
evaluate the extent to which these services align with
global best practice.
Methods
Study design and settings
This is descriptive study involving a survey conducted in
major referral hospitals in all the ten administrative re-
gions of Ghana to collect data on available acute stroke
services from key acute stroke care providers between
November 2015 and April 2016.
Ghana has a multi-health care system with the in-
volvement of both public and private health care pro-
viders where healthcare delivery is provided by the
formal medical healthcare system, faith-based health
care system and the services from the ethno-medical
system [38]. Of these, there are tertiary-teaching hospi-
tals, regional hospitals, psychiatric hospitals, district hos-
pitals and subdistrict health centres in the public sector
[39]. However, the district hospitals and sub-district
health centres often have limited clinical capacity for
stroke care and so were excluded in this study. This
study therefore purposively sampled only major public
referral hospitals representing four of the five teaching
hospitals as well as seven of the nine regional hospitals
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in Ghana. Except for one region (Greater Accra) where
it was convenient to collect data from two major referral
hospitals (one regional and one tertiary hospital), data
was collected from either tertiary teaching or regional
hospital which acted as the primary referral hospital in
that particular administrative region. In spite of differ-
ences in the clinical capacities of the study hospitals on
the basis of their status as a tertiary-teaching or regional
hospital, these hospitals were chosen because they act as
major referral hospitals for other hospitals and health
centres in each of the ten administrative regions. Unlike
the seven regional hospitals, the tertiary teaching hospi-
tals serve as larger referral centres and are better-
resourced with diagnostic and therapeutic facilities. They
also serve as tertiary academic centres offering training
in a range of highly specialised clinical disciplines. As
presented in Table 1, the overall hospital bed capacity
for admissions in the study sites ranged from 150 to 653
with annual stroke admissions for 2014 within the range
of 49 to 1500 stroke cases per hospital.
Study participants
Respondents comprised neurologists, medical officers
(general physicians) and physician specialists. These key
informants were targeted because: they have relevant
knowledge or expertise on acute stroke care in the study
hospital; they play central roles as either acute stroke
care providers or supervisors of the delivery of acute
stroke care in the hospital. Their inclusion was also in-
formed by the fact most play a role in making strategic
decisions in the organisation of acute stroke care. All re-
spondents were full time regular employees of the study
sites. Part-time employees and resident physicians were
not eligible. Administrative or other staff whose roles are
not directly involved in the provision of acute stroke
care to patients were also excluded.
Sampling and recruitment
We employed a non-probabilistic purposive sampling
technique to recruit respondents with one respondent
per hospital. All study hospitals were formally contacted
and their participation solicited using an official letter of
invitation with information about the study, researchers
and all ethical approval letters. The invitation letter also
included a detailed study protocol and a study statement
outlining the study purpose, potential study benefits,
and an estimated time for survey completion. Prior to
recruitment and actual data collection, discussions were
held with the health administrators, clinical coordina-
tors, regional human resource managers, medical direc-
tors and heads of department to select appropriate
respondents. Consequently, one eligible respondent per
study site was selected and contacted directly by the first
author to organise the survey administration.
Data collection
An interviewer-administered survey approach was con-
ducted in respondents’ offices, clinic rooms and wards
of each hospital. This approach was chosen to enhance
response and compliance rates, provide opportunity for
concepts and questions to be clarified and to ensure ap-
propriate responses were elicited [40, 41].
The survey instrument (Additional file 1) was adapted
from a previous national survey used in Australia [42]. A
review of other relevant studies on acute stroke care
quality indicators [25, 43–45] also informed the content
of this instrument. The instrument was a paper-based,
structured questionnaire containing 80-question items
which required respondents to provide responses on the
range of hospital-based services provided to acute stroke
patients. The questionnaire was written and adminis-
tered in English. Questions were mostly closed ended
in nature and categorised into eight sections. These in-
cluded information on respondents’ professional back-
ground and qualification, characteristics of study sites,
institutional services and arrangements to support early
presentation of acute stroke patients, and data on diag-
nosis, assessment services and stroke clinical guide-
lines. The remaining sections collected information on
available acute stroke services and treatments, the
stroke care workforce, key institutional policies, prac-
tices and interventions to support acute stroke care and
on key challenges to acute stroke care.
Quality control
The survey tool was pre-tested in six non-study sites
among six acute stroke care physicians, representing two
each from the southern, middle and northern belt of
Table 1 Characteristics of study hospitals and respondents
Hospital 2014 stroke
admissions
Hospital bed
capacity
Survey respondents
TH1 1500 653 Consultant Neurologist
TH2 1000 650 Neurologist
TH3 118 500 Physician Specialist
TH4 125 400 Medical Officer
RH1 409 194 Medical Officer
RH2 313 358 Medical Officer
RH3 - 250 Physician Specialist
RH4 520 235 Physician Specialist
RH5 71 400 Senior Medical Officer
RH6 39 226 Senior Medical Officer
RH7 49 200 Senior Medical Officer
Total 11
TH Tertiary (Teaching) Hospital, RH Regional Hospital
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Ghana to account for the varied geo-political and socio-
economic development differences. This process also
tested the instrument’s suitability and relevance to the
study settings, assess adequacy of response categories
and whether all questions were appropriate within the
study context [40, 41, 46]. The instrument was accord-
ingly revised. Additionally, preliminary survey results
were sent back to individual respondents for validation
to ensure the data reflected their earlier responses.
Data analysis
Analyses were conducted using the Statistical Package for
the Social Sciences (SPSS) Version 22.0. Findings from the
analysis were reported in the forms of numbers and per-
centages displayed in tables with scores underlying the
availability of acute stroke care service and according to
the study sites. Analysis also highlighted variances in avail-
able acute stroke services across the study hospitals. The
World Stroke Society stroke service guideline [25] was
used as a reference to evaluate the extent to which
available services align with global best practice
recommendations.
Results
Respondents included four female and seven male acute
stroke care providers, comprising Consultant Neurolo-
gist (1), Neurologist (1), Physician Specialist (3), Senior
Medical Officer (3) and Medical Officer (3). Participants’
clinical practice experience ranged from three to twenty
years. Table 1 presents the characteristics of the study
hospitals and respondents. The next section presents the
results from the survey as displayed in Table 2.
Acute stroke presentation in hospitals
All participating hospitals have designated accident and
emergency departments where acute stroke patients are
first triaged. Only 9.1% of the hospitals reported the ex-
istence of locally developed protocols to support rapid
triage of stroke patients. Both local ambulance services
and private cars/taxis are used to transport acute stroke
patients to hospital, with respondents indicating the pre-
dominant means of transport being commercial vehicles
(taxi/cab). Local ambulance services were mostly used
when patients were referred from another hospitals.
Acute stroke diagnosis and assessment services
Available diagnostic and assessment services were di-
verse. Although 72.7% (8) of the study hospitals indi-
cated the availability of a CT scan, only 63.6% (7) of
these major referral hospitals had functional CT scan
machines at the time of the survey. Access to brain CT
scanning was only available 24 h/7 days in only 18.2%
(2) of the study sites, whilst the rest only had access to
these services during weekdays from 9 am–5 pm.
Availability of MRI scan services and other advanced
neurovascular diagnostic services such as electroenceph-
alogram and interventional radiology were very limited
(See Table 2). The survey showed only 36.4% (4) of the
hospitals indicated the availability of MRI scanning ser-
vices although only 27% (3) hospitals had functional
MRI services. These services were only available only on
weekdays from 9 am–5 pm. Carotid Doppler services
were available in 3 hospitals with similar limited access
during weekdays. None of the hospitals had specific
stroke clinical guidelines. Instead, a general guideline for
all health conditions known as the standard treatment
guideline from which some guidelines on acute stroke
care are embedded was available. Observations were
made by the first author to ascertain the availability of
CT and MRI brain scanning services in those study
hospitals.
Acute stroke care interventions and services
The survey revealed only 9.1% (1) of the study sites was
reported to have a stroke unit. All hospitals had general
medical wards for admissions and continuous in-patient
care post-accident and emergency wards. Although ele-
ments of a multidisciplinary team for acute stroke care
were evident, no functional and standardised one was re-
ported in any of the hospitals. Furthermore, no provision
of thrombolysis using tissue plasminogen activator for
acute ischemic stroke care was reported in any of the
study sites although 6 of respondents acknowledged
awareness of this therapy. This absence was attributed to
limited skilled personnel, cost and lack of national and
organisational (hospital) level support to provide this
therapy. In contrast, the use of aspirin for acute ischemic
stroke was reported in all the hospitals. Surgical proce-
dures for acute stroke care such as revascularization, de-
compressive craniotomy, arteriovenous malformation
treatment, surgery for aneurysm treatment were not
conducted in any of the study hospitals.
Stroke care workforce
Specialist health workforce for acute stroke care was
limited from the study. For example, the results showed
only 36.4% (4) of the hospitals reported having a neur-
ologist as part of the acute stroke care team whereas
27.3% (3) of the hospitals also indicated the availability
of a neurosurgeon to their acute stroke care workforce.
Other medical specialities (physician specialists) were re-
ported in 72.7% (8) of the study sites. The availability of
a speech therapists, occupational therapists and stroke
nurses or stroke care coordinators was not reported in
any of the study hospital. On the other hand, the avail-
ability of other acute stroke care staff in the study hospi-
tals was within appreciable levels. All hospitals reported
having medical doctors, nurses, physiotherapists and
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Table 2 Stroke services and availability in study hospitals
Thematic areas Stroke services evaluated Hospital response to available stroke services
Tertiary-Teaching
Hospitals (n = 4)
Regional Hospital
(n = 7)
Overall Total
(n = 11) %
Acute Presentation of stroke Accident and Emergency Department 4 7 11 (100.0%)
Local emergency department protocols
for rapid triage
1 0 1 (9.1%)
Common means of stroke patient
transport to hospital
− Local ambulance services 0 0 0 (0.0%)
− Taxi/Private transport arrangement 4 7 11 (100.0%)
Diagnosis and Assessment Services Functional CT Scan Service 3 4 7 (63.6%)
CT scanner (24/7) 2 0 2 (18.2%)
CT scanner (weekdays 9 am–5 am) 2 4 6 (54.5%)
Functional MRI Scan Service 3 1 4 (36.4%)
MRI (24/7) 0 0 0 (0.0%)
MRI (weekdays 9 am–5 am) 3 1 4 (36.4%)
Electrocardiogram (ECG) 4 5 9 (81.8%)
Electroencephalogram 2 0 2 (18.2%)
Neurovascular ultrasound diagnostic
services e.g. Carotid Doppler Services
2 1 3 (27.3%)
Magnetic Resonance Angiography 3 0 3 (27.3%)
Computed Tomographic Angiography 4 4 8 (72.7%)
National Institute of Health Stroke
Scale (NIHSS)
2 2 4 (100.0%)
Acute Stroke services, treatments and
rehabilitation services
Dedicated stroke unit (ward) 1 0 1 (9.1%)
General (Medical) Ward 4 7 11 (100.0%)
Multidisciplinary stroke care team 0 0 0 (0.0%)
Thrombolytic therapy (t-PA) 0 0 0 (100.0%)
Aspirin (antiplatelet) 4 7 11 (100.0%)
Early discharge care plans 4 7 11 (100.0%)
Revascularization (Carotid Endarterectomy) 0 0 0 (0.0%)
Decompressive surgery (craniotomy) 0 0 0 (0.0%)
Arteriovenous Malformation Treatment 0 0 0 (0.0%)
Surgery for Aneurysm 0 0 0 (0.0%)
On site rehabilitation services 4 7 11 (100.0%)
Stroke care workforce Clinical psychologist 4 4 8 (72.7%)
Trained Stroke Nurses 1 0 1 (9.1%)
Physician Specialist 4 4 8 (72.7%)
Neurosurgeon 3 0 3 (27.3%)
Medical Officer 4 7 11 (100.0%)
Nurse 4 7 11 (100.0%)
Neurologist 3 1 4 (36.4%)
Emergency department staff 4 7 11 (100.0%)
Stroke care coordinator 0 0 0 (0.0%)
Occupational therapist 0 0 0 (0.0%)
Physiotherapist 4 7 11 (100.0%)
Speech pathologist 0 0 0 (0.0%)
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emergency department staff. In addition, clinical psy-
chologists and social workers were also found in seven
of the eleven hospitals.
Health policy support for stroke care
Respondents indicated no direct health policy support
from the state or national level for stroke care, or a na-
tional stroke policy framework, or national stroke clinical
guideline existed. The common form of state support was
a broad-based support for improvement of care across all
hospital units and health conditions. Respondents re-
ported that a national policy on non-communicable dis-
eases existed but was yet to be operationalised as a full
national policy framework due to lack of political will. On
available opportunities for staff professional development
and stroke care quality improvement programs, respon-
dents reported that although all hospitals had policies to
support staff develop professionally, these were not being
implemented due to lack of funds. Only two hospitals had
a stroke-specific database although all hospitals had a
common database for all health conditions. No national
level or hospital level community stroke awareness pro-
grams were reported.
Discussion
To our knowledge, this is the first study to present infor-
mation on the availability of best practice hospital level
facilities for acute stroke services in Ghana. Importantly,
the results from this study has clarified current uncer-
tainties and speculation about the extent of evidence-
based practice uptake for stroke care in a LMIC. Overall,
the results suggest a limited adoption of evidence-based
acute stroke care interventions, with the provision of a
stroke unit care in only a single study hospital and no
reported application of thrombolytic therapy as well as
limited access to surgical procedures for acute stroke
treatment. However, the use of aspirin for acute ische-
mic stroke was common to all study sites. Brain scan-
ning services especially CT scans were often available
but underutilised due to high cost of access. On the
other hand, access to MRI and other advanced diagnos-
tic services were more limited in the regional hospitals.
Overall, national and hospital level health policy initia-
tives to support acute stroke care specifically were lim-
ited. This study also demonstrated that despite overall
shortages in the specialist health workforce for acute
stroke (especially neurologists), shortage of specialists
were more predominant in the regional hospitals than
the teaching hospitals.
Globally, emergency transport systems via ambulance
and other emergency medical transport services are re-
ported to support early and safe arrival for immediate
provision of appropriate care to facilitate optimal patient
health outcomes [47, 48]. However, the use of taxis or
private cars was the commonest means of transport to
hospitals by stroke patients in the present study, a
Table 2 Stroke services and availability in study hospitals (Continued)
Social worker 4 7 11 (100.0%)
Dietician 4 7 11 (100.0%)
Health policy support for stroke care Staff professional development and
quality improvement for stroke care
0 0 0 (0.0%)
National level support/ policies for
stroke care
− High 0 0 0 (0.0%)
− Average 0 0 0 (0.0%)
− Low 0 0 0 (0.0%)
− No support 4 7 11 (100.0%)
Hospital level support/policies for
stroke care
− High 0 0 0 (0.0%)
− Average 0 2 2 (18.2%)
− Low 2 1 3 (27.3%)
− No support 2 4 6 (54.5%)
Stroke register/Database 2 0 2 (18.2%)
Community/hospital stroke awareness
program
0 0 0 (0.0%)
Access to community stroke rehabilitative
programs
0 0 0 (0.0%)
Note: The listed numbers within the body of the tables indicate a “yes” answer
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situation which may lead to considerable delays in pa-
tient arrival for care. This has the potential to comprom-
ise prompt and safe responses for acute stroke patients
in the major referral hospitals. Although this study re-
ported the presence of a stroke unit in only one study
hospital, this finding further corroborates previous re-
ports indicating the limited provision of stroke unit care
in LMIC [26, 27]. The stroke unit that was reported in
this study is a six-bed capacity unit, found within a lar-
ger medical ward. Given the finding of only a single
stroke unit of the eleven major referral hospitals in this
study, it means the general medical wards represented
the predominant acute stroke care wards despite evi-
dence of less optimal patient outcomes compared to a
stroke unit [19].
Additionally, evidence of no provision of thrombolytic
therapy from the study finding supports earlier studies
asserting the limited uptake of this treatment option in
LMIC [28, 49, 50]. This requires policy attention to sup-
port the provision of thrombolytic therapy in these
major referral hospitals in view of the substantial effects
of this therapy on stroke survival. The widespread use of
aspirin therapy by all study hospitals for acute stroke
care may reflect this intervention as an inexpensive choice
and easy to administer in clinical settings [51, 52]. The up-
take of aspirin could further be maximised with enhanced
access to brain scanning devices to ensure eligible patients
are treated with aspirin.
Although seven of eleven study sites provided brain
CT scan services, access was limited only to weekdays
(9 am–5 pm). This has important implications for early
access to appropriate care given that improved patient
outcomes are often time-dependent [53]. This highlights
the need for improved access to brain imaging services
in hospitals, especially regional, because most stroke pa-
tients are likely to be treated in non-teaching hospitals
before they are referred to tertiary teaching hospitals.
The importance of this is heightened by the fact that pa-
tient referral to such tertiary hospitals is however largely
dependent on the financial capacity of the patient. Al-
though there is still lack of clarity on the direct influence
of access to brain CT scanning services on mortality and
morbidity, without early access to brain scan services,
there is high potential for inappropriate provision of care
to patients (e.g. inadvertent administration of aspirin
therapy to a haemorrhagic stroke patient).
The considerable deficit in the human resource cap-
acity to treat acute stroke patients in all study sites, es-
pecially in regional hospitals, is also noteworthy. Acute
stroke care by a neurologist was limited to four of eleven
study hospitals whilst care provided by occupational and
speech therapists were not reported in any of the hospi-
tals. This gap will likely inhibit effective patient evalu-
ation for impairment and disability. For example, given
that the incidence of dysphasia following an acute stroke
is around 37–78% [54], the absence of speech therapist
to conduct effective assessment and support likely com-
promises the quality of life of stroke patients with dys-
phasia. These results reaffirm the limited availability of
acute stroke care workforce asserted in previous studies
[55–57]. In a key report [57] outlining the principal chal-
lenges compromising global efforts to control the in-
creasing burden of non-communicable diseases such as
stroke, the issue of inadequate skilled health work force
was highlighted. This indicates an important gap in the
capacity of the health care systems to provide acute
stroke care, although regional hospitals require more
policy attention, particularly via rehabilitative specialists,
neurologists, neurosurgeons and other stroke specialists
to support optimal recovery in view of reduced in-patient
stroke mortality and dependency at discharge following
treatment by neurologists [58]. As demonstrated in
Nigeria [59], in sub-Saharan Africa, a study on task shift-
ing of specialist stroke work force roles to non-specialists
demonstrated improved knowledge on acute stroke care
and so this could be explored by the Ghanaian health pol-
icy makers and managers as a short term measure to ad-
dress the current stroke workforce deficit.
The absence of national level support for acute stroke
care, limited funding from hospital management, no com-
munity/hospital stroke awareness program, and state sup-
ported community stroke rehabilitative programs reported
in this study raises important health policy questions
about the state’s readiness and commitment to reducing
the increasing stroke burden. Long-term and community-
level care after in-patient care remains largely a family
responsibility in the absence of a community level re-
habilitative care. This augments earlier reports of limited
health policy commitment to address the current disease
burden posed by stroke and other non-communicable dis-
eases in Ghana [39, 60–63]. It also concurs with reports of
low prioritization of stroke care in the health policy
agendas of most LMIC [64–67]. Contextualising this
within the global health policy support for stroke, the
deficit in health policy support in this study under-
scores previous reports of inadequate global health
funding for stroke and other non-communicable dis-
eases [3, 68]. For example, the Institute for Health
Metrics and Evaluation recently reported that only
1.3% of overall donor support for health was allocated
to NCDs in 2015 [68]. As demonstrated in some
other LMIC [69, 70], the capacity of Ghanaian health
systems could be improved to address the growing
stroke burden by increasing funding and infrastruc-
tural support, training for more stroke specialists, for-
mulating evidence-informed policies, plans, treatment
guidelines and strategies to support effective acute
stroke diagnosis and treatment.
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Table 3 World Stroke Organization checklist for health service capacity for acute stroke care
Component of acute stroke service Service availability
Tertiary-Teaching
Hospitals (n = 4)
Regional Hospital
(n = 7)
Overall Total
(n = 11) %
Advanced stroke services
Access to advanced diagnostic services
− Magnetic Resonance Angiography 3 0 3 (27.3%)
− Computed Tomographic Angiography 4 4 8 (72.7%)
− Electroencephalogram 0 0 0 (0.0%)
− Electrocardiogram (ECG) 4 5 9 (81.8%)
− Neurovascular ultrasound diagnostic services, e.g. Carotid Doppler Services 3 0 3 (27.3%)
− Magnetic Resonance Imaging 4 1 5 (45.5%)
− Computed Tomographic Scan 4 4 8 (72.7%)
Access to physicians with stroke expertise (and physician specialists)
− Neurologists 3 1 4 (36.4%)
− Neurosurgeon 3 0 3 (27.3%)
− Physician Specialist 4 4 8 (72.7%)
Access to advanced acute stroke care interventions
− Stroke unit care 1 0 1 (9.1%)
− Tissue plasminogen activator (t-PA) 0 0 0 (0.0%)
− Decompressive surgery 0 0 0 (0.0%)
− Arteriovenous Malformation Treatment 0 0 0 (0.0%)
Surgery for Aneurysm 0 0 0 (0.0%)
Revascularization (Carotid Endarterectomy) 0 0 0 (0.0%)
Access to specialist rehabilitation therapists
− Physiotherapists 4 7 11 (100.0%)
− Occupational Therapists 0 0 0 (0.0%)
− Speech Therapists 0 0 0 (0.0%)
Access to community programs for recovery after stroke 0 0 0 (0.0%)
Essential stroke services
Access to basic diagnostic services
− Laboratory 4 7 11 (100.0%)
− ECG 4 5 9 (81.8%)
− Computed Tomographic Scan (CT scan) 4 4 8 (72.7%)
− Neurovascular ultrasound diagnostic services 3 0 3 (27.3%)
− National Institutes of Health Stroke Scale (NIH) 2 2 2 (18.2%)
Access to nurses 4 7 11 (100.0%)
Access to physicians, not necessarily stroke specialists 4 7 11 (100.0%)
Access to acute thrombolysis with t-PA 0 0 0 (0.0%)
Access to stroke unit care 1 0 1 (9.1%)
Antiplatelet (Aspirin) therapy 4 7 11 (100.0%)
Access to rehabilitation services 4 7 11 (100.0%)
Minimal healthcare services
Variable access to healthcare workers (nurses or lay workers) 4 7 11 (100.0%)
Very limited access to physicians 0 2 2 (18.2%)
No access to diagnostic services or hospital care 0 0 0 (0.0%)
Care provided in local communities 0 0 0 (0.0%)
Note: The listed numbers within the body of the tables indicate a “yes” answer
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The historical development gap between northern
Ghana and the rest was also evident in the inequitable dis-
tribution of stroke services across the study sites. Overall,
the tertiary hospitals were much more equipped with
modern stroke services to support standard care com-
pared to the regional hospitals. However, the major refer-
ral hospitals in the northern part of Ghana recorded
limited evidence-based acute stroke services. For example,
apart from the single tertiary hospital in northern Ghana,
the other two northern regional hospitals do not have CT,
MRI brain scanning services or a neurologist. This finding
reinforces earlier reports of limited access to health care
facilities in the northern parts of Ghana and has often re-
sulted in poor health outcomes compared to the other
parts of Ghana [39, 71, 72]. To address this, an affirmative
action in the form of health policy reforms to address this
situation will be in the right direction.
Based on the global stroke services guideline for stroke
care proposed by the World Stroke Society [25] as re-
ported in Table 3, this study suggests an overall limitation
in the capacity of the health care system in both teaching
and regional hospitals to provide advanced evidence-
based acute stroke services. The present study results
shows the major tertiary - teaching hospitals have more
capacity to provide most of the essential elements of the
evidence-based acute stroke care recommendation com-
pared to the regional hospitals despite the fact that re-
gional hospitals first receive most of the acute stroke cases
before likely referring to a teaching hospital. In general,
the current results underline the overarching scope and
need to improve evidence-based practice for acute stroke
care in resource poor countries such as Ghana.
Strengths and limitations
This study is the first to inform on availability of
evidence-based acute stroke care interventions in Ghana.
An added strength relates to its focus on regional and
tertiary-teaching hospitals being the major referral hos-
pitals in each administrative region in Ghana, gives the
study a national character with potential generalizable
results and relevance to other low-middle income settings.
However, this was a descriptive study which limited our
ability to evaluate the effects of these services on patient
clinical outcomes. This study was also limited in scope by
restriction to eleven public regional and teaching hospitals
and excluding private and non-regional hospitals. Future
studies should focus on both public and private hospitals
to achieve better representation.
Conclusion
A growing body of evidence on effective acute stroke
care interventions exist. However, results from this study
highlight limited access to these services especially in
the regional non-tertiary teaching hospitals. Significant
effort is required to ensure acute stroke patients access
the best care not only in tertiary but also regional hospi-
tals given that not all acute stroke patients can afford
care in teaching hospitals.
Based on this study, it is clear Ghana is yet to ad-
equately translate in health policy wise its global com-
mitments to reducing the global burden of stroke. An
overall improvement in national policy for stroke care is
needed. This should be well targeted and equity-based
given the significant disparities found across these major
referral hospitals in our study. With current projections
of a global rise in stroke incidence and the increasing
aging population, demand for acute stroke care will in-
evitably witness further increase and so there is consid-
erable scope to improve acute stroke care in low middle
income countries such as Ghana in order to minimise
premature stroke-related mortality and disability.
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Additional file 1: Survey Instrument: Acute Stroke Care Services in
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4.2.1 Overview and rationale 
This section presents results of a retrospective cohort study to evaluate acute stroke patients’ 
in-patient mortality outcomes data to highlight the efficacy levels of existing acute stroke care 
interventions. Two key rationales informed the conduct of this study. First, there is general 
dearth of information on acute stroke treatment and patient outcome data in Ghana and most 
parts of Africa. Second, the quality of data from the few existing studies which have attempted 
to shed light on this problem are problematic. Most of such studies lack methodological rigour, 
used small sample sizes and with limited provisions to control the effect of confounding factors 
in the eligible studies which limited firm conclusions about the efficacy of the acute stroke care 
interventions. These assertions have been underscored by findings of the first systematic review 
in chapter two which highlights the paucity of information and limited nature of quality data 
on the eligible studies in the review. The above reasons emphasized the need for further 
research to bridge the knowledge gap and for robustly designed studies to report on the patient 
outcomes following acute stroke care in LMICs such as Ghana. As a result, a retrospective 
cohort study was conducted and the findings reported herein.  
Overall, the findings provide further evidence of high in-hospital mortality and varied levels of 
care for acute stroke patients in most LMICs. Importantly, aspirin intake was found as the most 
predominant acute stroke care therapy and this resulted in improved in-patient mortality 
outcomes. Hypertension was also highlighted as the most significant risk factor and predictor 
of in-patient mortality outcomes. In light of the limited and variable delivery of contemporary 
acute stroke care interventions, and a high case fatality rate in this study cohort, the need for 
increased policy attention to improve acute stroke care is imperative. The findings of this study 
are organised and reported in a typical research paper format, yet to be submitted for 
publication. The manuscript reporting the findings of this study is reported in the next section. 
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Abstract 
Rational aims and objectives 
In-hospital mortality following acute stroke varies across acute care settings globally. 
However, treatment outcomes after stroke in Ghana and most parts of the developing world 
remains limited. This study aims to compare in-hospital mortality following first acute stroke 
treatment in patients admitted to stroke, medical emergency or general medical wards in Ghana. 
Methods  
In a retrospective cohort study, consecutive patients with acute stroke, admitted to six major 
referral hospitals, were selected randomly using a probabilistic stratified sampling method 
aiming to have a sample of 50 patients from each hospital. Data relating to patient 
characteristics, medical condition, and mortality were extracted by medical chart review. 
Patients were followed from admission through to discharge from the hospital or death. A 
multivariable logistic regression was constructed to compare mortality according to ward of 
care after accounting for length of stay, demographic and medical risk factors.  
Results  
Patients (N=300) were recruited from three acute care admitting wards in six hospitals. Patients 
had diverse demographic and clinical characteristics. No significant age differences were 
observed between wards (p = 0.5). Compared to other wards, the stroke ward admitted stroke 
patients with more co-morbidities. Further, significantly more patients with haemorrhagic 
stroke were admitted to the stroke ward (48% compared to 22.4% in the medical emergency, 
and 14.9% in the medical wards, p < 0.001. Overall, in-hospital mortality rate was 31.7% at 30 
days for all admissions. Multivariate logistic regression analysis showed less in-hospital 
mortality among patients given aspirin, adjusted-OR 0.484, 95% CI 0.27 – 0.86, p = 0.013, but 
significantly more among those with hypertension, adjusted-OR 1.86, 95% CI 1.06-3.27, 
p=0.032. No significant differences in in-hospital mortality were observed between the wards. 
Conclusions 
These findings provide further evidence of elevated in-hospital mortality and varied levels of 
care from stroke in a developing country setting. Policy support to improve access to evidence-
based care may facilitate optimal in-patient outcomes. 
Keywords: Stroke, Acute care, mortality, outcome evaluation, process of care, in-hospital 
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Background 
Despite considerable therapeutic advances for acute stroke care in recent times, in-hospital 
mortality from stroke is still a major concern worldwide. The latest global burden of stroke 
study reported that about 5.9 million stroke-related deaths were recorded in 2010 of which 71% 
occurred in low-middle income countries (LMICs) [1], highlighting inequity in global stroke 
burden.  
In Ghana, although national stroke data are scant, current evidence suggests a rise in incidence 
and associated mortality [7, 9, 10, 74, 75]. Based on the country data from the global burden 
of stroke study, there has been over 100% increase in absolute stroke related deaths (2,484 in 
1990 to 5,771 in 2010) [1]. Further evidence suggests that in-hospital mortality following acute 
stroke in Ghana ranges from 41% to 43% [10, 76, 77]. In contrast, in-hospital stroke case 
fatality rates in developed countries are as low as 8% in France [6]. It is argued that the poor 
in-patient outcomes in LMICs such as Ghana are attributable to poor prognosis of acute stroke, 
limited medical facilities such as brain scanning services, a limited specialist workforce for 
acute stroke care and limited access to effective acute stroke care interventions such as stroke 
unit care and thrombolytic therapy [26, 36, 55, 56, 78]. Results from a study in South Africa 
demonstrating poor in-patient outcomes in general wards exemplifies this point [79]. Based on 
this, some stroke scholars suggest the quality of acute stroke care in these countries is below 
global standards [26-28, 37, 80]. Yet, data on clinical outcomes following treatment of acute 
stroke patients remains limited in most parts of the developing world. 
To our knowledge, research in Ghana on in-hospital mortality following acute stroke is limited 
to two teaching hospitals [7, 10, 77, 81] despite acute stroke care responsibilities extending to 
regional hospitals also. Despite evidence that the quality of such care can be affected by patient 
and treating wards characteristics [82, 83], it is however not clearly known how patient 
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characteristics and treatment outcomes such as in-hospital mortality differ across different 
admitting wards in Ghana. Therefore, this study compared in-hospital mortality following first 
acute stroke in patients among three stroke admitting wards: stroke, medical emergency and 
general medical wards with the objective of providing useful and comprehensive insights for 
future planning efforts to improve stroke care in Ghana, with potential applicability in other 
developing countries. 
Methods 
Ethics Approval 
This study received ethical approval from the University Human Research Ethics Committee 
(2015-154H), the Ghana Health Service Ethical Review Committee on Research Involving 
Human Subjects (GHS-ERC: 11/07/15), the Committee on Human Research Publications and 
Ethics of the School of Medical Sciences of the Kwame Nkrumah University of Science and 
Technology and the Komfo Anokye Teaching Hospital (CHRPE/AP/141/16). Ethical approval 
was also received from the Institutional Review Board of the 37 Military Hospital (37MH-IRB 
IPN 035/2015). The need for informed consent from patients was waived by the ethical 
committees due to de-identified data being used. 
Study Design and Setting  
Data from this study forms part of an original research conducted in Ghana to examine the 
provision of hospital services for the treatment and management of acute stroke patients. The 
study followed a multi-site hospital-based retrospective cohort design conducted in three major 
referral tertiary (teaching) and three regional (non-teaching) hospitals situated in the southern, 
middle, and northern regions of Ghana. Hospitals were purposively selected to take into 
account the geographic and socio-economic contrasts among the administrative regions of 
Ghana. Unlike regional hospitals, tertiary hospitals serve as larger referral centres for the whole 
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country and are well-resourced with diagnostic and therapeutic facilities. These tertiary 
hospitals are also semi-autonomous and serve as academic centres offering training in a range 
of highly specialised medical or clinical options. Regional hospitals also have the capacity to 
deal with acute stroke care and complications, although complicated cases are usually referred 
to tertiary hospitals. All study hospitals had accident and emergency department wards where 
acute stroke patients are first assessed and stabilised before being transferred to the three 
separate admitting wards, namely: stroke, medical emergency or general medical ward. The 
stroke ward is a designated admitting ward for stroke patients only, whereas the medical 
emergency ward provides intensive care to all acute cases including stroke. Patients were 
recruited from the general medical ward who had been admitted after assessment and 
stabilisation in an accident and emergency ward. Data were collected from the three wards in 
six hospitals, thus constituting the unit of analysis in this study. 
Population and Sampling  
Sample size calculation was based on an African study which found that 16% of those treated 
in a stroke ward died compared to 33% in medical wards [79]. Using a two-sided alpha of 0.05, 
power of 0.8, ratio of treatment of groups of 3:1, and proportions described above, the study 
needed a total of 284 patients with 71 being treated in specialised acute wards. Based on this 
study, a sample size of 300 patients was determined for this study. 
Inclusion and exclusion criteria:  All adult patients (aged ≥ 18) admitted to hospital for their 
first acute stroke in 2014 were eligible to be included in this study. Selection was based on a 
recorded diagnosis of acute stroke in the patient’s medical chart. Patients were excluded if they 
had recurrent strokes, or if they were diagnosed with transient ischemic attacks or any 
neurological deficits arising from a non-cerebrovascular cause or non-stroke diagnosis, or if 
clinical records were incomplete via limited clinical information to address the study aim.   
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Sampling method: Using the admissions and discharge logbooks as the sampling frame, a 
systematic sex-stratified random sampling technique was used to select the study population 
treated for acute stroke between January and December 2014 in each of the participating 
hospitals. In this procedure, every fifth individual enlisted in the admission and discharge 
logbooks as having an acute stroke was selected and their identification numbers noted. Based 
on this, 50 past stroke cases in each hospital, comprising approximately 25-females and 25-
males were included. Identification numbers were used by health information personnel to 
manually retrieve patient folders from the medical records unit of each hospital. Where 
retrieved patient medical records had limited information to address the study aim, random 
sampling of patient medical records continued by the researcher according to the above 
protocol until the required sample was met. 
Data Collection  
Using a paper-based structured data collection form, I extracted all medical and 
sociodemographic information relevant to the study from the patient medical records, discharge 
summary notes and case notes. Data collected included clinical demographic information (age, 
sex and employment status/type), patient admission and discharge information, and the process 
of care indicators where available. Data were primarily limited to whether the patient was 
admitted and treated in a stroke ward, general ward or a medical emergency ward. Data were 
also limited to treatment with thrombolytic therapy, aspirin or access to a brain scan. Other 
information such as co-morbidities, medical diagnoses of stroke subtype, stroke risk factors 
(hypertension, atrial fibrillation, asthma, smoking, diabetes and obesity) were recorded. 
The admission and discharge record books are prospective registers of all consecutive patients 
with a wide range of health conditions admitted to hospitals for clinical care. Health 
information officers (patient records personnel) assisted in the retrieval of patient folders at 
172
each of the study sites. All extracted data were de-identified and coded to ensure data 
anonymity.  
Statistical Analysis 
Pearson chi-square tests were used to compare categorical variables and the Kruskal Wallis test 
was used to compare mean differences between various groups. Survival was calculated from 
the day of hospital admission until discharge. Kaplan Meier survival curves were constructed 
to compare survival between male and female patients. The log rank test was used to evaluate 
differences in survival curves. Multivariate logistic regression was conducted to identify 
independent predictors of in-hospital mortality following acute stroke while accounting for 
collected demographic, medical, and other risk factors and length of stay in hospital. Covariates 
with a p value of < 0.4 from the bivariate logistic regressions that assessed the association of 
each variable and death were included in the multivariate model. Goodness of fit of the 
multivariable model was assessed by Hosmer-Lemeshow test. Statistical significance was set 
at a p value of <0.05 (two-sided). All analyses were conducted using SPSS version 22.0. 
Results 
Demographic and Clinical Characteristics  
A total of 300 acute stroke patients from three regional hospitals and three tertiary teaching 
hospitals. Table 1 shows the characteristics of patients according to admission into three 
separate hospital wards. A total of 99 patients (33.0%) were recruited from acute care wards 
(50 from a stroke ward and 49 from a medical emergency ward) and the remaining 201 (67.0%) 
came from four general medical wards. Confirmation of a stroke subtype through a brain CT 
scan was available in 40% (120) of the sample population. No age differences were observed 
between patients admitted to the different wards. The mean age (standard deviation) were 59.2 
(15.9), 59.3 (15.9) and 61.4 (16.4) years for stroke ward, medical emergency ward and general 
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medical wards (p = 0.5), respectively. Compared to other wards, those admitted in the stroke 
ward were more often males and more likely to have co-morbidities such as hypertension and 
atrial fibrillation. Significantly more patients with haemorrhagic stroke were admitted to the 
stroke ward (48% compared to 22.4% in the medical emergency ward, and 14.9% in the 
medical ward, p < 0.001). Furthermore, compared to the other two wards, the stroke ward 
admitted more male stroke patients, with a history of smoking (30%) and alcohol consumption 
(22%). The median length of hospital stay was 6.0 days (range 0-163 days). No statistically 
significant differences in the length of stay between males and females were observed (p = 
0.17). The mean length of stay was 7.0 and 10.2 days for males and females, respectively. 
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Table 1: Demographic and Clinical characteristics of acute stroke patients by admitting hospital wards 
Characteristics Stroke unit 
N=50 (16.7%) 
Medical Emergency 
Ward 
N=49 (16.3%) 
General Medical 
Ward 
N=201 (67.0%) 
P value! 
Age, mean (SD), range years 
      
59.2 (15.9), 30-87 
 
59.3 (15.9), 25-86 61.4 (16.4), 18-92 0.5 
 
Sex, % 
     Females 
     Males  
 
44.0 
56.0 
 
67.3 
36.7 
 
49.8 
50.2 
 
0.043 
Type of stroke, % 
     Ischemic      
     Haemorrhagic 
     Not documented 
 
38.0 
48.0 
14.0 
 
30.6 
22.4 
46.9 
 
20.4 
14.9 
64.7 
 
 
<0.001 
Hypertension, % 58.0 26.5 34.3 0.002 
Diabetes, % 40.0 24.5 30.3 0.234 
Atrial Fibrillation, % 44.0 22.4 22.9 0.008 
Asthma, % 4.0 0.0 10.9 0.021 
Obesity, % 20 22.9 19.4 0.861 
Smoking, % 30.0 6.1 18.4 0.009 
Alcohol consumption, % 22.0 4.1 10.9 0.018 
! Between-group comparisons were analysed using the non-parametric Kruskal-Wallis test, whereas proportions 
were compared using Chi-square tests. Statistical significance was determined at p value = < 0.05. 
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Process of Care 
Patients admitted to a stroke ward were more likely to receive a brain scan (70%) compared to 
53.1%  and 29.4% in medical emergency and general medical wards, respectively (p = 0.001). 
Provision of in-patient care using thrombolytic therapy (t-PA) was not found in any study site. 
No statistically significant differences were observed among the three different hospital wards 
relating to aspirin administration, or provision of care by physiotherapists, dieticians, or clinical 
psychologists (See Table 2).  
Table 2: Process of medical care  indicators for patients with acute stroke by admitting hospital 
ward 
Process of medical 
care 
Stroke unit 
N=50 (16.7%) 
Medical Emergency 
Ward 
N=49 (16.3%) 
General Medical 
Ward 
N=201 (67.0%) 
p value 
Brain scan, % 70.0 53.1 29.4 <0.001 
Aspirin intake, % 38.8 51.0 55.5 0.109 
Physiotherapist,% 58 55.7 62.3 0.590 
Dietician, % 26 26.1 24.6 0.966 
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In-hospital mortality  
The overall in-hospital mortality rate was 31.7% (95) for all admissions within the sample 
population with risk of dying over time marginally higher among males as shown in the Kaplan 
Meier graph (Figure 1), although this difference did not reach statistical significance (log rank 
test p = 0.06). The total case fatality rate for males within 48 hours was 15.2% compared to 
9.0% for females (p =0.102), and one-week rates were 24.8% for males and 19.4 for females 
(p = 0.25). See Table 3. 
Figure 1. Kaplan-Meier Survival Estimates for acute stroke patients according to sex 
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Table. 3: Proportions of In-hospital mortality at 48hours, 1week, 2weeks and 30days by gender  
Study variables 48-hours 1-week 2-weeks 30-days In-hospital 
Mortality 
Sex, % 
        Male  
 
        Females  
 
15.2 
 
9.0 
 
24.8 
 
19.4 
 
30.3 
 
25.2 
 
33.1 
 
28.4 
 
34.5 
 
29.0 
P-value 
 
0.10 
 
0.25 
 
0.32 
 
0.38 
 
0.31 
Overall % 
 
12.0 
 
22.0 
 
27.7 
 
30.7 
 
31.7 
 
 
Bivariate logistic regressions (Table 4), showed that survival of patients in a stroke ward was 
not different to that in a medical emergency ward; Odd Ratio (OR) = 1.3, 95% Confidence 
Interval (CI) 0.7-2.5, p = 0.4. Hemorrhagic stroke was associated with increased mortality, 
OR= 2.5, 95% CI 1.23–5.16, p = 0.011, and patient history of hypertension also increased 
mortality odds, OR=1.9, 95% CI 1.15–3.12, p = 0.012. Conversely, aspirin usage was 
associated with less in-hospital mortality; OR of 0.41, 95% CI 0.25 – 0.68, p = 0.001. Staying 
fewer days in hospital was associated with less mortality; OR 0.96, 95% CI 0.92 – 0.99, p = 
0.025. 
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Table 4: Odds ratios for in-hospital mortality: logistic univariate analysis 
 Odds ratio, 95% CI p value 
Admitting ward 
     Stroke unit 
     Medical emergency ward 
     Medical ward (reference) 
 
1.32 (0.7 – 2.5) 
1.25 (0.64 – 2.42) 
1.00 
 
0.4 
0.5 
Age categories, years 
18-50 
51-61 
62-75 
76 + 
 
1.00 
0.92 (0.45 – 1.88) 
1.32 (0.68 – 2.57) 
1.44 (0.74 – 2.84) 
 
 
0.8 
0.4 
0.3 
Female sex 0.78 (0.48 – 1.27) 0.3 
Type of stroke 
     Ischemic (reference) 
     Haemorrhagic 
     Not documented 
 
1.00 
2.53 (1.23 – 5.16) 
1.19 (0.64 – 2.22) 
 
 
0.011 
0.6 
Hypertension 1.90 (1.15 – 3.12) 0.012 
Diabetes 1.06 (0.64 – 1.75) 0.8 
Atrial Fibrillation 1.03 (0.56 – 1.90) 0.9 
Asthma 0.80 (0.30 – 2.10) 0.6 
Obesity 1.27 (0.66 – 2.44) 0.5 
Smoking 1.18 (0.62 – 2.25) 0.6 
Alcohol consumption 1.30 (0.57 – 2.96) 0.5 
Brain scan 1.14 (0.69 – 1.86) 0.6 
Aspirin intake 0.41 (0.25 – 0.68) 0.001 
Physiotherapist 0.71 (0.44 – 1.17) 0.2 
Dietician 0.91 (0.51 – 1.61) 0.7 
Length of stay (continuous) 0.96 (0.92 – 0.99) 0.025 
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In multivariable logistic regression adjusted for all variables listed in Table 5, aspirin intake 
was significantly associated with less mortality. Those who took aspirin immediately after they 
were admitted were 52% less likely to die compared to no aspirin treatment; adjusted OR 0.48, 
95% CI 0.27 – 0.86, (p = 0.013). Hypertensive patients were 86% more likely to die than those 
without hypertension, adjusted-OR 1.86, 95% CI 1.06 – 3.27, p = 0.032. No statistically 
significant differences in in-hospital stroke mortality were observed between the wards. 
 
Table 5: Odds ratios for in-hospital mortality following acute stroke: multivariable logistic analysis 
 Odds ratio, 95% CI p value 
Admitting ward 
     Stroke unit 
     Medical emergency ward 
     Medical ward (reference) 
 
0.95 (0.44 – 2.05) 
1.35 (0.65 – 2.80) 
1.00 
 
0.9 
0.4 
Age categories, years 
     18-50 
     51-61 
     62-75 
     76 + 
 
1.00 
0.90 (0.42 – 1.95) 
1.66 (0.80 – 3.43) 
1.62 (0.78 – 3.36) 
 
 
0.8 
0.2 
0.2 
Female sex 0.79 (0.44 – 1.39) 0.4 
Type of stroke 
     Ischemic (reference) 
     Haemorrhagic 
     Not documented  
 
1.00 
1.74 (0.75 – 4.02) 
1.05 (0.53 – 2.11) 
 
 
0.2 
0.9 
Hypertension 1.86 (1.06 – 3.27) 0.032 
Atrial Fibrillation 1.12 (0.57 – 2.21) 0.7 
Asthma 0.66 (0.22 – 1.93) 0.4 
Smoking 1.19 (0.57 – 2.53) 0.6 
Alcohol consumption 1.37 (0.54 – 3.48) 0.5 
Aspirin intake 0.48 (0.27 – 0.86) 0.013 
Physiotherapy 0.75 (0.43 – 1.29) 0.3 
Length of stay, days (continuous) 0.96 (0.92 – 0.99) 0.026 
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Discussion 
This study sought to evaluate risk adjusted in-hospital mortality outcomes of acute stroke 
patients in three admitting wards after initial assessment and stabilization in the accident and 
emergency departments of the study sites. Patients admitted in a stroke unit were more likely 
to receive a brain scan compared to the medical and general medical wards. Our study found 
no significant association between in-hospital mortality and the three admitting wards even 
after adjusting for various risk factors. Given an overall 31.7% in-hospital mortality rate at 30 
days, the study findings support previous suggestions that the provision of best practice acute 
stroke care in LMICs is limited [26-28, 37]. Aspirin therapy for acute stroke patients proved to 
be a principal protective intervention among acute stroke patients in this study population.  
Overall, these findings provide new insights into in-hospital mortality outcomes after acute 
care in different admitting wards in a developing country context where data on in-hospital 
stroke mortality are limited. Whilst this finding corroborates a recent South African study [84], 
the finding that age did not predict in-hospital mortality differs from prior studies in Ghana [9, 
77], which showed age as a strong predictor of stroke in-hospital mortality. The present study 
findings are also inconsistent with extensive body of evidence in other countries where age has 
been reported as a predictor of in-hospital mortality following acute stroke [84-87]. This 
inconsistency may relate to the limited study sample. Although no current evidence exists to 
support this, such a finding could also have been attributed to less number of older stroke 
patients being admitted because of limited geographical and financial access to care. However, 
the mean age reported in this study did not differ from previous studies in Ghana [10, 76] and 
in other African countries [79, 88-91].  
Hypertension as a risk factor for in-hospital mortality had a significant association with in-
hospital mortality in both the univariate and multivariate logistical analyses. Similar to these 
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results, previous studies in Ghana also reported a statistically significant relationship between 
hypertension and in-hospital mortality [8, 81]. Previous works have also emphasized the 
significant role of hypertension as a risk factor to stroke associated mortality [6, 85, 92, 93]. 
Given that in-hospital stroke mortality was independently associated with patient history of 
hypertension, this emphasized the need for pragmatic measures to control hypertension and the 
other risk factors as primary drivers of stroke mortality in Ghana. 
Access to CT or magnetic resonance imaging (MRI) scanning to distinguish stroke subtype is 
highly recommended as best practice in acute stroke treatment [94, 95]. However, this is often 
lacking in LMICs [36, 55, 96]. In the present study, patients admitted to a stroke ward had 
better access to CT scans compared to other admitting wards. In Ghana, previous research 
reported access to CT scans  was limited due to patients’ financial constraints since the National 
Health Insurance does not cover these costs [97]. Comparable to our finding of increased access 
to CT scans in stroke ward admissions, a study in South Africa on multidisciplinary acute 
stroke care revealed that patients admitted to a stroke ward had increased accessed to CT 
scanning services compared to general ward [79]. Given that most patients in the present cohort 
did not receive a CT scan, a health policy to enhance access to brain scanning could potentially 
improve clinical outcomes.  
Consistent with previous evidence, the odds of death for hemorrhagic stroke patients were 
higher than ischemic stroke patients in univariate analysis. Although this association was not 
statistically significant in the adjusted model, this condition has clinical importance and further 
highlights the increased risk of deaths associated with hemorrhagic stroke patients worldwide. 
Prior studies in Ghana and other African countries have reported similarity of higher mortality 
risk in patients with hemorrhagic stroke [9, 77, 98]. This is comparable to in-hospital stroke 
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mortality risk in other LMICs compared to HICs [6, 85]. However, this contrasts with the latest 
report on the global burden of stroke where ischemic stroke mortality is much  higher [99].   
Unexpectedly, no statistically significant differences in in-hospital mortality across the three 
admitting wards were reported. Even though there is preponderance of evidence about the 
effect of patient care in a stroke unit on reduced in-patient mortality [12, 70, 71], with 
favourable outcomes up to 10 years post stroke [72, 73], evidence from this study reports no 
significant relationship with in-patient mortality. Such a finding is not uncommon as past 
studies have reported similar results [74, 75]. This finding could arise from a multiplicity of 
factors. Firstly, the nature of acute stroke care provided in these admitting wards could 
influence mortality outcomes.  Also, more severe patients from smaller non-tertiary hospitals 
are mostly referred to and admitted in wards of major tertiary hospitals thus exposing them to 
potentially admit more severe stroke patients with multiple comorbidities. Thirdly, the most 
likely residual confounding factor for in-hospital stroke mortality in this study was severity of 
stroke which could not be assessed in the present study due to limited documentation on 
severity scores in almost all study sites. This may be a source of bias in the present study as 
severity levels have been reported previously as a strong predictor of in-hospital mortality 
variation [82]. 
Although the efficacy of acute stroke interventions such as stroke ward care, thrombolytic 
therapy and aspirin administration has been widely studied, there is limited information about 
the levels of usage and efficacy in LMICs such as Ghana. Evidence from this study indicates 
limited access to stroke ward care and lack of evidence of thrombolytic therapy for acute 
ischemic stroke patients, which is consistent with previous studies asserting the limited nature 
of evidence-based acute stroke care in LMICs [27, 28, 49]. The capital-intensive nature of 
stroke unit care and the limited availability of specialized health staff to administer 
thrombolytic therapy are the likely reasons for these findings. However, the use of aspirin 
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therapy was revealed as the strongest protector of life for stroke patients after adjusting for 
possible confounding predictors of in-hospital mortality. As demonstrated in the multivariable 
logistic regression model, those taking aspirin were 60% less likely to die than those who did 
not take aspirin (Adjusted-OR = 0.40, 95% CI 0.2-0.7, p=0.002). As posited previously by 
researchers [51, 52, 100], the present finding on aspirin could be attributable to the cost-
effective nature of this therapy as well as the ease of its usage in clinical settings by care 
providers. This revelation accentuates the need for continuity of aspirin therapy for acute 
ischemic stroke patients in LMICs where access to stroke unit care and thrombolytic therapy 
are still limited. Notwithstanding this, due to limited access to brain scanning in the study 
hospitals and as reported in other studies in Africa [79, 101-104], it is plausible that aspirin 
therapy is still highly underused despite its proven efficacy. In order to improve patient clinical 
outcomes using aspirin, it is important for decision makers and health managers to formulate 
interventions to increase access to CT scanning and to optimize the use of aspirin among a 
greater proportion of eligible patients. 
Limitations and Strengths  
The present study did not account for stroke severity in adjusting mortality outcomes for the 
different case mix, thus presenting a potential confounding factor for in-hospital mortality. 
Only all-cause stroke-associated mortality was examined because information on the cause of 
in-hospital acute stroke mortality (confirmed through autopsy report) was limited. Nonetheless, 
this study is important in many respects. First, whilst providing further evidence on in-hospital 
mortality in Ghana and other LMICs where data are limited, the present findings provide new 
insights into in-hospital stroke mortality in different acute care wards in both teaching and non-
teaching hospitals. 
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Conclusion  
In this study, risk-adjusted in-hospital mortality outcomes in different admitting acute care 
hospitals were evaluated. Whilst adding to previous studies in Ghana on in-hospital stroke 
mortality, the present study findings were extended to include in-hospital mortality outcomes 
from non-tertiary teaching hospitals. No differences in in-hospital stroke mortality across the 
three wards were found. Aspirin therapy was demonstrated as a significant protector against 
in-hospital stroke mortality. Notwithstanding this, the overall high in-hospital stroke mortality 
rate of  31.7% at 30 days further highlights the need to improve acute stroke care such as 
improved health infrastructure and more specialist care in these and other hospitals by health 
policy makers and relevant stakeholders. Even though stroke risk factors such as hypertension, 
atrial fibrillation, asthma, alcohol intake and smoking were not reported as independent 
predictors of in-hospital stroke mortality, their emergence as contributory factors to in-hospital 
stroke mortality raise further concern on the need for more pragmatic statewide policies to 
control their occurrence. Controlled prospective studies and larger sample population data 
taking into account stroke severity scores are needed in future studies to provide definitive 
evidence on in-hospital mortality in these admitting hospital wards. This is an essential step 
towards efforts to improve acute stroke care and to further reduce the current disproportionate 
burden of stroke in LMICs such as Ghana. 
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4.3.1 Overview and rationale 
Global uptake of contemporary acute stroke care interventions is hampered by multiple 
barriers. Importantly, the uptake of current best practice interventions in LMIC remain low and 
there is limited contextualized information explaining reasons for the current situation in such 
settings. On the basis of this, the second systematic review reported in chapter two (Section B) 
presents information about the barriers to delivery of key contemporary acute stroke care 
interventions. The findings from this review highlighted multidimensional barriers. Also, 
barriers were focused more on the uptake of thrombolysis. Importantly, the findings from this 
review emanate from studies conducted in only HICs, hence little is still known about the 
barriers underpinning the low uptake rates of current acute stroke care interventions in LMICs. 
The research paper reported in this section was designed and conducted against the backdrop 
of this knowledge gap. This was a qualitative study aimed to advance understandings of the 
factors perceived by acute stroke care professionals as barriers to delivery of acute stroke care 
in Ghana.  
Largely, this study reported multiple barriers at the patient, health professionals, health 
system/organizational context and the broader national level barriers. Whilst corroborating 
with some existing barriers in the literature from HICs, some unique and context specific 
barriers were observed. Factors such as discharge against medical advice and the role of socio-
cultural and religious beliefs/practices remain as substantial barriers to optimal patient care. 
All in all, the findings also indicate the need for future plans and interventions to consider the 
nature and uniqueness of these barriers in order to develop well-tailored interventions for 
improved patient outcomes. The next section reports findings from this qualitative study. 
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ABSTRACT
Objective Despite major advances in research on acute 
stroke care interventions, relatively few stroke patients 
benefit from evidence-based care due to multiple barriers. 
Yet current evidence of such barriers is predominantly 
from high-income countries. This study seeks to 
understand stroke care professionals’ views on the 
barriers which hinder the provision of optimal acute stroke 
care in Ghanaian hospital settings.
Design A qualitative approach using semistructured 
interviews. Both thematic and grounded theory approaches 
were used to analyse and interpret the data through a 
synthesis of preidentified and emergent themes.
Setting A multisite study, conducted in six major referral 
acute hospital settings (three teaching and three non-
teaching regional hospitals) in Ghana.
Participants A total of 40 participants comprising 
neurologists, emergency physician specialists, non-
specialist medical doctors, nurses, physiotherapists, 
clinical psychologists and a dietitian.
Results Four key barriers and 12 subthemes of barriers 
were identified. These include barriers at the patient 
(financial constraints, delays, sociocultural or religious 
practices, discharge against medical advice, denial of 
stroke), health system (inadequate medical facilities, lack 
of stroke care protocol, limited staff numbers, inadequate 
staff development opportunities), health professionals 
(poor collaboration, limited knowledge of stroke care 
interventions) and broader national health policy (lack of 
political will) levels. Perceived barriers varied across health 
professional disciplines and hospitals.
Conclusion Barriers from low/middle-income countries 
differ substantially from those in high-income countries. 
For evidence-based acute stroke care in low/middle-
income countries such as Ghana, health policy-makers 
and hospital managers need to consider the contrasts 
and uniqueness in these barriers in designing quality 
improvement interventions to optimise patient outcomes.
BACKGROUND
Recent significant technological advance-
ment in medical practice has increased 
demands, expectations and pressures on 
healthcare staff to provide quality and 
evidence-based care. This is exacerbated 
by the wide knowledge-clinical practice 
gap across the world,1particularly in low/
middle-income countries2 where research 
translation has become an urgent health-
care agenda.3 Empirical evidence in the 
USA and Europe, for example, demonstrates 
how only about 30% to 50% of patients 
receive evidence-based interventions in clin-
ical settings.4 5 It is further suggested that 
translation of an evidenced-based health 
intervention into routine clinical practice 
can take up to 17 years.6 The need to iden-
tify barriers that underpin the slow uptake 
of evidence-based care in clinical settings 
is essential in understanding the extent to 
which health professionals provide such 
care to patients.5 7 As a result, theoretical 
and conceptual attempts have been made 
to shed light on the factors which affect the 
current knowledge-practice gap in healthcare 
settings.5 8 9
Due to the increasing global stroke-re-
lated mortality and morbidity,10 
the past  decades  have witnessed a 
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Strengths and limitations of this study
 ► This study represents the first in Ghana to explore, 
in-depth, the barriers perceived by stroke care 
professionals to optimum provision of acute care in 
hospital settings.
 ► The work focused exclusively on the perspectives 
of acute stroke care professionals from diverse 
professional disciplines, expertise, gender, 
tertiary and non-tertiary hospitals across different 
geographical settings.
 ► This study did not focus on barriers to a specific 
stroke care intervention, as reported extensively in 
previous works, but rather on barriers across the 
continuum of stroke care.
 ► The study reported results from a limited set of 
participants whose views may not be reflective of 
the wider health staff responsible for acute stroke 
care in Ghana.
 ► Given the qualitative nature of the study, data 
interpretation could be subjective and thus, caution 
should be applied in interpretation.
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proliferation of evidence-based acute stroke care interven-
tions.11–16Throughout this paper, the term evidence-based 
acute stroke care interventions also referred to as optimal 
acute stroke care comprised all acute stroke care interven-
tions based on scientific evidence, clinical judgement and 
expertise of a clinician and the needs of patients.17 Other 
key stroke experts have also recommended essential compo-
nents of an evidence-based acute stroke care for improved 
patient outcomes.18 19 Notwithstanding such advances, 
uptake of such recommendations in clinical settings 
remains slow,20 21 suggesting that only a small proportion 
of stroke patients receive optimal care. Although the low 
uptake of these interventions is a global health challenge, 
evidence suggests the pace of uptake in high-income coun-
tries exceed that of low/middle-income countries.20–22 
Numerous barriers have been identified to explain the low 
uptake of such evidence-based stroke care interventions 
into routine clinical practice. Some of these barriers include 
inadequate medical facilities, inadequate knowledge and 
skill levels of stroke care providers, low awareness of current 
acute stroke care interventions and the perceived efficacy 
levels of acute stroke care interventions.23–25 There are also 
barriers at the patient level which include delays in seeking 
emergency care due to lack of awareness of early stroke 
symptoms or financial constraints.26 27
Although research has increased our knowl-
edge about the range of barriers to the uptake of 
evidence-based stroke care in clinical settings, a more 
balanced and holistic understanding of such research 
is needed. Existing research to date only presents a 
one-sided view, and bias towards high-income coun-
tries (eg, Australia and USA) and moreover, is focused 
primarily on barriers inhibiting uptake of thrombo-
lytic therapy.23 25 27 28 However, only few studies have 
looked at barriers to other components of acute stroke 
care interventions.24 29 30 A study by Langhorne and 
colleagues also provides insightful information on the 
uptake of stroke unit care components in resource-poor 
settings.20 It is unclear if these barriers apply to low/
middle-income countries such as Ghana, where the 
geopolitical, socioeconomic and health system contexts 
vary. An investigation of such barriers is important in 
low/middle-income countries because the global stroke 
burden is much higher there,10 31 and yet evidence 
suggests uptake of evidence-based acute stroke care 
interventions is relatively lower.20 21
This study therefore aimed to identify the views of 
stroke care professionals on barriers inhibiting the provi-
sion of optimal acute stroke care in Ghanaian hospitals, 
since such information is non-existent. Acute stroke 
care in this context applies to the provision of care in 
the initial days and weeks after a stroke. Greater insights 
about these barriers and how they differ according to 
hospital settings and across stroke care professional 
disciplines are important for developing interventions 
towards enhancing optimal patient outcomes in Ghana. 
The findings may also have broader relevance to other 
resource-poor settings.
METHODS
Study design
This study is part of a larger multisite study to evaluate 
the provision of evidence-based acute stroke care in 
acute care in major referral hospitals in Ghana. A qual-
itative study design using semistructured interviews was 
employed to gain a rich and in-depth understanding 
of the barriers faced by stroke care professionals. The 
importance of qualitative data to successful translation of 
best scientific evidence into clinical practice has also been 
recommended.32 The study design, data collection, anal-
ysis and reporting were conducted in accordance with the 
consolidated criteria for reporting qualitative research33 
as shown in online supplementary file 1.
Settings
The study was conducted in a convenient sample of 
three referral tertiary (teaching) and three regional 
(non-teaching) hospitals from the southern, middle 
and northern belts of Ghana, between November 2015 
and April 2016. This represents three of the five tertia-
ry-teaching hospitals and three of the nine regional 
hospitals in Ghana. The study hospitals are major referral 
hospitals for other hospitals and health centres located 
in 6 of the 10 administrative regions of Ghana and were 
chosen to account for the geographical and socioeco-
nomic contrasts among the 10 administrative regions of 
the country. The hospital bed capacity for these hospi-
tals is as low as 150 for the regional hospitals, whereas 
the teaching hospitals bed capacity is approximately 653. 
The tertiary hospitals are larger referral centres and are 
well resourced with diagnostic and therapeutic facilities, 
while the regional hospitals act as major referral points 
to other hospitals and health centres within their catch-
ment areas. Overall, the annual stroke admissions for 
2014 ranged from 49 for the regional and 1500 stroke 
cases for the teaching hospitals. See  online supple-
mentary file 2 for additional information on the study 
hospitals.
Research team
Participants have no prior relationship with the 
researchers but because of the previous works of two of 
the researchers (LB and Ad-GA) in some of the study 
regions, it is possible participants have met or are aware 
of their works. LB is a health services researcher with 
interest in health services and policy research, research 
on implementation science and quality improvement 
interventions for stroke care health professionals. He 
is skilled in both qualitative and quantitative research 
works. Ad-GA conducts social and health psychology 
research using largely qualitative methods. AS is a 
health services researcher employing a mixed methods 
approach. The remaining researchers (GM, CKYC and 
SS) on the other hand, also have relevant skills, knowl-
edge and interest in qualitative studies and the topic 
under study. . Overall, the research team comprised two 
women and four men.
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Participants
Participants comprised key hospital staff, primarily 
involved in directing or providing acute care for stroke 
patients. To achieve maximum variation in the continuum 
of care that would reflect a real life setting, the study 
recruited nurses, specialist medical doctors (neurologists, 
emergency physician specialist), non-specialist medical 
doctors, clinical psychologists, physiotherapists and a 
dietitian, representing diverse expertise and experience 
relevant to acute stroke care. Table 1 shows participants’ 
distribution across study sites.
Sampling and recruitment
Purposive sampling was used to recruit all study partic-
ipants. Participant recruitment was facilitated by two of 
the researchers (LB, Ad-GA). . To commence recruitment 
and promote the study to eligible participants, meet-
ings were held with hospital administrators, in-service 
training and research coordinators, department heads 
and nurses incharge in the study hospitals. Potential 
participants were then recommended from these meet-
ings and engagements. Initial contact with prospective 
participants was made face-to-face or by telephone calls 
by the first author to identify the date, time and venue 
for the interviews. Potential participants were identified. 
Due to time and workload restrictions, three partici-
pants declined to participate in the study. The number 
of participants enrolled into the study was determined by 
data saturation.
Data collection
All interviews were conducted face-to-face in English 
by LB. Data collection was conducted in various venues 
including: general and emergency wards, consulting 
rooms, conference rooms, participants’ office rooms 
and physiotherapy departments. The interviews were 
facilitated by an interview guide (see online supplemen-
tary file 3) developed by the researchers and informed 
by an extensive literature review on the topic. The inter-
view guide was pilot-tested with three nurses and three 
medical doctors at non-study sites and adapted to reflect 
the professional role of the interviewees. With the permis-
sion of interviewees, each interview was recorded using a 
digital voice recorder. Detailed field notes were also taken. 
The study repeatedly used prompts to facilitate the elic-
itation of more and clearer information or clarification 
of certain concepts used by participants. The interviews 
lasted 45 min on average and all recorded interviews 
were transcribed verbatim by professional transcribers 
for the final data analysis. About a third of the transcripts 
were shared with selected participants to crosscheck and 
ensure the information reflected the interview process 
and 13 transcripts were returned.
Data analysis
Thematic data analysis,34 35 combined with some 
elements of a grounded theory approach,36 were used 
to analyse the data. Pre-existing thematic categories 
based on relevant literature were used in the data anal-
ysis. The grounded theory took an inductive approach 
to ensure all essential emergent themes from the codes 
not included in the deductive pre-existing coded list of 
barriers were captured. An initial codebook based on 
prior codes was developed and subsequently modified 
with the addition of new emergent themes after a line-by-
line reading and rereading of transcripts by one author 
(LB). A second author (Ad-GA), crosschecked the final 
coded results with a sample of the transcripts. Using the 
constant comparison approach,36 37 a comparative anal-
ysis of both emergent and prior themes was conducted 
between study sites and participants to understand areas 
of convergence and divergence. NVivo software package 
V.10.0 (38)38 was employed to organise, code and iden-
tify all data.
Trustworthiness and transferability in the study results 
were facilitated by the consistent use of the interview 
guide during the interview process, audio recording of 
all interviews, professional transcription of the interviews 
and the use of the NVivo software to manage the entire 
data analysis process. As a measure to further enhance 
data trustworthiness,39 some transcripts were shared 
with selected participants for crosschecking, known as 
member validation.
FINDINGS
A total of 40 participants took part in the study, approxi-
mately 6 participants per study site. Participants included 
both men  and women of varied professional disciplines, 
ranks and years of practice in the study sites (see table 1).
Table 1 Distribution of interview participants and study hospitals
Participants Tertiary/teaching hospitals Regional hospitals Total
Nurses 11 9 20
Medical doctors/physicians 6 6 12
Clinical psychologist 1 1 2
Physiotherapist 2 3 5
Dietitian 0 1 1
Total 20 20 40
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Barriers to acute stroke care
Four key themes of barriers to the provision of optimal 
acute stroke care emerged from the data; patient, hospital 
or health system, healthcare providers and national 
health policy factors. Table 2 describes each of these 
barriers. Embedded in these themes were 12 subthemes 
which provided specific and contextualised meaning to 
the main themes.
Patient factors
Under this category of barriers, five subthemes were 
identified: financial constraints, delays, sociocultural or 
religious beliefs and practices, discharge against medical 
advice and denial of stroke.
Financial constraints
In all the study sites and across participants from the 
various professional disciplines, barriers such as lack 
of funds to transport patients to the hospital, inability 
to pay for medical expenses (eg, CT brain scanning 
services, laboratory tests and other healthcare associated 
expenses) were consistently raised. Patients’ or their care-
givers’ decision to first seek medical care, organise means 
of transport to the hospital or pay for medical expenses 
were often constrained by their level of financial capacity. 
As a result, access to care was often delayed or deprived. 
An excerpt from a participant emphasised this:
‘poverty and ability to pay for medical cost is the issue 
over here,…let’s say a doctor will request a patient to 
do a CT scan, do some lab tests …, but the patient just 
simply cannot afford it, or it takes too long for them 
to gather the money, so for two, three and sometimes 
five weeks you are treating a patient without a CT 
scan investigation’ (Medical doctor, ID 9)
Delays
Patients’ late arrival to the hospital was commonly cited 
as another barrier to acute stroke care. Participants 
suggested the reasons for such delays arose from their 
lack of awareness of early stroke symptoms and decision 
to first seek herbal or faith-based, rather than medical 
care. Delays were also attributed to financial capacity of 
the family to seek medical care, especially in instances 
where the family breadwinner was the stroke victim. 
Hence, patients with good financial circumstances were 
more likely to seek early acute medical care compared 
with those with poor finances:
‘…they don’t bring the patients early and when they 
come, they will tell you the condition just started, 
that they just noticed the symptoms and rushed the 
patient to the hospital. But you realize  that this 
patient had the stroke for long, not very acute as 
they described, either they have sought treatments 
elsewhere or other interventions before arriving 
here’ (Nurse, ID 4)
On the low awareness of early stroke symptoms, one 
participant noted:
‘They don’t have knowledge of early stroke symptoms, 
they are ignorant about stroke symptoms…, Because 
they don’t know what the condition is, patients 
or families will rather prefer to self-medicate with 
painkiller or remain at home upon symptoms onset 
Table 2 Themes and definitions
Coding categories Definition of barriers
Patient level Includes factors, such as late arrival or low awareness 
of stroke symptoms, denial of stroke, financial capacity, 
sociocultural practices or beliefs inhibiting access or 
adherence to optimal acute stroke care.
Hospital or health system level Relates to a lack of inadequate medical facilities or equipment, 
staff numbers, protocols, management support, supporting 
policies, organisational context or norms which support 
implementation of standard care and availability of staff 
professional development opportunities to support the 
provision of standard care.
Stroke care professionals Describes acute stroke care providers’ level of team support, 
communication or collaborations which affect the provision of 
care. Also includes competence, skill, knowledge, awareness, 
familiarity or agreement to specific treatments, their values, 
motivations or attitudes towards particular treatments or 
intervention.
National/state health policy context Relates to the level of political will for acute stroke care in the 
form of national stroke policies, limited allocation of resources 
for acute stroke care, reimbursement of funds to hospitals, 
national health policies to support stroke patients' access to 
optimal care and the lack of any regulatory frameworks or 
policies to support stroke care.
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with the hope that the symptoms will disappear’ 
(Medical doctor, ID2)
Sociocultural and religious beliefs
Patients’ sociocultural or religious beliefs and practices 
emerged as another predominant barrier. Cultural beliefs 
and practices (eg, view stroke having a spiritual cause, 
retribution from their gods and not a condition which 
can be managed medically) were often very important 
and likely to influence patient health-seeking behaviour. 
A common practice from such beliefs was patients’ 
desperate attempts to defer medical care for herbal or 
traditional medical care or make attempts to combine 
both while hospitalised. Some nurses noted such prac-
tices or beliefs have often compelled families of patients 
to abandon medical care in the hospital for alternative 
care provided by traditional or faith healers. For example, 
all physiotherapists interviewed believed sociocultural 
beliefs and practices have limited patient attendance 
of outpatient care after discharge as most resorted to 
local herbal treatment options or to prayer camps. A 
participant had this to say about the religious beliefs on 
treatment compliance:
‘…they become very spiritual once they are diagnosed 
with a stroke; most now want to focus on their spiritual 
life instead. You realize that consistently our stroke 
patients want to talk about God, talking about how 
lucky they have been, how God has saved them from 
death’ (Clinical psychologist, ID 1)
Discharge against medical advice
‘Discharge against medical advice’ was consistently 
discussed  by participants and emerged as a key barrier 
to optimal acute stroke care. This practice was gener-
ally perpetuated by two factors; financial capacity to 
meet medical expenses and families’ desire to resort to 
other forms of care such as traditional herbal medicine, 
consultation of spiritualists or faith healers. Participants 
attributed the increased patient and family interest to 
such alternative forms of care to the vibrant advertise-
ments across the media by traditional herbal medicine 
practitioners and faith healers. Indeed, promises were 
made by such individuals to cure stroke and other chronic 
conditions within a week or two after commencing treat-
ment:
‘I recently heard one advertisement which said 
acute stroke patients should just come here and will 
be made to walk within a week. So it has gotten to 
the point where patients easily get misled by these 
adverts, they find these traditional or faith healers 
attractive and accessible’ (Medical doctor, ID 11)
According to nurses, such incidences were also linked to 
the sociocultural beliefs and practices of the people where 
health conditions such as stroke, were associated with 
supernatural or spiritual causes. After being informed 
about their stroke condition, some stroke patients often 
insisted on being  discharged. Moreover, refusal to heed 
patients' or families’ requests for early discharge often 
resulted in non-compliance to treatment, sudden disap-
pearance of patients or desertion of patients by family 
members:
‘with the relatives, as soon as they find out that it is 
a stroke, they start finding ways of transferring the 
patient to seek herbal medication or to a prayer camp 
…, so they request for discharge against medical 
advice and take the patient away’ (Nurse, ID 15)
Denial
It was also reported that some family members or 
patients sometimes rejected the diagnosis and dissoci-
ated their condition from stroke after being informed 
about the condition. Participants even acknowledged 
instances where some family members challenged their 
professional competence because they felt an incorrect 
diagnosis was made. The denial of stroke stemmed from 
the diverse misunderstandings of the illness, with some 
patients/family members viewing it as an attack or retri-
bution from their gods or spirits for a wrongdoing. In 
such situations, the provision of care was difficult, as 
some family members were less compliant during treat-
ment:
‘I remember one care giver following up to me 
to inquire whether we were sure the condition of 
their relative was a stroke, as she believed a wrong 
diagnosis was documented. Because to her, their 
relative does not deserve to have a stroke’ (Nurse, 
ID 11)
Hospital or health system factors
The subthemes of these system factors were shortage of 
medical facilities/equipment, lack of a stroke specific 
protocol, inadequate staff numbers and limited staff 
professional development opportunities.
Shortage of medical facilities
The limited availability of essential medical equipment 
to facilitate effective provision of acute stroke care was a 
common feature in study hospitals within the northern 
belt. There was a shortage of medical facilities such as 
blood pressure (BP) monitoring apparatus, cardio moni-
tors, suction machines, adjustable hospital beds and 
inadequate space to facilitate patient care. For example, 
participants in the only stroke unit in this study believed 
that the inadequate bed capacity (six-bed capacity) 
limited admission of many patients to receive optimal 
care. One participant commented:
‘Unfortunately, you find stroke patients, they come 
in, no bed, they are sitting on chairs, sitting on the 
wheel chair or on the bare floors, these are the 
conditions under which we are expected to provide 
standard care…”(Medical doctor, ID 2)
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This experience and another comment below exempli-
fied this barrier:
‘We have just one oxygen for all the patients in this 
ward so the nurses are sometimes compelled to use 
their discretion to wean patients off oxygen to enable 
another patient benefit if his/her condition is more 
severe’ (Medical doctor, ID 7)
Additionally, the lack of a stroke unit was a common 
concern expressed by medical doctors from hospitals in 
the middle and southern belts, a situation they believed 
was caused by limited funds allocated by hospitals and 
a low priority for acute stroke care. A lack of medical 
equipment and consumables could delay or deprive 
patients of standard care. Participants also talked about 
instances where some medical doctors acquired personal 
BP monitoring devices to support patient care because 
of shortages. Another issue was the absence or frequent 
malfunction or breakdown of diagnostic services such 
as CT scanning services, a situation which often delayed 
care delivery or led to referral of patients to other hospi-
tals. According to some medical doctors, this situation 
sometimes compelled them to proceed with care delivery 
without a CT scan investigation to inform treatment 
options:
‘I can say the biggest problem we face is our 
diagnostic equipment. See the whole of this so called 
big hospital, we have only one CT scan machine. The 
machine has been out of service for over 6 to 8 weeks 
and was only put to use again two  weeks ago …,” 
(Medical doctor, ID 11)
Lack of a specific protocol for acute stroke care
Most nurses believed the absence of a specific protocol 
or clinical guideline for acute stroke care was a key 
barrier:
‘….sometimes the cases come and you've forgotten 
some important procedures because I left the 
classroom a very long time ago’ (Nurse, ID 13)
One nurse recounted her experience of providing an 
acute stroke care with much uncertainty because there 
was no medical doctor or a senior colleague to guide her. 
This nurse stressed the importance of a clinical protocol, 
which she argued could facilitate the provision of stan-
dardised care even in the absence of a specialist or a 
medical doctor:
‘Most of the stroke cases I have witnessed were rushed 
in here during late hours, sometimes after mid-night 
and most times, its only nurses present to attend to 
the case. So the patient has to wait until a doctor 
arrives, sometimes the next morning and that is why 
I think the protocol will at least guide us to safely 
initiate initial treatment’ (Nurse, ID 18)
Limited staff
Limited staff especially stroke specialists (eg, neurolo-
gists, neurosurgeons and trained stroke nurses) were 
also a key barrier across the study sites. This issue was 
more dominant in the non-tertiary regional hospitals and 
participants in the northern belt of Ghana. Participants, 
especially nurses, believed the current staff numbers 
were inadequate to provide optimal acute stroke care 
(eg, regular checking of BP levels, sugar levels, regular 
turning of patients to prevent pressure sores and manage-
ment of urinal incontinence to minimise risk of urinary 
tract infections).They expressed frustration about the 
high workload, which often compromised effective 
patient care:
‘you could have patients running over 40,…, some 
are in the wheel chair, some are on the chairs you see 
over there, some are on the beds, sometimes some 
are on the stretchers’’ (Nurse, ID 5)
Limited staff professional development opportunities
With the exception of medical doctors, nurses and allied 
health staff expressed great interest in opportunities 
for staff professional development, mainly in hands-on 
training workshops related to stroke clinical care. Although 
there were policies to support staff develop their current 
knowledge and skills, such opportunities were very rare. 
Nurses, for example, emphasised the importance of 
continuous education and professional development as 
current clinical practice was underpinned by what they 
were taught in schools many years ago. Overall, there was 
strong opinion on this matter and a lack of continuous 
training opportunities inherently affected the quality of 
care provided to acute stroke patients:
‘we don’t have regular workshops…, even if there will 
ever be such an opportunity, you will only consider 
attending provided you can afford the cost as this 
hospital won’t support us attend such a workshop’ 
(Nurse, ID 4)
Healthcare providers’ factors
Two main subthemes of barriers were identified at the 
healthcare staff level; limited knowledge in acute stroke 
care and inadequate team collaboration and coordina-
tion.
Inadequate knowledge
Lack of knowledge on how to provide appropriate treat-
ment was often discussed, particularly by nurses. Unlike 
the medical doctors, the nurses were unware of throm-
bolytic therapy. This particular type of therapy was not 
part of what the medical doctors recommended for acute 
ischaemic stroke care:
‘What did you say again? thromboly… what? Not 
here, I am hearing thrombolysis for the first time. It 
is not part of our treatment plan for stroke patients 
in this hospital. How come you say it is one of the 
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key therapies for acute ischemic stroke and I am not 
aware of it?’ (Nurse, ID 9)
Most nurses also identified insufficient knowledge of 
certain acute stroke care procedures as a barrier, especially 
in triaging unconscious stroke patients. They expressed 
uncertainty about their ability to often proceed with care 
delivery in the absence of a medical doctor. Although 
nurses talked about consulting senior colleagues, some 
level of uncertainty was still noted in proceeding to 
provide care in the absence of a medical doctor. Despite 
their clinical training, nurses cited difficulties arising 
from efforts to respond to unconscious stroke patients 
and conduct assessment to support an accurate stroke 
prognosis:
‘Sometimes a stroke case arrives unconscious and you 
start shivering especially when it is in the night and 
there is no doctor around to respond immediately. I 
feel very nervous when I realise I am the only senior 
nurse in the ward to attend to this patient’ (Nurse, 
ID 12)
Team collaboration and communication
According to most nurses and all allied health staff, 
collaborative work in a multidisciplinary stroke team was 
inadequate, and an obstacle to effective patient care. 
Physician driven stroke care without adequate involve-
ment of other staff, was frequently discussed:
‘I don’t even think we have a working team here, 
it is more of a doctor giving instructions…,giving 
instructions to nurses, though nurses are there with 
the patients 24 hours, the medical doctors just come 
to see their patients and then disappear. Is that what 
you call teamwork?’ (Nurse, ID 14)
Allied health staff expressed a sense of marginalisation 
and disconnectedness, especially in the early stages 
of care. A dietitian for example cited instances where 
medical teams (doctors and nurses) often discharge 
patients without his view on dietary plans at discharge. 
Three physiotherapists expressed similar concerns of 
limited involvement which in their view inhibited their 
ability to develop initial rapport with patients or the 
opportunity to educate patients about the importance of 
self-care practices, following discharge:
‘There was an occasion my rounds coincided with 
the medical team’s rounds; I quickly joined them. I 
made a suggestion on a particular patient we were 
attending to but this was brushed off and the medical 
doctor behaved as if I was trying to direct him what to 
do or take over his job’ (Physiotherapist, ID 3)
National policy context factors
Participants identified one key barrier under this theme; 
lack of political will for acute stroke care.
Lack of political imperative 
The lack of national level support and political imper-
ative  for acute stroke care was consistently cited as a 
broad level barrier, particularly by medical doctors. 
They expressed strong views on this issue, attributing 
it to the increasing out-of-pocket medical expenses for 
patients. Despite the existence of the national health 
insurance policy which was supposed to replace the 
practice of ‘cash and carry’, a lack of political impera-
tive  for the scheme has gradually introduced the policy 
of upfront payments by patients prior to acute care in 
most hospitals in Ghana presently. They believed this 
has negatively affected patients’ access to care (not only 
stroke patients) because of their inability to pay for 
medical expenses. The limited coverage of the national 
health insurance scheme on chronic care, such as 
stroke, was also stated as a key barrier. Patients expe-
rienced difficulties paying for stroke-related medical 
costs (eg, CT brain scans and other laboratory tests) 
that were not covered by the national health insurance 
scheme. Overall, there was a sense of powerlessness 
about national level neglect for acute stroke care. 
Consequently, this resulted in staff dissatisfaction and a 
lack of motivation to provide effective care:
‘The problems we face in our current health sector has 
very little to do with health professionals’ reluctance 
to provide standard care. It is the health system!…, 
we are under a system where every medication is 
expensive for the ordinary Ghanaian to afford and 
yet, we make the patients to believe the national 
health insurance policy covers everything. Now almost 
every medication has to be paid for by the patient 
and if they can’t afford what we recommend as best 
treatment option for their condition, we provide the 
alternatives which may not be very effective’ (Medical 
doctor, ID 11).
DISCUSSION
Summary of main findings
This study provides in-depth insights of the barriers to 
the delivery of optimal acute stroke care in Ghana, a 
largely neglected low/middle-income country in Africa. 
The findings suggest that although the barriers iden-
tified share some commonality with those reported in 
previous studies in high-income countries, some barriers 
are unique to optimal stroke care in low/middle-in-
come settings such as Ghana. Some of the predominant 
barriers to acute stroke care in high-income countries 
often comprised patient delay in seeking early care, 
inadequate medical facilities to support optimal patient 
care, healthcare providers’ attitudes towards some acute 
stroke care interventions, poor communication and 
lack of cooperation among healthcare providers.23–25 
On the contrary, although there is an overlap of these 
barriers in both high-income and low/middle-income 
countries, the issue of discharge against medical advice 
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and the role of sociocultural and religious beliefs or 
practices of stroke patients and their families charac-
terise the present study. While illuminating the reasons 
influencing the provision of optimal acute stroke care 
in a typical resource-poor setting, the findings further 
unravel barriers peculiar to different stroke care 
professionals and hospital settings where much policy 
attention is required for effective and timely translation 
of evidence-based stroke care intervention into routine 
clinical practice.
Comparison with previous literature
As found in this study, stroke care in high-income coun-
tries with modern resources has consistently reported 
barriers corresponding to patient, health system/
hospital, health staff and the national level factors.23 25 40 
Highlighting patient level barriers as the most predom-
inant of all barriers identified in our study, a previous 
study corroborated this by reporting 91% of partic-
ipants viewed prehospital delay at the patient level as 
the most dominant barrier to providing thrombolytic 
therapy.27 An earlier study in Ghana41  found that only 
40% (277/693) could correctly identify stroke symp-
toms, reinforcing the importance of our finding that 
participants identified patient delays to seek care due 
to low awareness of stroke symptoms.
Although our findings on the importance of 
patient level barriers to optimal stroke care are in line 
with previous research,23 27 30 42the explanation and the 
circumstances in which some patient level factors acted 
as barriers to optimal acute stroke care were somewhat 
different . For example, sociocultural or religious beliefs 
and practices were perceived to underpin health-seeking 
behaviours of stroke patients and their families in Ghana. 
Although this is inconsistent with the literature on 
barriers to acute stroke care in high-income countries, 
our findings corroborate with research on other chronic 
diseases and health-seeking behaviour in Ghana.43 44This 
underscores the influence of such beliefs and practices 
to health-seeking behaviours of patients and families in 
Ghana. Evidence within the African contexts suggests 
patient access to traditional and faith healers as compli-
mentary avenues of care is due to the easy access, lower 
cost and cultural legitimacy of such alternatives.45 46
In addition, patient discharge against medical advice 
was also a key barrier affecting optimal clinical care. This 
finding is also largely inconsistent with published barriers 
to acute stroke care from high-income countries. Despite 
the limited popularity of such barriers in previous studies, 
this has been well articulated in other health contexts 
and conditions with conclusive arguments of the prac-
tice being a drawback and an obstacle to provision of 
adequate and quality healthcare.47–50 Clearly, this issue 
requires further investigation in Ghana, and possibly 
other low/middle-income countries. L
Other important barriers from this study were related to 
the health system, such as limited stroke care specialists, 
increased workload for staff, inadequate medical facilities, 
lack of protocols and unavailability or limited access to 
CT brain scans. The importance of this set of barriers has 
been reported previously,23 29 51 highlighting the extent 
to which they affect provision of optimal patient care. 
For example, one study found that 71% of participants 
identified lack of protocols, care paths and opportuni-
ties for staff professional education as important barriers 
to the provision of optimal acute stroke care.27 Compa-
rable to our study, a Swedish study identified low staffing 
levels as a major barrier to optimal stroke care.25 Despite 
these studies being conducted in high-income countries, 
their corroboration with the present study reinforces the 
importance of hospital/health system level barriers to the 
uptake of evidence-based practice.
The issue of limited collaboration or involvement of 
allied health staff and other providers in the provision 
of care is also worthy of attention. Multidisciplinary 
and coordinated care remains a central component in 
contemporary evidence-based practice for acute stroke 
care.18 52 As a result, inadequate involvement of these staff 
is a significant issue since participants noted that their 
limited involvement is detrimental to optimal patient 
care. Evidence from existing scholarship on such barriers 
has been previously reported,53–55 thus stressing the 
need to consider interventions to improve collaboration 
among stroke care professionals in acute stroke care.
Nurses’ knowledge of acute stroke care interventions 
such as thrombolytic therapy was also identified as a 
barrier, consistent with previous studies.23 27 40 This issue 
has also been identified in an Australian study where 50% 
of nurses reported having limited knowledge of thrombo-
lytic therapy.27 Such findings highlight the importance of 
this issue to optimal stroke care in both low/middle-in-
come and high-income countries.
Finally, another barrier identified in the present study 
relates to the low level of political will for optimal acute 
stroke care. This barrier is evident in the absence of a 
national stroke clinical guideline, a national frame-
work for quality improvement interventions for stroke 
and limited coverage of the national health insurance 
scheme to cover patients’ medical expenses. While this 
finding corroborates with previous studies asserting the 
limited prioritisation of acute stroke care by health poli-
cy-makers in resource-poor settings,56–59 this could also 
likely be symptomatic of the current limited global health 
funding for stroke and other non-communicable diseases 
compared with communicable diseases.60
Implications for future research, policy and clinical practice
The present findings have several important implications 
for the provision of evidence-based acute stroke care in 
Ghana. First, patient financial constraints appear to be a 
key barrier to optimal care and needs urgent attention. 
It is apparent that patients and family members struggle 
with the financial costs of stroke treatment and strate-
gies are needed to overcome this burden. The current 
Ghana National Health Insurance Policy offers limited 
financial risk protection for stroke care. This epitomises 
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the fragile nature of healthcare systems in low/middle-in-
come countries, which require significant structural 
and policy reforms to minimise the current high cost 
of treatment for chronic diseases such as stroke. If left 
unaddressed, the consequent increased incidence of late 
arrival or refusal to seek care, limited treatment options 
and patient discontinuation of treatment will negatively 
affect optimal patient outcome.
Second, the evidence of sociocultural or religious beliefs 
and practices as a barrier to optimal care also deserves 
attention, particularly since this has received little atten-
tion in the current literature . More research in other 
settings may be useful to unravel the extent to which such 
practices influence provision of optimal care. In addition, 
national and local public awareness campaigns to increase 
the health literacy levels of the populace regarding stroke 
risk factors, early stroke symptoms and the need to seek 
early medical care are critical. This level of public aware-
ness and education campaigns have been implemented 
in high-income countries such as UK,61 62 Australia,63 64 
Canada65 and Germany.66 Hence, Ghana and other low/
middle-income countries can clearly draw lessons from 
such public awareness campaigns on early recognition of 
stroke symptoms to minimise patient delays to seek care. 
Such interventions however would need to be adapted 
to suit the particular country and health context. They 
should be mainstreamed in the healthcare systems of 
such countries through collaboration with the public and 
private sectors to optimise the impact.
Importantly, the finding of patient discharge against 
medical advice has revived debates about the place of 
patients within the current evidence-based medicine 
paradigm where patients' needs and preferences are 
essential.67 While more research on the implications of 
this issue is required, institutional measures exploring 
safe and appropriate times and conditions under which 
such requests could be granted should be identified. More 
importantly, strategies need to be adopted to ensure that 
requests by patients and families to be discharged against 
medical advice be counterbalanced with tailored commu-
nication and public campaigns to improve awareness of 
the risks and benefits. The roles of clinical psychologists 
and nurses can be pivotal in such communication. This 
has the potential to minimise the incidence of patient 
discharge against medical advice.
The limited collaboration and poor communication 
among stroke care professionals also warrants attention. 
Highlighted as an imperative in providing optimal acute 
stroke care by previous research,12 54 55 the finding in 
this study further emphasises the need to explore effec-
tive ways to build collaborative working environments. 
Structural policy reforms are needed to ensure equal 
respect for individual professional experiences, identity, 
autonomy and responsibilities. This may be in the form of 
healthcare professional trainings, educational meetings 
and conferences, workshops to explore ways of improving 
clinical outcomes. As indicated earlier, staff professional 
development plays a critical role to stroke care quality 
improvement68 and overall health outcomes,69 and as 
such, efforts to provide staff educational and professional 
development opportunities in stroke care could be useful 
in the Ghanaian setting.
Given that health system and hospital level factors 
were observed as important to stroke care, strength-
ening health systems through the provision of adequate 
and effective acute stroke care services is essential. For 
example, to address the issue of limited staff numbers, 
an immediate short-term measure would be to consider 
task shifting approaches, as has been trialled in Nigeria. 
This Nigerian study70 showed improved knowledge of 
non-neurologists in acute stroke care, thus potentially 
translating into improved patient outcomes.
Another health system barrier which has critical impli-
cations is the reported arrangement of upfront payment 
by patients prior to delivery of healthcare services . This 
suggests that people with symptoms of stroke and other 
emergency conditions such as heart attack and asthma 
may be provided optimal care on condition the patient 
is able to pay for such services. A health policy effort 
to expand the current package of the Ghanaian health 
insurance policy to cover the cost of CT brain scanning 
services will be in the right direction. In line with this, 
regular reimbursement of claims by the appropriate state 
institutions may address the issue of upfront payment 
prior to care.
Finally, to increase implementation of evidence-based 
acute stroke care, there is the need for increased policy 
commitment for optimal acute stroke care through 
increased allocation of resources to hospitals in the form 
of infrastructural support, a comprehensive coverage of 
the current national health insurance policy to include 
CT brain scan services and medical expenses for chronic 
care, staff professional development opportunities, and 
development of a stroke-specific clinical guideline are 
urgently needed.
LIMITATIONS AND STRENGTHS
As a limitation, this study reported results from a limited 
set of participants whose views may not be reflective of 
the wider health staff responsible for acute stroke care 
in Ghana. Nonetheless, this was conducted in six major 
referral hospitals in 6 of the 10 administrative regions of 
Ghana and so the findings may be applicable to other 
stroke care professionals. Future studies should target 
a larger and more representative study sample to also 
include health planners and administrators in district 
and municipal hospitals. Further, given the qualitative 
nature of the study, the use of a semistructured interview 
guide and data interpretation could be subjective and 
thus, caution should be applied in interpretation. Never-
theless, using a robust reporting guideline, participant 
crosschecking and validation of interview transcripts, and 
the consistent use of the interview guide during the inter-
view process minimised any possibility of bias but rather 
enhanced the study validity and reliability. Another key 
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limitation is the lack of observational or documentary 
evidence which could have accounted for any potential 
important information which may not have been shared 
by the participants during the interview process.
Notwithstanding these limitations, this study also has 
several strengths. First, to our knowledge, this study 
represents the first in Ghana to explore, in-depth, the 
barriers perceived by stroke care professionals to optimum 
provision of acute care in hospital settings. Another key 
strength is its exclusive focus on the perspectives of acute 
stroke care professionals from diverse professional disci-
plines, expertise, gender and tertiary and non-tertiary 
hospitals across different geographical settings. Using 
qualitative design, the findings provide contextually rich 
information of such barriers which would have been more 
difficult to unravel quantitatively. The study findings 
provide some new insights of other factors which have 
been less recognised in previous literature on the barriers 
to evidence-based acute stroke care. Added to this, this 
study did not focus on barriers to a specific stroke care 
intervention, as reported extensively in previous works, 
but rather on barriers across the continuum of stroke 
care.
CONCLUSION
Overall, the views on barriers to optimal stroke care 
varied significantly based on specific professional disci-
pline and study sites. Although most of the barriers were 
largely consistent with previous studies in high-income 
countries, the study unravelled some unique barriers 
which extend the body of literature on barriers to acute 
stroke care. Importantly, barriers in low/middle-income 
countries showed important differences to those from 
high-income countries. Greater political will for acute 
stroke care in terms of increased coverage of the national 
health insurance scheme, increased resource allocation, 
recruitment and training of an expanded stroke health 
workforce could improve uptake of evidence-based acute 
stroke care interventions. The information provided in 
this paper is potentially important to health managers, 
policy-makers, patients, grant managers or holders and 
other health stakeholders as it presents various reasons 
why delivery of acute stroke care in clinical setting may 
be far from optimum. To this end, to translate current 
evidence-based acute stroke interventions for optimal 
patient outcomes in Ghana and potentially in other 
resource-poor settings, a clear-cut understanding of these 
barriers to inform policy formulation, quality improve-
ment and staff professional development, is critical.
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CHAPTER FIVE 
DISCUSSION AND CONCLUSION 
5.0 Introduction  
The preceding chapter presented results of three separate but interconnected studies on the 
translation of key contemporary interventions for acute stroke care, patient outcomes data from 
acute stroke care and the barriers potentially accounting for the uptake of such interventions. 
However, what do the findings from the three different studies mean to contemporary efforts 
to translate current interventions for acute stroke care into better patient outcomes? This last 
chapter presents an overall synthesis of the thesis findings as a single integrated body of 
scientific exploration, illuminating on a wide range of implications for policy, clinical and 
public health practice and future research. The first section of this chapter presents the overall 
findings of the thesis. Second, an outline of the key findings in relation to pre-existing studies 
is discussed. Following, an in-depth and critical exploration and analysis of the findings is 
presented and any potential implications for clinical/public health practice and health policy 
herein discussed. Fourth, the chapter reports the study limitations, the key contributions of the 
thesis to scientific knowledge and the potential areas for future research. The last section 
outlines the thesis conclusion. 
5.1 Summary of main findings 
This thesis sought to examine the extent to which proven interventions for acute stroke care 
are implemented in standard practice in Ghana, a LMIC. To address this issue, three study aims 
were pursued. The first sought to understand what hospital-based services/therapies are 
available to support acute stroke care in Ghana and the extent to which such therapies/services 
are consistent with international best practice recommendations. The second evaluated in-
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hospital mortality outcomes among acute stroke patients admitted in Ghanaian hospitals 
settings. The third aim explored the perspectives of stroke care professionals on the practical 
barriers militating against the delivery of evidence-based care for best patient outcomes. The 
overall discussion of the main study findings will be presented in relation to interventions for 
acute stroke care, the clinical effectiveness of the services/therapies and the factors which 
underpin the translation of such interventions into standard practice. The next section thus 
summarises the key findings from the thesis as follows: 
First, despite the large and growing body of evidence on evidence-based acute stroke care, a 
systematic review in chapter two (accepted manuscript with minor revisions under review) 
indicated there remains limited evidence on the extent to which resource poor settings are 
implementing best practice interventions for acute stroke. Notwithstanding the limited eligible 
studies in this review, the evidence further points to some positive patient outcomes following 
the implementation of current evidence-based acute stroke care interventions in such countries, 
especially in the African region. This implies that there is a potential for optimal patient 
outcomes if such interventions are widely scaled up in LMICs especially those within the 
African region. 
Second, whereas uptake levels of evidence-based interventions are inadequate at the global 
level, it is much lower in LMICs. In an effort to unravel the possible factors underpinning the 
situation of inadequate uptake, as part of this thesis, a systematic review was conducted to 
understand the current state of evidence and areas for future research. This review shed light 
on multiple barriers at the patient, individual healthcare professional, professional interaction, 
organizational context, acute stroke care interventions/guidelines, resources and incentives and 
organizational capacity levels which potentially influence the uptake of contemporary 
interventions for acute stroke care. However, this review did not locate any relevant study 
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within the context of LMICs, Ghana in this context, to help clarify the main reasons for the 
inadequate and much lower uptake levels of such best practice interventions/services for acute 
stroke care. The evidence was also predominantly focused on thrombolysis implicating partial 
and incomplete understanding of the barriers to the other interventions. 
Third, a finding which remains central to the thesis was the largely limited uptake of evidence-
based acute stroke care interventions in Ghana. For example, the evidence points to limited 
emergency medical transportation services such as ambulances in the hospitals surveyed. 
Access to brain scanning services such as CT and MRI services were limited with patient access 
to such services constrained by limited opening hours or financial capacity. Of the eleven study 
hospitals surveyed, only one had a stroke unit with no evidence of thrombolytic therapy use. 
Whilst teaching hospitals seemed better equipped with advanced and modern medical facilities 
to support the delivery of standard stroke care, regional hospitals, especially those in the 
northern part of the country, had relatively limited evidence-based acute stroke care services. 
In addition, the study confirms there is limited health policy support for acute stroke care and 
limited opportunities to support the professional development of acute stroke care providers. 
Further, the findings indicate that only the teaching-tertiary hospitals were in a position to 
provide the essential acute stroke care services. Disparities in acute stroke care service 
availability were also found across the study hospitals. In contrast to the referral hospitals in 
the southern and middle belts of Ghana, the regional referral hospitals in the northern belt, 
except one tertiary hospital, lacked stroke care specialists such as neurologists, neurosurgeons 
as well have inadequate medical doctors and nurses. This also included lack of brain scanning 
services and thus patients were often referred to the tertiary hospitals to enable access to 
Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) brain scanning 
services. Using the World Stroke Society Guidelines as a focal point, this thesis argues that 
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there is an overall deficit in the capacity of the Ghana healthcare system to deliver advanced 
and evidence-based acute stroke care. 
Fourth, this thesis has demonstrated that, despite the existence of considerable and diverse 
evidence-based acute stroke care interventions, delivery of acute stroke care remains variable 
from one healthcare setting to another. As a result, patient outcomes, primarily in-hospital 
mortality, were also higher compared to international standards and varied across the study 
hospitals. Of the six sampled hospitals, only a single stroke unit was identified. Significantly, 
aspirin uptake was widespread across the study hospitals. Based on a multivariate logistic 
regression analysis where residual confounding factors were controlled, patients provided with 
aspirin recorded less in-hospital mortality. There was also insignificant variance in in-hospital 
mortality across the admitting wards. In addition, hypertension and haemorrhagic stroke sub-
type were identified as the predominant risk factors for in-hospital mortality. 
Finally, this thesis highlights multiple barriers at the patient, stroke care professional, 
healthcare system/organisation and the national context level as probable determinants for low 
uptake levels of such interventions and the high stroke related in-hospital mortality. 
Importantly, the barriers were context-specific and varied according to professional disciplines. 
In other words, barriers identified in Ghana and possible other LMICs may not be comparable 
to those from high income countries (HICs). These findings provide an alternative and unique 
perspective on the barriers to acute stroke care such as the influence of patients’ socio-
cultural/religious beliefs and practices since such findings have not been sufficiently 
emphasised in the international literature.  
5.2 Comparison with pre-existing studies 
The findings from this thesis will be discussed in relation to previously published studies on 
evidence-based acute stroke care services, in-patient mortality outcomes among acute stroke 
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patients following acute stroke care and the potential barriers responsible for evidence-based 
care for acute stroke.  
5.2.1 Evidence-based services and interventions for acute stroke care  
As part of efforts to enhance optimal patient care for suspected stroke cases, scientific 
statements and evidence from research have recommended the need for stroke patients to be 
transported immediately to a care centre by emergency medical transport services such as an 
ambulance [1-3]. Indeed, research evidence suggests the use of ambulance and other 
emergency medical transport services potentially facilitate early and safe patient arrival for 
prompt assessment, diagnosis and delivery of appropriate care, hence the potential for better 
health outcomes [2, 4]. Despite this best practice recommendation, emergency medical 
transport services are still underutilised globally. Access to emergency medical transport 
services however appears to be higher in HIC than LMICs, as the case appears to be in Ghana 
based on findings from this thesis. A study in Australia [5] and Canada [6] reported about 80% 
and 70% of stroke patients, respectively, arrived in the hospital setting for care using 
emergency medical transport services. Evidence from the USA also reported that a third of 
stroke patients arrived for care with an emergency medical transport service [7]. In comparison, 
findings from this thesis reported limited or no access to these emergency medical transport 
services. The findings indicate patients’ overreliance on private non-emergency medical 
transport services such as a taxis to seek care following a stroke [8]. Given that most of the 
current pharmacological therapies for acute ischemic stroke such as thrombolytic therapy are 
time-limited and more effective when administered immediately after stroke onset, late arrival 
to seek care due to limited access to emergency medical transport services will inherently 
deprive patients of optimal treatment. In other words, the potential for optimum benefits from 
thrombolysis is contingent on the availability of support services to fast-tract patients to 
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hospitals for treatment following symptoms onset. This key point has previously been 
emphasised in the popular ‘Time is Brain’ publication [9].  Due to the importance of 
transporting patients rapidly for early care using emergency medical transport services, there 
is evidence to suggest some HICs even provide air transport services for patients [6, 10] or 
incorporate brain scanning services in ambulance services [11], thus highlighting the urgency 
of this point. However, evidence of such innovations remains unknown in LMICs. 
Stroke unit care has been distinguished as a core component of modern stroke services given 
its proven benefits to stroke patients in general [12], and the cost-effectiveness of such care 
[13-15]. According to level one evidence, acute stroke care in a stroke unit reduces in-patient 
mortality by about 20% [16]. As a result, current clinical guidelines for stroke care include 
stroke unit care protocols [17-21]. However, there is limited and inequitable uptake of such 
evidence-based intervention globally. Evidence from this research points to a limited 
availability of stroke unit care. In fact, only one stroke unit facility was available in the sites 
surveyed. This concurs with widely documented evidence about the limited availability of 
stroke unit care in LMICs such as Ghana [22, 23]. In view of this, the general medical wards 
may be the predominant admitting wards in most hospitals where stroke patients are admitted 
despite evidence of suboptimal patient outcomes in general medical wards relative to stroke 
unit care [12]. Conversely, although uptake is far from ideal in HICs, it is relatively higher 
compared to LMICs such as Ghana. Evidence from the UK showed about 82% patients receive 
care in a stroke unit [24], in addition to 86%  in Sweden [25]. This disparity in uptake also 
raises equity-based questions given that LMICs bear a larger share of the global burden of 
stroke and yet have limited access to the best interventions for optimal patient care. This finding 
thus underscores a clear need for the establishment of more stroke units to facilitate optimal 
patient care in Ghana. 
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Similar to stroke unit care, thrombolysis using t-PA is another important treatment option for 
optimal acute stroke care. To date, it is the single most effective pharmacological therapy for 
acute ischemic stroke. However, its translation into standard practice in clinical settings has 
been very slow so far [26]. Findings from this study showed non-utilisation of thrombolytic 
therapy. This finding is consistent with earlier research which points to its limited uptake in 
LMICs [26, 27]. However, uptake levels are relatively better in HICs. As demonstrated in the 
first systematic review in chapter two, some LMICs in Africa have however documented 
evidence of utilising thrombolysis with evidence of improved patient outcomes [28, 29], thus 
suggesting its feasibility in these countries. This finding also raises an important question about 
the possible factors for the non-utilisation of thrombolysis. The qualitative study [30] and 
systematic review [31] of this thesis highlighted potential factors for the non-utilization of this 
therapy in the Ghanaian context and beyond.  The non-utilization of this therapy reinforces 
previous evidence indicating lower uptake in resource poor settings [26, 32]. 
Based on the findings from this thesis, aspirin uptake was noted to be higher compared to stroke 
unit care and thrombolytic therapy. This was a common treatment option for acute ischemic 
stroke patients in the study sites. This finding lends support to previous indications of this 
therapeutic option as inexpensive and easy to administer, and thus a better choice for resource 
poor countries such as Ghana [33, 34]. However, there is a question of whether this option 
could be associated with better clinical outcomes compared to other interventions within 
resource poor settings. The evidence to date on this issue is limited. However, evidence in this 
thesis showed aspirin therapy reduced in-patient mortality following a stroke, that is, it is 
widely applied and a better protector of life compared to stroke unit care, and thus the need to 
ensure more eligible patients have uninhibited access to this therapy.  
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As part of current best practice guidelines for acute stroke care, decisions on stroke diagnosis 
and treatment should be supported by results from CT and MRI since different treatments apply 
to the two stroke subtypes [18, 19, 21, 35]. However, access to such brain and neuroimaging 
services are often limited especially in LMICs. This is a critical barrier to the delivery of some 
evidence-based acute stroke care [36, 37]. Consistent with these suggestions, evidence from 
this thesis also points to limited access to such brain scanning services. Even in hospitals where 
such services were available, access was mediated by patients’ ability to afford such services 
[30], and the time services are available to the general patient population, as 24/7 access was 
very limited. As shown in this thesis, seven of the 11 major referral hospitals provided CT brain 
scan services, though patient access was limited only to weekdays (9am-5pm). This has far-
reaching ramifications for prompt diagnosis and treatment per the best practice guidelines for 
acute stroke care. Limited access to CT/MRI brain scanning services will likely pave the way 
for clinical decisions on treatment options to be based solely on the judgement and clinical 
experience of the physician without recourse to CT scan confirmation of the stroke subtype. 
Though clinical judgement and expertise are still relevant, standard practice now requires 
stroke treatment decisions to be guided by CT scan evidence. This is done to minimise the 
consequences of errors in clinical decisions (e.g. a haemorrhagic stroke patient could be 
considered for thrombolytic or aspirin therapy). Current best practice for thrombolytic and 
aspirin therapies recommend CT/MRI scan to confirm there is no contraindication before 
aspirin or thrombolysis can be initiated [18, 19, 21, 35]. This indicates that, even in settings 
where best practice interventions such as thrombolysis and aspirin are available for patient 
care, limited access or unavailability of brain scanning services potentially limits efforts to 
provide such evidence-based acute stroke care interventions. 
Inadequate human resource capacity for the treatment of NCDs such as a stroke has been 
highlighted as a potential challenge to addressing the current health threat posed by such NCDs 
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[38-40]. However, the point must be stressed that the issue of limited human resource capacity 
gap is a global one, although the situation in LMICs is worse. Studies in Australia [41-43]  and 
other countries in HIC regions [44, 45], allude to this fact. In line with this, the findings from 
Ghana point to a significant gap in the human resource capacity of the healthcare system to 
deliver optimal care. The survey in this thesis on hospital-based acute stroke care services and 
interventions revealed the limited availability of neurologists, neurosurgeons and allied health 
staff such as speech/occupational therapists. A study in the USA also reported the limited 
availability of neurologists and neurosurgeons [46, 47], although direct comparability with 
resource poor countries is complex. This finding emphasised the need for increased support to 
improve the current deficit in human resource capacity for acute stroke care. This is important 
because stroke care led by a neurologist/specialist stroke physician leads to better patient 
outcomes compared to care led by non-stroke specialists [48]. As has been shown in many 
conceptual frameworks [49-51], and other evidence for translating evidence based 
interventions for stroke care [52], a competent human resource capacity component is a 
requisite for translating evidence into practice. 
The development of best practice interventions without corresponding health policy responses 
and interventions to ensure rapid uptake of such interventions creates the situation where 
proven interventions are likely to be underutilised. Based on previous evidence of limited 
health priority towards the control and treatment of NCDs such as a stroke [53], a fundamental 
reason for the slow evidence uptake in most LMICs is a lack of national policy commitment. 
Though some efforts have been made in these countries since the UN political declaration in 
2011 to increase support for the fight against NCDs,  evidence to date highlights inadequate 
political commitment in the form of national policies and interventions specifically on NCDs 
such as stroke [53]. Even in situations where policies are formulated, there is no corresponding 
funding support or specific action plans towards the implementation of the policies. For 
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example, findings in this thesis showed that, in the three referral centres in the northern belt of 
Ghana, only one had brain scanning services and stroke specialists such as neurologists and 
neurosurgeons were also limited. As reported in prior studies [54-57], most LMICs commit 
fewer health resources to support the treatment of NCDs, stroke in this case. So, it was not 
unexpected to find low health policy attention to stroke care in Ghana. This may be in part due 
to a global phenomenon because stroke and other NCDs do not receive adequate financial 
support from the overall global health funding [58-61]. This does not however preclude action 
in resource poor settings since some LMICs have prioritized and increased national 
commitment to management of NCDs such as stroke [62, 63].  
5.2.2 Efficacy of acute stroke care therapies and services 
Although there were no significant variations in in-hospital mortality between the three 
different admitting wards, the overall 30-day case fatality rate was 31.7%. Such a finding 
suggests low survival rates, that is, high mortality from stroke in LMICs, a situation that may 
be a result of limited evidence-based acute stroke care. Though the 31.7% in- hospital mortality 
at 30-days was relatively high compared to HICs where this can be as low as 7% [64], this 
seems to be the common phenomenon in most LMICs especially those in Africa where 30-day 
mortality rates can even be above 40% [65-67]. Given an overall 31.7% in-hospital mortality 
rate at 30-day, the study findings support previous suggestions that the provision of best 
practice care for acute stroke in LMICs is limited and potentially contributes to high patient 
mortality outcomes [22, 23, 26, 68].  
In addition, the thesis findings indicate the process of care indicators such as patient access to 
brain scanning services (CT/MRI scan) varied. Compared to the other hospitals, patients 
admitted to the stroke unit had better access to CT scans (p = 0.001). This appears consistent 
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with prior research also indicating higher patient access to CT brain scan among stroke unit 
patients compared to those admitted to the general wards [69].  
Largely, the findings confirm previous evidence of limited and variable nature of acute stroke 
care in LMICs [23, 26, 32]. For example, there was no evidence on the utilization of 
thrombolysis. Also, even though there is a preponderance of evidence about the effect of patient 
care in a stroke unit on reduced in-patient mortality [12, 70, 71], with favourable outcomes up 
to 10 years post stroke [72, 73], evidence from this study reports no significant relationship 
with in-patient mortality. Such a finding is not uncommon as past studies have reported similar 
results [74, 75]. These findings can be attributed to multiple factors. First, more severe patients 
from smaller non-tertiary hospitals are mostly referred to wards of major tertiary hospitals, thus 
exposing them to more severe stroke patients with multiple comorbidities. The findings 
indicate that the stroke unit admitted more patients with a history of hypertension and other co-
morbidities. Data on a critical stroke mortality predictor (the extent of severity at admission) 
were not available and could be a potential source of bias as previously documented to be a 
principal predictor of variations in-hospital mortality [76, 77]. Having said this, it is important 
to indicate that, such a finding is not uncommon as past studies have reported similar results 
[74, 75]. 
Aspirin therapy can reduce stroke-related morbidities and recurrent strokes. Significantly, the 
use of aspirin proved to be a reliable therapy for acute stroke care. Multivariate logistic 
regression analysis showed less in-hospital mortality among patients given aspirin, (p = 0.013). 
The findings showed those taking aspirin were 60% less likely to die than those who did not 
take aspirin. This finding is commensurate with findings from previous studies [78, 79] and 
confirms the effectiveness of this therapy, particularly where thrombolytic therapy remains 
inaccessible. In order to improve patient clinical outcomes using aspirin, it is imperative for 
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policy makers and health managers to ensure increased and uninhibited access to brain 
scanning services as this has been highlighted to be a key impediment to patients receiving 
optimal benefits from aspirin therapy [80]. 
In keeping with previous evidence within Africa [67, 81], and elsewhere [82, 83],  findings 
from the retrospective study also reported higher in-hospital mortality among stroke patients 
documented with hemorrhagic stroke sub-type. This is also consistent with global evidence 
which appears to suggest in-hospital mortality among hemorrhagic stroke patients are much 
higher compared to ischemic [64, 84, 85]. Thus, it was not surprising to see evidence from this 
thesis mirroring the global trend.   
5.2.3 Barriers to evidence-based acute stroke care  
Closing the evidence-practice gap in acute stroke care is a long-standing challenge with no 
single validated approach. A central aspect of addressing this gap is the need to identify the 
multiple barriers which influence the evidence-practice translation process [86]. Current 
understandings of such barriers are limited to studies from HICs (see evidence from a 
systematic review in chapter two). To address this knowledge gap, a qualitative study was 
conducted to explore these barriers [30]. Multiple barriers at patient, stroke care provider, 
healthcare system and the broader national health policy context levels emerged from this 
research. Overall, the majority of the barriers identified in this study have been reported 
previously [45, 87, 88].  
A key barrier in the present study was the influence of patient level contexts to the current 
uptake of proven acute stroke care interventions. This study showed in most cases, patients are 
either unable to afford the medications, pay for laboratory and brain scanning services, or delay 
in seeking care due to limited awareness of early symptoms. Similar barriers have also been 
reported in previous studies. In the study by William et al [89], patient level barriers such as 
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delay in seeking care were identified as the most dominant barrier to providing thrombolytic 
therapy. In fact, 91% of the participants identified this as a critical barrier. In light of this, any 
intentions to improve uptake must be comprehensive and cover a broad range of such patient 
level barriers. An important dimension of the patient level barriers in this study which seems 
to be at odds with existing literature, is the nature and circumstances within which such barriers 
occur. Notably, it was revealed that socio-cultural or religious beliefs/practices as well as 
patient discharge against medical advice appeared to contribute to a patient’s decision to seek 
or adhere to care. Previous studies in Ghana have highlighted the role of such factors in patient 
healthcare seeking behaviours and treatment of other chronic conditions [90, 91]. Studies in 
other African countries such as Tanzania and South Africa have also affirmed the influence of 
religious and socio-cultural beliefs in the health seeking behaviours of people with chronic 
conditions such as stroke [92, 93]. However, the findings are less popular in the mainstream 
literature on barriers to evidence-based stroke care. These observations confirm the important 
role of context and the need for a broader understanding of the barriers from all countries to 
develop better and well-targeted interventions to facilitate rapid translation and use of 
contemporary acute stroke care interventions in clinical settings. 
The findings in this thesis also highlight barriers at the healthcare system level particularly in 
relation to infrastructural and logistical provisions. In order to ensure successful and rapid 
translation of contemporary acute stroke care interventions for best clinical outcomes, it is 
imperative to address infrastructural and logistical deficits (e.g. adequate healthcare spaces, 
stroke care specialists, availability of BP and cardio morning devices, pulse oximeters, suction 
machines, brain scanning services and acute stroke units, etc.) highlighted both in the survey 
and qualitative interviews. These barriers are consistent with what has been reported previously 
[43, 87, 94]. It is also important to emphasise that the predominance of such barriers is not as 
pronounced in HICs compared to LMICs as the evidence suggests in this thesis. Nonetheless, 
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the comparability of such barriers reinforces the critical roles of such barriers to closing the 
translation gaps in all countries where there are limited infrastructural and financial 
investments in healthcare systems. 
The present thesis also highlights stroke care providers’ role in the overall delivery of optimal 
care for best clinical outcomes. Barriers at the provider level were diverse though some were 
common across all stroke care professionals. For example, consistent with other evidence [45, 
87, 89], the present thesis noted limited health provider knowledge in acute stroke care and in 
some cases apparent lack of knowledge on certain interventions such as thrombolysis. A key 
barrier underscored in previous literature pertains to stroke care professionals’ preferences for 
a particular therapy or disapproval of the use of proven and well-established interventions [88, 
95]. Interestingly, there was a lack of similar evidence in the present thesis, suggesting this is 
plausibly a barrier common in only HICs. Limited collaborative or team work was also 
perceived by stroke care professionals as a barrier to acute stroke care. This issue has been 
recognised internationally and gained much policy and scholarly attention over the past decade 
as a challenge to effective and quality delivery of health care [96-99]. This is also consistent 
with previously identified barriers to acute stroke care [41, 100-103]. The consistency in the 
finding of limited inter-professional relationship among acute stroke care providers with the 
existing international literature suggests this is a global challenge which requires greater 
universal and local attention to optimise acute stroke care.  
Barriers were also reported in the broader national and political contexts. Findings associated 
with this category of barriers related to the lack of specific health policy interventions to 
prioritize and promote acute stroke care as well as inadequate coverage of the national health 
insurance scheme to cover stroke care expenses such as brain scanning services. Owing to the 
lack of political imperative for acute stroke care in the hospitals surveyed [8], and as observed 
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in the qualitative study of this thesis [30], there is likely an increased out-of-pocket expenditure 
for patients. This situation will potentially exacerbate the situation of those already under 
financial stress, pushing them to find alternative means of care such as traditional or faith 
healers, often less optimal. Such findings of limited investment and priority for health care 
have also been observed previously [54, 55, 57, 104]. For any intervention to be effective 
towards closing the evidence-practice gaps, it is therefore essential to ensure insights from 
these barriers are incorporated into the design of future interventions.  
5.3 Implications for policy and practice  
The growing stroke burden and its threat to public health in LMICs are placing an enormous 
burden on the health systems of these countries. In view of this, it is important to appraise the 
overall implications of the thesis findings, in terms of policy, practice and the future research 
agenda. The ultimate goal of these reflections will be to explore how these findings could 
advance alternate perspectives and insights to close the current gap between evidence and 
practice in acute stroke care. Whilst reporting evidence on acute stroke care, scope of 
variability, efficacy of current interventions and the practical barriers to evidence uptake from 
a context which has received limited attention in evidence-based practice acute stroke care, the 
contextual insights from this study have implications which health policy makers and managers 
in Ghana and probably other LMICs could draw from to improve uptake of evidence based 
interventions for better patient outcomes.  
First, despite evidence that patients use of ambulance transportation services enhances early 
arrival [7, 105], it was highlighted in the survey that most patients resort to private non-
emergency medical transport systems following a stroke. This implies that patients are unable 
to access timely and appropriate care and thus are likely to suffer irreparable damage with 
compromised survival rates due to the potential delays associated with the non-utilization of 
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emergency medical transport services at stroke onset. Every minute of delay without immediate 
transport to a hospital for care results in a 2.5% reduction in treatment time [106]. For example, 
thrombolysis therapy has a treatment window of 4.5 hours [107]. Given that studies have 
consistently identified patient delays as one of the fundamental reasons for low thrombolysis 
therapy globally [31], the currently limited access to emergency medical transport services as 
demonstrated in this study will undoubtedly limit access to thrombolysis once it is available as 
a treatment option. The ‘time is brain’ study was emphatic about the need to minimise delays 
in seeking care following symptom onset [9]. However to date, patient delays remain one of 
the critical barriers to the low uptake levels of thrombolytic therapy [7, 108, 109]. For these 
reasons, there is a clear policy need to address limited access to emergency medical 
transportation services in Ghana and other LMICs. The need also to educate the public on early 
recognition of stroke signs and the subsequent need for urgent transport is imperative.. 
Allocating adequate resources to support the work of stroke care professionals in educating the 
public on early stroke symptoms and the necessity to first seek early medical attention using 
emergency medical transport services has the potential to reduce pre-hospital delays in seeking 
care. 
Another key finding was the limited, variable and inequitable distribution of hospital-based 
services and interventions to support evidence-based stroke care. For example, thrombolytic 
therapy was non-existent, only a single stroke unit was found in the study sample and access 
to brain scanning services was also limited. It is therefore imperative for greater policy attention 
to increase patient care in a stroke unit, increase the availability of thrombolysis as a treatment 
option and provide 24-hour access to brain scan in all major referral hospitals, particularly in 
regional hospitals where some were found to lack brain scanning services. Without the 
introduction of such relevant policy reforms to scale up the availability and access to these 
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services, the current evidence-practice gap will remain and patients will continue to be deprived 
of optimal care.  
Evidence from this thesis and that from previous literature clearly suggest the limited and 
variable nature of acute stroke care in LMICs, Ghana for the purpose of this thesis. Current 
interventions for acute stroke care are yet to be widely available in Ghana for optimal patient 
outcomes. The high case fatality rate of 31.7% compared to international standards may reflect 
the limited and variable nature of acute stroke care or the active influence of the aforementioned 
barriers to evidence uptake.  Hence, it is necessary for policy makers and other healthcare 
stakeholders to ensure these factors are reflected in any local or national intervention to 
promote evidence-based care and thus close the knowledge-practice gap. 
Thrombolysis and Aspirin are highly recommended pharmacological therapies for optimal 
acute ischemic stroke care. However, this thesis revealed the former was non-existent whilst 
the latter was widely used. In relation to thrombolysis, as noted previously, there is a limited 
policy priority for treatment of stroke and other chronic NCDs in most parts of the developing 
world [57, 104], and this plausibly explained the unavailability of thrombolytic therapy despite 
the unequivocal evidence of its relative net benefits to patient outcomes. There is an imperative 
for health policy to support the application of this therapy for patient benefits in Ghana. It is 
clear from the research findings that aspirin appears to be the mainstay for patient survival in 
Ghana. Previous studies have noted that the net benefit of aspirin is potentially limited in 
LMICs because of the limited  CT scan services in order to ensure appropriate patients be given 
this therapy [110]. It is therefore important to ensure barriers impeding patient access to brain 
scanning services are removed. A fundamental issue in this regard is the high cost of brain 
scanning services which makes it financially difficult for a majority of patients to access. To 
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this, it would be useful to ensure the existing national health insurance policy covers brain 
scanning expenses. 
As highlighted earlier in this thesis, translating current best practice interventions for acute 
stroke care will require concerted efforts to identity and address existing multiple barriers.  The 
findings from this thesis show these barriers are complex, context and discipline specific. 
Developing interventions based on insights of such complexity and variability by health policy 
makers and managers remains critical. Across the major barriers reported at the patient level, 
it is clear creating  awareness on early signs of a stroke and to first seek care in a hospital setting 
is imperative. The existing empirical literature documents a significant number of stroke 
awareness campaign interventions, mainly from HICs including the UK [111, 112], Australia 
[113, 114], Sweden [115], Canada [116] and Germany [117], from which Ghana and other 
LMICs can draw some lessons. As shown in the survey results, community-based interventions 
to raise stroke awareness are non-existent and thus highlighting an overarching need to make 
this a policy priority. These campaigns could also act as avenues to dispel erroneous public 
perceptions about stroke as a non-medical condition.  Offering the public such reliable 
information could prevent the patronage and access to non-medical care (e.g. herbal or spiritual 
care), hence, enhancing the potential to improve the uptake of evidence-based interventions for 
acute stroke care. It is also important to design interventions to educate patients and their 
families on the the need to seek medical attention and demystify the erroneous beliefs they hold 
about stroke as a non-medical condition which cannot be treated medically. Here, individual 
local hospitals, as well as national level interventions, could be explored and implemented. 
Similarly, the issue of patient needs, interests and preferences is a fundamental aspect of the 
evidence-based paradigm. The prominence of patient discharge against medical advice as a 
principal barrier to evidence-based acute stroke care revives the debate around the role of 
patients in the evidence-based practice discourse. The general medical literature suggests 
219
patient discharge against medical advice potentially put the patient at risk of adverse outcomes 
especially mortality [118, 119]. However, at present, there are limited empirical studies 
addressing this particular issue within the context of acute stroke care and thus it is essential 
for further investigation to shed light on the extent to which such practices compromise efforts 
aiming at translating current interventions for evidence-based stroke care.  
Parallel to the preceding issue, the critical role of socio-cultural or religious beliefs and 
practices require close scholarly scrutiny and greater health policy attention. This particular 
issue has not been sufficiently recognized in the international academic literature and as a 
result, the existence of specific interventions to mitigate these patient level barriers are 
unknown. It will be worthwhile for future research efforts to elicit further understandings of 
the scope of this practice and its possibility of undermining optimal patient care. As noted in 
this thesis, this phenomenon often results in the incidence of patient discharge against medical 
advice, non-adherence to medical care and an unhealthy relationship between acute stroke care 
professionals (healthcare providers) and patients or their families. Given the centrality of this 
issue, it is important multiple interventions be taken at the healthcare providers’ level, the 
hospital/organizational level and the broader policy level. This could be in the form of 
increased public campaigns about acute stroke, the potential adverse effects of seeking non-
medical care for acute stroke and awareness creation about the debilitating effects of delays in 
seeking medical care such as the risk of mortality and the high cost of care. More community 
level engagement is required on these specific issues especially in the design of campaign 
interventions and the need to access medical care for acute stroke care. However, campaign 
messages should be culturally and contextually appropriate to ensure an emphasis on the need 
to seek medical care and at the same time challenging the prevailing socio-cultural or religious 
beliefs and practices impeding access and adherence to hospital-based acute stroke care.  
Health care providers could play a key role in reinforcing such information to patients in the 
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early stages of admissions. Sufficient time needs to be spent educating patients and families 
about the causes and risk factors for stroke and the implications of seeking other forms of care 
outside the orthodox framework of care in hospital settings. Increased patient education in these 
lines could minimize the influence such beliefs, norms and practices have on the optimal 
delivery of acute stroke care.  
As highlighted in the qualitative study of this thesis [30], the interference of socio-cultural and 
religious beliefs and practices to optimal patient care requires close policy scrutiny as part of 
efforts to improve uptake of contemporary interventions for acute stroke care. Evidence 
suggests that the patients’ increasing utilization of services provided by traditional and faith 
healers is potentially due to the fact that such services are relatively easy to access and 
considered inexpensive and culturally appropriate compared to the orthodox medical care 
[120]. This situation has led to the current predominant practice of ‘healer shopping’  in Africa 
where patients explore multiple options of care including the biomedical services, ethno-
medical services, faith healers or spiritualists [90], depending on their beliefs about the cause 
of the disease, perception about the effectiveness of the care option, its appropriateness or 
affordability [92, 120, 121].   
To mitigate this, it is important to take certain appropriate policy measures and actions relevant 
to clinical practice for acute stroke care. These may be in the following: First, there is the need 
to ensure the existence of a culturally and contextually responsive health system for acute 
stroke care, that is, a system which ensures care plans are prepared and implemented without 
total disregard to the cultural and religious beliefs, values and practices of patients. As 
previously demonstrated, the provision of culturally responsive healthcare potentially improves 
patient access to healthcare [122].  In light of this, it is important for stroke care professionals 
to be educated about the diverse cultural and religious beliefs and practices of patients and how 
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these are often reflected in their attitudes, adherence to treatment and largely how these often 
conflict with biomedical healthcare options. An informed understanding of these practices, 
beliefs and patient health seeking modalities on the part of stroke care professionals will ensure 
contextually appropriate and patient centered care. This is supported by the previous 
acknowledgement that healthcare systems are not independent of the culture, ideologies, social 
values and norms of the populace which the healthcare system seeks to serve [123]. Second, 
there is an increasing global recognition of the role of faith and traditional healing and their 
subsequent integration with the modern healthcare delivery system in most parts of the 
developing world [124-126]. The WHO estimates about 80% of people in Africa access such 
services, and that plausibly explains the finding in this thesis where stroke patients patronize 
such services or combine with the modern healthcare delivery. In view of this, a robustly 
functional regulatory body or institution is required at the national level to regulate such 
partnership or activities and practices of traditional or faith healers. Such regulatory bodies 
could focus on promoting a positive partnership between orthodox healthcare providers and 
the various faith or traditional healers. This could create an opportunity for faith and traditional 
healers to be educated on the etiology of certain illness such as a stroke and the need for them 
to encourage community members to seek immediate care at symptoms onset or make referrals 
to hospitals for treatment. Aspects such as the psychospiritual needs of the patients could then 
be tackled by them. Third, a well comprehensive social health insurance policy which 
subsidizes and covers a considerable percentage of the costs incurred by patients could improve 
access to current interventions for acute stroke care in hospital settings.  As demonstrated in 
the qualitative study [30], patients sometimes request for discharge against medical practice 
due to the rising medical expenses during in-patient care in order to continue unorthodox 
treatment from traditional and faith healers, perceived to be relatively cheap 
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In general, a collaboration between health care staff remains a major organisational challenge 
in health care organisations [127], despite evidence of its prospects to advance optimal care 
[128]. As stroke patients often receive care from an array of clinicians, the extent to which 
these multidisciplinary teams collaborate is critical. In fact, this has been advocated as an 
indispensable element for a successful translation of evidence-based acute stroke care [52]. 
There are convergent views about the fact that inadequate coordination and collaboration by 
healthcare providers has the potential to threaten effective multidisciplinary stroke care, a core 
component of evidence-based stroke care [12, 99, 100]. Thus, the need to create a supportive 
and collaborative working environment to promote evidence uptake remains fundamental. A 
way forward in this regard is the introduction of health policy reforms relevant specifically to 
human resource development within the current health system in Ghana to ensure equal 
recognition of individual professional expertise. Creating platforms and training workshops 
among stroke care multidisciplinary staff could also promote effective working contexts.  
Insights from this thesis also highlight the fundamental need for health systems reform and 
reorientation to increase attention and support for acute stroke care. Based on findings from 
this thesis, health policy attention for stroke care in Ghana is lacking and so the need for 
increased health policy attention is recommended. This may be approached in various ways. 
First, in terms of the limited human resource capacity for stroke care (such as neurologists, 
neurosurgeons, speech pathologist and occupational therapists) and inadequate opportunities 
for staff professional development, the current national policy and plan on the human resource 
development in Ghana [129] could be harnessed to make adequate resource allocations to 
support the recruitment and training of stroke care specialists. In the same light, prospects for 
professional growth in stroke clinical care are essential towards quality improvements in stroke 
care [130] and overall health outcomes [131]. Thus, efforts to provide staff with the opportunity 
to enhance their competences and knowledge in stroke care is recommended.  
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Second, the provision of quality stroke care is underpinned by reliable outcome data [132]. As 
noted in the survey findings, most of the major referral hospitals do not have a stroke register 
or a well-established database to document data on the incidence, prevalence, outcomes and 
other clinically relevant information about stroke. This was also evident in the retrospective 
cohort study where significant gaps in the stroke data records were evident. As a case in point, 
subtypes for stroke, stroke severity and treatment times were rarely recorded. The paucity of 
such relevant and standardised data is not only peculiar to the Ghanaian context but 
characterised in most LMIC regions. In view of this, there is a potential to have most health 
policy and clinical decisions based on inaccurate and partial data in such contexts. For example, 
in this thesis, the lack of stroke severity data limited efforts to report with greater certainty the 
effect of the types of care provided in the three admitting wards on in-hospital mortality. Other 
data documentation limitations such as limited data on stroke subtypes, or use of broader codes 
such as cerebrovascular diseases limited data analysis for important clinical and policy insights. 
The current paucity and compromised nature of available stroke data restricted efforts to 
advance evidence-based practice for acute stroke care. The need for robust surveillance systems 
to ensure accurate and consistent documentation of stroke data is essential to support evidence-
based health policy decision making process.  
As will be discussed subsequently, most HICs (e.g. Australia [133], and USA [134, 135] ) have 
or are currently establishing robust stroke registers which support evidence-based health policy 
decisions for quality improvement processes. The current Ghanaian government e-health 
policies [136], could be a relevant guide to inform electronic profiling and documentation of 
stroke patient records. This should be an important policy imperative given that relevant and 
appropriate interventions to improve uptake and patient outcomes arguably, cannot be done 
without reliable data on the burden of stroke. The fragmented and insufficient nature of existing 
data hinders any informed and meaningful discourse or debate on quality of acute stroke care 
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in Ghana. Hence, it is important to prioritise the collection of stroke data in a more standardised 
way in order to offer policy makers better insights about the burden and trends of stroke. 
Third, based on insights from this thesis, an important component with high potential to support 
the optimal use of current best practice interventions for acute stroke care is human resource 
capacity development. As noted earlier, this is a persistent challenge in most LMICs and 
previous studies have emphasised this issue [40, 137, 138]. Whilst this has been previously 
highlighted as a major impediment to reducing stroke/NDCs burden in LMICs [137, 139], very 
little progress has been made in this regard. The findings from the survey and qualitative 
interviews in this thesis support this position. Any shortfall in policy efforts to address this will 
continue to perpetuate the current evidence-practice gap in acute stroke care. Although 
investment in long term efforts to recruit and train stroke care specialists such as neurologists, 
neurosurgeons, speech and occupational therapists is the logical way to proceed, short term 
measures need to be explored to mitigate the current deficit in stroke care professionals. As 
highlighted earlier in this thesis, a potent way could be the introduction of the concept of task 
shifting to augment the current human resource capacity gap for acute stroke care. This has 
been proven to be effective in the management of NCDs, stroke in this case [140-142], reduce 
remunerations and training of specialists and as well promote staff retention [143]. A study in 
Nigeria has shown how shifting certain tasks from specialised roles to non-specialists staff 
could potentially address the human resource deficit for acute stroke care [144]. Task shifting 
played a fundamental part in the prevention and treatment of HIV/AIDS in Africa [145-147], 
and this could also prove to be worthwhile in acute stroke care. In exploring this, the WHO 
framework [143] for implementing this policy option could be used to address the shortage of 
stroke care professionals although note should be taken to contextualise this within acute stroke 
care domain since these recommendations were situated within new-born and maternal 
healthcare arena. 
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With the low application of stroke unit care and thrombolytic therapy, the need to explore 
alternate models of care interventions for acute stroke within LMICs is imperative. One such 
approach worth policy consideration is centralising stroke care services. Centralised stroke care 
services involve rerouting and transferring all suspected stroke cases to a specialist referral 
centre [148]. This is also particularly important because the health systems of Ghana and most 
LMICs are highly under-invested and thus often lack the needed resources to provide adequate 
healthcare. Hence, a strategy to ensure patients are provided optimal stroke care is to centralise 
stroke services as a short-term measure. This could take the form of demonstration projects 
where a full range of acute stroke care services are offered by a multidisciplinary team with 
collegiate support and opportunities for staff professional development in all aspects of stroke 
care in selected referral sites. Such hospitals are often tertiary hospitals that are well-resourced 
with stroke specialists experienced in providing evidence-based care for patients. The limited 
and variable nature of acute stroke care as found in this thesis supports the need for such a 
policy direction. This has been established to reduce cost, in-patient mortality and reduced 
length of stay [149]. Uptake of this model of care is also documented even in HICs including 
the UK [148, 150, 151], Denmark [152, 153] and Australia [154]. However, given that the 
evidence to date suggests this is feasible in HICs, it is imperative future research examine the 
possibility of introducing such a model of care in LMICs, Ghana in this instance.  
Besides centralising stroke care services and exploring task-shifting as potent measures to 
addressing current deficits in the delivery of evidence-based care, the implementation of 
telestroke could also be part of the health system reconfiguration efforts. In simple terms, 
telestroke refers to the process of remotely identifying, assessing, treating and monitoring 
stroke patients using internet or telephone based techonological devises. Common in HICs, 
telestroke has proven to be effective in improving access to specialised evidence-based stroke 
care resulting in improved outcomes [155-158]. This is also cost effective [157, 159], and thus 
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could be an important consideration in efforts to improve uptake of best practice 
services/therapies. Given findings of variability in the available application of evidence-based 
interventions, inequities in access to services and where most of the few available stroke 
specialists are concentrated in tertiary-teaching hospitals located in urban centres, telestroke 
can play a role in ensuring improved and equitable access to stroke care in other areas. With 
telestroke, patients can be evaluated and treated remotely. This has tremendously improved 
access to t-PA in most HICs [160, 161].   
Furthermore, a potential policy option could be to explore international collaborations and 
partnerships with HICs where current uptake levels of contemporary acute stroke care 
interventions are better. Though context and geo-political spaces within which these healthcare 
systems operate vary considerably, LMICs could explore such partnerships in order to draw 
from HICs best practice ways of facilitating speedy uptake of existing proven interventions in 
standard clinical practice. Although this is an underexplored option, a cogent argument in 
support of this is made based on the observation that, compared to LMICs, HICs are already 
forerunners and so will have many insights to offer. This action should undoubtedly be 
preceded by some critical analyses of the context-specific and feasibility issues. In Ghana, 
evidence of an earlier collaboration to optimise acute stroke care was reported [162].  The 
results of this partnership are yet to be reported but may offer some vital lessons for other 
LMICs.  
Finally, in this thesis, four thematic and eleven sub-thematic barriers to uptake of evidence-
based practice for stroke care were reported. Notably, most of these barriers also underline the 
key drivers of change or uptake of innovations in clinical practice and healthcare settings, as 
espoused in the conceptual and theoretical frameworks for the thesis [49, 50, 163]. On the basis 
of this, future health policy interventions, reforms or implementation strategies to promote the 
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rapid translation of the current best practice interventions for acute stroke care in Ghana and 
potentially in other LMIC contexts should be carried out with reference to these barriers, 
especially those unique to LMIC contexts. 
5.4 Limitations of this research 
This research was conducted in a purposive sample of the main public referral hospitals in the 
ten administrative regions of Ghana. As a result, the evidence was limited in terms of the 
broader perspective of evidence-based practice in both public and private hospitals as well as 
non-referral hospitals. This may limit the external validity and transferability of these results. 
Although these findings are context-specific and thus may have limited implications and 
relevance to broader policy reforms on evidence-base practice for acute stroke care, important 
lessons can be drawn for other LMICs, especially within Africa, where uptake is also 
documented to be slow. This is because the health system, clinical practice and policy context 
of Ghana has many similarities with other countries within Africa.  
Another important limitation of this research was the paucity of information on stroke severity 
which may have affected the mortality outcome of stroke patients in the retrospective cohort 
study. This is critical because stroke severity is a potential confounding factor for in-hospital 
mortality and so may have affected in-hospital mortality outcomes in the admitting wards of 
the study hospitals. However, the use of a strict eligibility criteria applied in the collection of 
patient clinical data and reporting the results according to the RECORD guideline potentially 
minimised the risk of any significant bias of the final in-patient mortality outcomes analysis. 
In relation to the qualitative in-depth interviews, the views on the barriers to acute stroke care 
could be compromised on three grounds. First, this thesis highlighted barriers perceived by 
stroke care professionals but such perspectives may not be representative of the generality of 
health staff in charge of acute stroke care across Ghanaian hospitals. Second, the use of a semi-
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structured interview guide and the role of the researcher in interpreting the data may have 
affected the quality of the results, hence this should be taken into account in any effort to apply 
the study findings. Nevertheless, a number of strategies were employed to minimise any 
potential threat these may have posed. These comprised using the consolidated criteria for 
reporting qualitative research (COREQ), a well-established reporting guideline for qualitative 
research, including among others, participant cross-checking of selected transcripts and the 
continuous use of interview guide in all interviews mitigated subjectivity. Last, the findings 
from the interviews did not report observational or documentary evidence of the barriers to 
evidence-based stroke care within the study contexts. This is an area future research should 
explore since this has the potential to uncover additional relevant information which may not 
have been reported by participants during the interviews.  
The final limitation is the approach of this thesis to employ only three different studies to 
present the extent to which the best research evidence on acute stroke care can be translated 
rapidly into clinical practice. Insights from further research on the viewpoints of stroke patients 
on what impedes their access to stroke care could have provided valuable complementary 
information. Such insights would have broadened the spectrum of insights to improve uptake 
and implementation of quality improvement measures given that patient level factors were 
found to play central roles in the evidence-practice translational process.   
5.5 Thesis contribution to knowledge 
Largely, to the best of my knowledge, the findings reported in this thesis is about the earliest 
to present evidence of the extent to which evidence-based interventions for acute stroke care 
are translated into standard practice drawing from multiple perspectives. Before this study, no 
study had examined evidence-based practice within the context of acute stroke care in Ghana 
and most parts of LMICs. The systematic reviews reported in chapter two confirmed the 
existence of limited empirical studies in relation to this within Africa. Even with the few studies 
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found and reported in the systematic review, a unidirectional approach was taken to only 
evaluate the effectiveness of specific acute stroke care interventions. Although this is an 
important consideration in the evidence-based stroke care scholarship and discourse, these have 
been limited as they only focused on the interventions outcomes but the ‘what’, ‘how’ and 
‘why’ aspects integral to the implementation contexts within which evidence-based practice 
for acute stroke care occurs were not addressed, a gap which has been filled in this thesis 
through the qualitative study. 
An important specific contribution to the stroke care literature is the documentation of evidence 
providing a wide-ranging picture of different acute stroke care services and interventions in 
Ghana. To date, such works are only known to be reported from HICs such as the UK, Canada, 
and Australia, among others. As a result, the findings of this thesis have made an important 
contribution to knowledge in Ghana and other LMICs. The results have improved 
understandings of current evidence-based acute stroke care services from a LMIC, and where 
important gaps in the delivery of evidence-based acute stroke care have been identified for the 
consideration of health authorities.  
Furthermore, findings from the in-depth qualitative interviews in this thesis contribute to 
original knowledge in many significant ways. First, to my knowledge, and based on 
information from the systematic review reported in chapter two of this thesis [31], the findings 
provide the first evidence of the specific barriers to evidence-based acute stroke care from a 
LMIC setting. Such findings have balanced the current knowledge on this topic which hitherto 
was limited to only evidence from HICs. Beyond this, the findings in this thesis also extend, 
empirically and conceptually, the framework on barriers to change in clinical practice for stroke 
care and overall healthcare. For instance, this research has unraveled certain context specific 
barriers such as discharge against medical advice and the role of socio-cultural /religious beliefs 
and practices to the application of evidence-based acute stroke care. These have not been 
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sufficiently documented in the previous empirical literature on the barriers to acute stroke care, 
and as a result, their revelation in this thesis is indispensable towards developing well-targeted 
and contextually appropriate interventions to optimize the provision of acute stroke care. It is 
important to emphasize that the socio-cultural/religious beliefs and practices aspects of 
evidence-based acute stroke care revealed in this thesis have somewhat pointed to a 
theoretical/empirical deficit in the known barriers to evidence-based practice care for stroke 
patients. As reported in the systematic review in chapter two, the social-cultural aspects of 
patient care were not emphasized. Thus, this thesis has made a significant conceptual and 
empirical contribution by underscoring the importance of such contextual factors to evidence-
based practice for acute stroke care. Future efforts to optimize care for stroke patients should 
not ignore the role of such contextual actors because of their potential to compromise the 
implementation and uptake of evidence-based interventions for stroke care. 
There is a large body of research on stroke mortality outcomes and risk factors within the 
Ghanaian and African contexts. However, data on stroke treatments and the associated 
outcomes is considerably limited. Thus, this research is an essential advancement of knowledge 
through the retrospective cohort study in chapter four which has not only contributed to 
bridging this gap but has at least illuminated health policy makers on the extent of treatment-
mortality gaps. The use of data from treatment outcomes serves as an important source of 
information on matters related to enhancing the quality of care and the performance of 
healthcare systems worldwide [74, 164]. However, such data are sparse and hard to come by 
in LMIC settings such as Ghana. Where available, these are often fraught with methodological 
issues and thus less reliable to support any meaningful decision-making process. For this 
reason, the findings from this thesis are anticipated to support evidence-based decision-making 
process related to quality improvement or performance management on stroke care. 
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Finally, the contribution of this thesis to the field of implementation science, more importantly, 
within LMICs cannot be overemphasized globally. The field of implementation science is still 
in a nascent state and this work is among the earliest to have reported evidence on some of its 
core elements: the nature and state of interventions, the possible factors accounting for the 
application of evidence-based interventions and the outcomes arising from the implementation 
of such interventions [165, 166]. In other words, the findings have supported a clearer 
understanding of the nature of evidence, drivers for evidence implementation in stroke care, 
implementation outcomes and the likely relationships with outcomes of implemented 
interventions. The use of theories and conceptual frameworks have been strongly 
recommended in implementation science towards understanding the nature of interventions, 
factors influencing the uptake levels of such interventions and the outcomes arising from the 
implementation of such interventions [167-169]. In keeping with these key traditional attributes 
of the field of implementation science, this thesis used known and well established theoretical 
and conceptual frameworks on changing practice or promoting evidence uptake [49, 50]. As 
has been highlighted by researchers in the field of implementation science [168, 170, 171], the 
contexts where implementation occurs largely plays an essential role to evidence uptake and 
insights from the qualitative data have uniquely and unequivocally demonstrated this. The 
findings and policy/practice implications from this thesis, including highlights of immediate 
and long-term stop-gap measures to addressing the highlighted gaps could serve as an 
implementation framework towards best practice for acute stroke care in Ghana and may be 
the wider LMICs.  
5.6 Future research opportunities 
The findings from this thesis have important implications for future research in many strands. 
First, the findings were derived from a focus on only public referral regional and teaching 
hospitals within the Ghanaian context. Therefore, future studies should focus on both public 
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and private hospitals for greater coverage and clearer picture of the extent to which evidence-
based practice for acute stroke care occurs. Such an attempt would undoubtedly extend the 
potential for generalisability of the findings. As demonstrated within Europe [172], a more 
ambitious research agenda should be conducted within Africa in order to map and compare 
current acute stroke care services among hospitals, using the World Stroke Society Service 
Guidelines as a best practice benchmark. This would bridge a significant gap in the stroke care 
literature from resource-poor settings. 
Another area to consider in future research endeavours is conducting further qualitative in-
depth interviews with health planners, managers, administrators, health policy advisors 
especially on the barriers to the prioritization or allocation of resources to support evidence-
based acute stroke care stroke care. Due to lack of time and resources, it was not possible to 
collect data from such participants on these equally essential stakeholders to translating 
contemporary acute stroke care interventions into standard practice in clinical settings. The 
need to conduct further in-depth interviews to ensure a clearer and richer understanding of 
these barriers is indispensable.  
The perspectives of stroke patients or their carers on the barriers to accessing or adhering to 
acute stroke care in clinical settings are indispensable to the whole translation process. This 
point is underscored by the fact that the perspectives of patients on the available treatment 
options for them occupies a key position in the evidence-based practice paradigm and the field 
of implementation science [173-175]. However, due to time and resource constraints, this could 
not be included in the present research scope. In light of this, future studies should consider 
eliciting the views of patients or their carers on the potential factors affecting access and 
utilization of acute stroke care services/therapies.  
Also, worth considering in future research agenda is the need to conduct controlled prospective 
studies using larger sample populations and taking into account stroke severity scores to 
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provide definitive evidence on in-hospital mortality in admitting hospital wards. Although 
important variables such as in-patient mortality are often relied upon to evaluate the extent of 
effectiveness of stroke care interventions [74, 176], which this study also incorporated to some 
extent, this was still limited in the sample for this analysis and the lack of stroke severity data 
could have also biased the reported outcomes. It is therefore important for future controlled 
studies to be conducted in order to address this gap. 
Although insights from this thesis support pre-existing views about the low application of 
evidence based interventions for acute stroke care, it further calls into question the external 
validity of current interventions for acute stroke care. As noted earlier, despite the fact that 
evidences from the qualitative study and other studies have advanced understandings of the 
potential reasons for the low uptake, subsequent research efforts should take interest in 
evaluating the widespread feasibility of applying contemporary interventions in LMICs such 
as in Africa. This point is important because the studies reported in the pooled analysis which 
recommended and standardized current acute stroke care interventions were all from HICs [12, 
79, 158, 177, 178]. However, it is not known if such interventions or the protocols and clinical 
guidelines which currently support stroke professionals’ incorporation of such interventions 
into routine practice have been customized to suit varying contexts especially LMICs. Adaption 
of clinical guidelines to local contexts, has been shown to improve adherence, local ownership 
and uptake of interventions in general [179-181], thus the need for further investigation into 
this issue.  
5.7 Dissemination plan of research findings 
In order to optimize the impact of the research findings with the aim of closing the knowledge-
practice gap in acute stroke care, a research dissemination plan is currently being 
operationalized. First, a dissemination plan in the form of preparing and publishing the research 
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findings in international peer reviewed scientific journals is underway. As noted in chapter two 
and four of this thesis, parts of the research findings are already published and this is envisioned 
to illuminate understandings of the current knowledge gaps and recommendations to address 
these emphasized gaps have been provided. It is envisioned such recommendations will inform 
new policies and interventions to optimize acute stroke care in Ghana and may be in other 
LMICs. Second, plans to present the results at peer reviewed scientific conferences are 
underway. For instance, findings from part of this thesis have already been presented at an 
international scientific conference and plans are underway to disseminate the results in similar 
platforms in the future. Third, the dissemination plan will also target stroke care professionals 
in Ghana and LMICs. This includes plans to hold workshops with acute stroke care providers 
in the study hospitals to share and engage them on the existing acute stroke care capacity gaps 
and barriers to acute stroke care and elicit their views on how to optimize care in light of these 
findings. Finally, particularly for policy makers and health managers, discussion papers and 
policy briefs on key policy relevant findings will be developed in non-scientific terms. This 
will particularly focus on disseminating the findings and specific policy-relevant 
recommendations made in order to address especially the broader national level barriers to 
acute stroke care. 
5.8 Conclusion 
This study is the first in Ghana, and among the earliest in the African region to advance 
understandings on the application of contemporary acute stroke care interventions in routine 
clinical settings. 
In brief, as demonstrated in a systematic review, this thesis reports evidence of apparent gaps 
in the academic literature on the general uptake of evidence-based interventions for acute stroke 
care in Africa, Ghana in this context. Evidence on the clinical efficacy of such interventions 
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was also limited and weak in these contexts. Despite, the thesis also found inadequate and 
imbalanced understandings on the factors underlining the limited uptake of contemporary 
interventions for optimal patient outcomes as existing studies were reported from only HICs. 
These critical gaps necessitated the need for three empirical studies in Ghana to bridge these 
knowledge gaps and the findings of these studies are as follows: The first empirical study found 
limited availability and application of current hospital-based acute stroke care services and 
interventions in the Ghanaian contexts. Largely, the findings highlight an overall deficit in the 
capacity of the healthcare system to implement contemporary acute stroke care interventions 
for optimal patient outcomes. Second, the thesis also found high in-patient mortality outcomes 
among stroke patients compared to international standards. The thesis suggests such relatively 
high mortality outcomes were attributable to the variable and compromised the quality of acute 
stroke care in the study hospitals. Based on the findings of the qualitative study which sought 
to provide contextual insights to the findings of the first and second studies, the third study 
explored and documented multiple and fresh insights regarding the barriers to optimal patient 
care. Barriers were identified at the patient, stroke care professionals, healthcare 
system/organizational context and the broader national health policy contexts levels. On the 
basis of these findings, the thesis proposes the need for broader health system reforms to 
optimize the application of contemporary interventions for better patient outcomes.  
In sum, the push for evidence-based healthcare is longstanding and has continued to gain 
increased international importance due to the persistent gap where available best practice 
interventions to improve health outcomes are systemically underutilized. To address the current 
growing and projected demand for acute stroke care owing to the aging population, increasing 
risk factors and unplanned urbanization, a health system reform and strengthening is needed. 
This will require a holistic and system-wide approach where a deeper understanding of the 
knowledge-practice translation process is developed to inform the development of targeted 
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interventions. This cannot be achieved only by evaluating patient outcomes following 
prospective studies/clinical trials, or by examining the availability of contemporary 
interventions for acute stroke care via an organizational/hospital audit or by only exploring 
evidence of the barriers to translating evidence into practice. An integrated and system-wide 
approach is advocated which incorporates knowledge from all these components. Arguably, 
this is the only way current efforts to standardize best practice interventions would yield any 
material effect and thus close the long-standing gap between evidence and practice.  
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Appendix 2: Data Collection Instruments 
1. Survey instrument/questionnaire  
 
 
 
 
 
Introduction  
My name is Leonard Baatiema, a research student with the Australian Catholic University undertaking this 
research as part of the requirements for my PhD in Public Health. This survey seeks to understand the nature 
of current acute stroke care services in the main referral hospitals in Ghana. For this purpose, I seek to gather 
information from you about the nature of acute stroke services in your hospital.  Please note that this survey is 
not a test or assess your clinical knowledge of acute stroke care or the decisions you make in relation to the 
provision of acute stroke care. Results from this survey will help characterise the picture of acute stroke services 
in the hospitals, identifying gaps in acute stroke care services and consequently make recommendations for a 
clear evidence-based health policy action to improve acute stroke care. 
In addition, participation in this survey is voluntary and if you do not feel like answering any question, kindly 
let me know so I can skip to the next question; or you can stop the interview at any time. However, I hope you 
will participate in the survey since your views are important. The information collected will be strictly 
confidential. I will not give your name or information to anyone outside this research project. There are no 
known risks to participating in this survey.  With your permission, I would like to ask you a series of questions 
that will take approximately 45 minutes. Thank you for taking time from your busy schedules to participate in 
this survey 
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   SECTION A: RESPONDENT'S INFORMATION  
1 Position of Respondent  …………………………………………………………
………………………………………………………… 
2 Gender Male...……………………………....………………..1          
Female ……………………………………..………...2 
3 Years of work experience  0-5yrs………………………………………….…..…1 
6-10yrs………………………….…………….….…...2 
11-15yrs………………………….………….……..…3 
16years and above………………………………..…..4 
                                       SECTION B: HOSPITAL DATA 
4 Name of Hospital …………………………………………………………
………………………………………………………… 
5 Status of Hospital Regional Hospital…………………………….…..….1 
Teaching Hospital……………..……………….…… 2 
6 Number of beds in the hospital …………………………………………………………
…………….………………………………………….. 
7 How many acute stroke patients were admitted 
in your hospital in the last year (2015) 
…………………………………………………………
………………………………………………………… 
                                        SECTION C: ACUTE PRESENTATION AND EARLY ASSESSMENT  
8 Which ward is a patient with acute stroke 
symptoms most likely to be admitted first? 
Accident and Emergency Department……………......1 
General medical ward…………………………….......2 
Neurology ward.……………………….…………......3 
Intensive Care Unit (ICU)…………………...…….…4 
Medical Ward…………………………………...……5 
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If others, specify...………….…………..………….....6 
9 Are there accident and emergency department 
protocols for rapid triage for patients 
presenting with acute stroke in your hospital? 
Yes …………………..…………………………..…...1 
No …………………………………………..….…….2 
 
10 
Are there arrangements in place with local 
ambulance services to fast-track patients 
presenting with acute stroke? 
Yes……………………………………………………1 
No…………………………………………………….2 
 
 
11 
If no to Q10, what is the common means of 
transport for rapid patient transfer to your 
hospital? 
Taxi /private arrangements…………………………...1 
Others………………….………………………...…...2 
If others, please specify……………………………… 
12 Are there protocols for transfer of stroke 
patients to other hospitals for care? 
Yes……………………………………………………1 
No…………………………………………………….2 
Don’t know………………………………….…...…...3 
13 Are there clinical management guidelines for 
acute stroke care 
Yes ………………………………..………………….1 
No……..……………..…………………….…………2 
 
14 
If yes to Q13, which clinical management 
guidelines is/are used for acute stroke care in 
the hospital? 
 
National clinical guideline for stroke…………….…..1 
Standard Treatment Guideline…………….………….2 
World Stroke Society Clinical guideline…………......3 
NICE Clinical Guideline……………………...……...4 
If others, specify ……………………………………..5 
 SECTION D: DIAGNOSIS AND SCREENING SERVICES 
15 Does your health service have access to 
functional CT scanner? 
Yes ………………………………………………..…1 
No …………..……………………....…………….…2 
16 If yes to Q15, what hours is the service 
available? (Select one option only) 
Monday – Friday, 9am – 5pm…………………….….1 
Monday – Friday, extended hours……………….…...2 
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Extended hours including weekends……..…………..3 
24 hours a day, 7 days a week ……………….………4 
17 If no to Q15, can you get CT offsite within 24 
hours of stroke presentation to your hospital? 
Yes …………………………….………..………...….1 
No ……………………………………….………...…2 
18 Does your health service have access to 
functional MRI services? 
Yes ……………………………………….………….1 
No …………………………………..…….…………2 
19 If yes to Q18,what hours is the service 
available? (Select one option only) 
Monday – Friday, 9am – 5pm………………….…….1 
Monday – Friday, extended hours…………….……..2 
Extended hours including weekends………….……..3 
24 hours a day, 7 days a week ………………………4 
20 If no to Q18, can you get MRI offsite within 
24 hours of stroke presentation to your 
hospital? 
Yes……………….……………………………….….1 
No……………………………………………………2 
21 Do you have neurovascular ultrasound 
diagnostic services such as Carotid Doppler 
Services in the hospital? 
Yes ……………….…………………………….…….1 
No ……………………………………………………2 
22 If yes to Q21, can you access this service 
onsite within 24 hours of stroke presentation to 
your hospital? 
Yes ……………………….………………….……….1 
No ……………………………………………………2 
23 If no to Q21, can you access this service offsite 
within 24 hours of stroke presentation to your 
hospital? 
Yes ……….……………….………………………….1 
No ……………………………………………....……2 
24 Do you have Electrocardiogram (ECG ) 
services in the hospital? 
Yes …………………….…………………………….1 
No ……………………………………………………2 
25 If yes to Q24, can you access this service 
onsite within 24 hours of stroke presentation to 
your hospital? 
Yes ……………………….………………………….1 
No ……………………………………………………2 
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26 If no to Q24, can you access this service offsite 
within 24 hours of stroke presentation to your 
hospital? 
Yes ………………………….……………………….1 
No ……………………………………………………2 
27 Do you have Electroencephalogram service in 
this hospital? 
Yes ………………………….……..……….….…….1 
No ……………………………………………………2 
28 If yes to Q27, can you access this service 
onsite within 24 hours of stroke presentation to 
your hospital? 
Yes ……………….……….………………..…….….1 
No …………………………………………..…….…2 
29 If no to Q27, can you access this service offsite 
within 24 hours of stroke presentation to your 
hospital? 
Yes ……….……………….………………………….1 
No ……………………………………………………2 
30 Do you have Magnetic Resonance 
Angiography services in this hospital? 
Yes ………………………….…………………….….1 
No ……………………………………………………2 
31 If yes to Q30, can you access this service 
onsite within 24 hours of stroke presentation to 
your hospital? 
Yes ……………………………………………….….1 
No ……………………………………………………2 
32 If no to Q30, can you access this service offsite 
within 24 hours of stroke presentation to your 
hospital? 
Yes ………………………….…………………....….1 
No ……………………………………………..….…2 
33 Do you have Computed Tomographic 
Angiography services in this hospital? 
Yes ………………………….……………………….1 
No ……………………………………………………2 
34 If yes to Q33, can you access this service 
onsite within 24 hours of stroke presentation to 
your hospital? 
Yes ………………………….……………………….1 
No ……………………………………………………2 
35 If no to Q33, can you access this service offsite 
within 24 hours of stroke presentation to your 
hospital? 
Yes ………………………….………….……………1 
No ……………………………………………………2 
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36 
 
Do you have functional acute stroke 
assessment scales? 
Yes ………………………….……………………….1 
No ……………………………………………………2 
 
 
 
37 
If yes to Q36, which of the following are used 
in the hospital? 
 
 
National Institutes of Health Stroke Scale NIH…..….1 
Scandinavian Stroke Scale……………………………2 
Canadian Neurological Scale……………………....…3 
European Stroke Scale……………….……...………..4 
Oxfordshire Community Stroke Project Classification 
(Bamford)…………………………………...………..5 
If others, specify……………………….…….…….…6 
38 If no to Q36, how do you conduct patient 
assessment without the use of the 
recommended tools?  
Previous knowledge or experience…….………..……1 
Others, specify………………………………………..2 
39 Does your health service have a dedicated 
stroke unit (ward)? 
Yes …………………………………..………..…….1 
No……………………………………….…………..2 
 
40 
 
If yes to Q39, is it a 
 
 
Stand-alone…………………………….……………1 
Within another ward……………………………..….2 
Combined acute and sub-acute care (e.g. includes 
rehabilitation) …………………………………….....3 
If others, specify …………………………………....4 
 
41 
 
If yes to Q39, please describe what this is 
comprised of 
………………………………………………………… 
………………………………………………………… 
………………………………………………………… 
42 If yes to Q39, how many beds are in the stroke 
unit? 
…………………………………………………………
…..…………………………………………………….. 
 
43 
How adequate are the number of beds? Very adequate………………………..……………..1 
Adequate………………………………………....…2 
Inadequate……………………………………..……3 
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Very inadequate………………………………..…...4 
 
44 
If no to Q39, dedicated stroke unit, does your 
hospital have a dedicated, multidisciplinary 
stroke team? 
Yes ………………………………………..…….….1 
No ……..…………………………………..…….…2 
45 If no dedicated stroke unit as asked in Q39, 
which wards are mostly used to admit stroke 
patients. 
General wards…………………………………….….1 
Neurological wards…….……………………….……2 
Intensive Care Unit……………………………….….3 
Others (specify)…………….………………………..4 
 
46 
Can you briefly describe what this consists of? …………………………………………………………
…………………………………………………………
………………………………………………………… 
47  
Which of the following factors account for the 
lack of or absence of a stroke unit care? 
 
  (Tick where applicable) 
 
Inadequate stroke clinical staff…………………...…1 
Financial constraints ……………………..……...….2 
Lack of administrative, policy support ………….….3 
unware of the use of stroke unit care ……………….4 
If others, specify ……..……………………….…….5 
48 Will you recommend the provision of a stroke 
unit in this hospital? 
Yes ……….……..………………………..……….....1 
No ………..……………………………………..…...2 
Not sure………………………..…………………….3 
 
49 
Is your hospital able to provide thrombolytic 
therapy using intravenous recombinant tissue 
plasminogen activator (t-PA or alteplase) for 
ischemic stroke patients? 
Yes ……………………………..………………..….1 
No ………………………………..…………………2 
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50 If yes to Q49, is there a standardised protocol 
or treatment guideline to guide administering 
of t-PA? 
Yes ………………………………………………..….1 
No ……………………………………………………2 
51 If no to Q49, thrombolytic therapy, what is 
your opinion about the following factors 
accounting for the non-use of thrombolytic 
therapy for acute stroke care?  
(Tick where applicable) 
Inadequate stroke clinical staff…………....……….…1 
Financial constraints …………………...…………….2 
inadequate administrative or policy support ……...….3 
unware of the use of thrombolysis …………..……….4 
If others, specify ………………….………………….5 
 
52 
Does your hospital provide aspirin for stroke 
patients eligible for this type of treatment? 
Yes ……………………………………………….….1 
No ……………………………………………………2 
53 If yes to Q52, do you use a standardized 
protocol when administering aspirin? 
Yes …………………………………………..……….1 
No ……………………………………………...…….2 
54 If no to Q52, aspirin therapy, do you agree the 
following factors account for the non-use of 
aspirin therapy for acute ischemic stroke care? 
  (Tick where applicable) 
Inadequate  stroke clinical staff………………………1 
Financial constraints ………………………..…….….2 
inadequate administrative, policy support ……….…..3 
unware of the use of aspirin .………………….….…..4 
If others, specify………….………………………..…5 
55 If no to Q52, would you consider 
recommending the use of aspirin? 
Yes ……………………………………………….….1 
No ……………………………………………………2 
56 Does your hospital carry out surgical 
treatments for acute stroke patients? 
Yes……………………………………………..….…1 
No……………………………….…………..……….2 
57 If yes to Q56, what surgical treatments or 
procedures are conducted in the hospital? 
Revascularization (Carotid Endarterectomy )……..…1 
Surgery for Aneurysm…………………………….….2 
Arteriovenous malformation treatment……………....3 
Decompressive craniotomy………………….…….…4 
If others (specify)…………………………...…….….5 
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SECTION  F:   STROKE REHABILITATION SERVICES  
58 Does your hospital have effective 
rehabilitation services on the same site? 
Yes …………………………………………..……….1 
No …………………….………..……………….……2 
59 If no to Q58, on-site rehabilitation service, do 
you have access to off-site rehabilitation 
service? 
Yes…..…………………………………..……..…….1 
No……..………….…..……………….………..……2 
60 If yes to Q58, please indicate the nature of the 
rehabilitation service 
Public Facility …….………………………………….1 
Private Hospital …………………….……………...…2 
If others, specify …………………………..…...…….3 
61 Do you have hospital discharge care plans for 
stroke patients? 
Yes ………………………..…………….………..….1 
No ………………………………….…..……………2 
62 If yes to Q61, what do they include? Self-management strategies…………………………..1 
Out-patient Appointments…….……..……………….2 
If others, specify ……………………………………..3 
63 At discharge, are patients or carers provided 
with a hospital staff contact number at 
discharge? 
Yes ……………………………....…….…………….1 
No ………………………….……………..…………2 
64 Is there patient information leaflets/literature 
available/offered on the following topics 
during admission and at discharge 
Stroke condition………………………………………1 
Local community care arrangements…………………2 
Local voluntary associations………….. …………….3 
Community stroke support groups……….………..…4 
 SECTION G: ORGANISATION OF WORKFORCE 
 
 
 
65 
 
How many of the following professionals do 
you have in your stroke team at your health 
institution 
 
Clinical psychologist…………………………………1 
Nurse …………………………….………..….….…..2 
General practitioner………………………...….….…3 
Neurologist………………………………...…….…..4 
Neurosurgeon………………………………….….…5 
281
  (Tick where applicable) 
 
Physician specialist………………………….……....6 
Medical Officer…………………………………..….7 
Stroke care coordinator………………...………........8 
Trained stroke nurses…………………………..……9 
Emergency department staff……………………...…10 
Occupational therapist………………………...….…11 
Physiotherapist…………………….………….….….12 
Speech pathologist ………………..……..……...…..13 
Social worker…………………….………....….…....14 
Dietician……………..…………………………...….15 
If others, specify ………………..…………………..16 
None……………………………………………..….17 
66 Is there a physician specialist as the principal 
person for stroke at your hospital? 
Yes ……………………………………………..….…1 
No ………………………….……………….…..……2 
67  
If yes to Q66, please select one option 
 
Doctor…………………………………………….….1 
Nurse…………………………………………….…..2 
Therapist………………………………………..……3 
If others, specify ………..…………….………..……4 
 SECTION H: CONTINUING EDUCATIONAND QUALITY IMPROVEMENT 
68 
 
Is there a program for the continuing education 
and professional development of staff on 
stroke clinical care 
Yes …………………………………….………....….1 
No …………………………………………..….……2 
 
69 Has the stroke team in the hospital been 
involved in quality improvement activities and 
on strategies to improve care?  
Yes …………………………………………..…..….1 
No …………………………….…………….………2 
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SECTION I: HEALTH SYSTEM POLICY SUPPORT FOR STROKE CLINICAL CARE 
70 Are there some specific health policies or 
interventions (national or hospital specific) 
meant to improve stroke care? 
Yes …………………………………………………..1 
No……………………………………………..……..2 
71 If yes to Q70, which of the following do you 
have in your hospital? 
National health policy for stroke…………………..…1 
Hospital interventions and initiatives to support stroke 
care………………………………………….….….....2 
Donor interventions to support stroke care………..….3 
If others, specify..…………….…………………..…..4 
None……………………………………….…….....…5 
72 How will you describe the current level of 
health policy support (oversight) from the 
national level for acute stroke care? 
Limited support…………….…………………………1 
Average support……………………………….…..….2 
High support.................................................................3 
Low support……………………………………….….4 
No support……………………………………….…...5 
73 How will you describe the current level of 
health policy support (oversight) at the hospital 
level for acute stroke care? 
Limited support………………………………………1 
Average support………………………………..…….2 
High support................................................................3 
Low support………………………………………….4 
No support………….………………………………...5 
74 What do you see as the current limitations of 
the acute stroke services package? 
No stroke unit (ward) ……………...….…….…....…..1 
Inadequate stroke clinical staff……………….…....…2 
Financial constraints…………………………...…..…3 
Health-policy support………...…………………..…..4 
Lack of political will………..…………..……………5 
If others, specify ….……………..………………..….6 
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75 What plans does the hospital have to promote 
acute stroke care? 
…………………………………………………………
………………………………………………………… 
                        SECTION J: STROKE DATA 
76 Do you have a stroke register or database Yes…………...…………………………………..…..1 
No………………………………………………….....2 
77 If yes to Q76, is it  Electronic stroke data filing system……………….…1 
Manual/facility based paper register………….…..….2 
None of the above….………………………….……..3 
If others, specify...…………….…...…………....……4 
78 In what ways is the stroke register important? 
Select where applicable 
To identify stroke or other ill-health determinants…...1 
To assess the health system performance……….……2 
To assess the health status of patients…….………….3 
None…………………………………….……………4 
Others…………………………………….…………..5 
79 Are there community or hospital 
programs/interventions to promote stroke 
awareness? 
Yes …………………………………….……….…….1 
No ……………………………………………………2 
80 Are there community stroke rehabilitative 
programs? 
Yes …………………………………….…………….1 
No……………………………………………………2 
                        SECTION K: CONCLUSION 
81 Do you have any final comments on any specific section or the interview overall? Any suggestions or 
ideas?  
………………………………………………………………………………………………………………
……………………………………………………………………………………………………………… 
83 Contact email (optional)  
84 Telephone number (optional)  
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2. Instrument for Retrospective Chart Review  
                                SECTION A: HEALTH FACILITY DATA 
1 
Name of Hospital  
2 
Status of Hospital Regional Hospital ………………….……………………...1 
Teaching Hospital………………………………………..…2 
3 
Department/Unit of Admission  
 
                                   SECTION B: PATIENT DATA 
4 Age:  
5 Sex: Male ………………………………….…….………….…..1 
Female …………………………………………...…….....2 
6 Employment Status  
7 Stroke onset date   
8 Date of Admission  
9 Time of stroke  Accurate…………………………..1 
Estimate………………..…………2 
10 Was the patient discharged alive 
after acute care? 
Yes…………………………………………………………1 
No…………………………...……………………………..2 
11 If yes, date of discharge  
12 Destination at Discharge Discharged home…………………………………………1 
Referred to a different hospital……………………………2 
Discharged against medical advice…………………………3 
13 Did the patient die during acute 
care? 
Yes…………………………………………………………1 
No………………………………………………………….2 
14 If yes, date of death  
                                             SECTION C: PROCESSES OF CARE 
 
15 
 
Did the patient have a brain scan 
at the hospital 
Yes …………………………………………………..….....1 
No …………………………………………………….……2 
Not documented………………………………...……..……3 
 
16 
If yes, what type of scan was 
performed? 
CT………………………………………………………….1 
MRI…………………………………………………….…..2 
Both………………………………………………………..3 
17 If yes, date of brain scan  
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 18 
 
Stroke Unit Care 
Yes ……………………………………………..…………1 
No ………………………………………….……..……....2 
 
19 
 
Treatment with t-PA  
Yes ………………………………………………………..1 
No ………………………………………….…………..….2 
20 If yes, date of treatment  
21 Use of Aspirin  Yes ………………………………………………………..1 
No ………………………………………….………….…..2 
22 If yes, date of treatment  
 
23 
 
Multidisciplinary acute stroke 
care 
 
Yes………………………………………………………...1 
No………………………………………………………….2 
Not documented…………………..……………………….3 
 
24 
 
If yes, choose which of the 
following provided 
multidisciplinary care? 
 
Physiotherapist…………………………………………..….1 
Dietitian……………………….……………………………2 
Clinical Psychologist…………………………...…………..3 
Speech therapist………………………………………...….4 
Social Worker……………………………………..…...…..5 
                                            SECTION D:  DETAILS OF STROKE 
 
25 
 
Type of stroke 
Hemorrhagic ………………………….………………..…..1 
Ischemic ……………………………………………....……2 
Not documented……………………………..……..…..…...3 
 
26 
 
Known stroke risk factors at 
admission  
 
(Tick where applicable) 
Hypertension………………………………………..…..….1 
Diabetes Miletus………………………………………..….2 
Smoking………………………………………………..…...3 
Obesity………………………………………………..…….4 
Family history of stroke…………………………….……...5 
Atrial 
Fibrillation…………………………………….…..………..6 
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Alcohol Intake………………………………………………7 
Asthma………………………………..……………………8 
Others…………….…………………………….……….…..9 
Not documented………………………..…………………10 
 
27 
Was the patient hypertensive prior 
to stroke? 
Yes…………………………………………………………1 
No………………………………………………………….2 
Not documented………….……………………………….3 
 
28 
 
Was the patient on anti-
hypertensives prior to the stroke? 
Yes…………………………………………………………1 
No…………………………………………………………..2 
Not documented……………………………………….….3 
29 Reported complications and 
impairment during admission 
Aspiration pneumonia……………………..…………….....1 
Pressure sores………………….…………….……………..2 
Incontinence ………..………………………………………3 
Unable to walk independently……………………….…….4 
Visual……………………………………………….……..5 
Cognitive impairment…………………..…………………6 
UTI……………………………..…………………………7 
Others ………………………………………………….…8 
Not documented…………………….…………………….9 
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3. Interview guide for qualitative study  
 
In-depth qualitative interviews guide on barriers to acute stroke care 
Introductory Remarks  
Let me first thank you for agreeing to participate in this interview today.  My name is Leonard 
Baatiema, a research student with ACU undertaking this research as part of the requirements for my 
PhD in Public Health. This interview will take about 45minutes and will focus on questions regarding 
your work experience in providing clinical care for acute stroke patients and more importantly the 
barriers affecting optimal delivery of clinical care for acute stroke patients.  
Although notes will be taken during the interview, this will not be at a fast pace to capture all your 
comments so I will be grateful if you grant me the permission to audio-record our discussion in order 
to enable me capture accurately and correctly all information you will be having with me.  This 
interview is done at your volution and so you are at liberty to ask me to stop with the recording or 
the entire interview in the course of the interview if you so wishes. All information shared is strictly 
confidential and will be used purposely for the research and not for any other purpose. Any 
information to be included in this research will de-identify you as the participant. 
Do you have any questions, clarifications at this point before we commence the interview? If none 
then I will humbly request we begin the interview. 
Thank you 
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Interview Guide 
a. Let’s start with a brief explanation of what you do in this hospital in terms of stroke care?
Kindly explain to me what you are expected to do when a stroke patient has been transferred or
report to the hospital with a stroke-like symptoms?
b. What different acute stroke care services or treatments are provided for the care of acute stroke
patients in this hospital? (Probe for the awareness and use of stroke unit care, aspirin therapy
or thrombolytic therapy, etc.)
c. Do you perceive the current acute stroke care services and therapies for stroke patients as
helpful in providing care or there are some challenges in using them?
d. What guides the provision of acute stroke care in this hospital? If a clinical guidelines or
protocols are used, probe for the types of guidelines or protocols used.
e. Do you find these guidelines helpful in providing care or face some challenges in trying to use
them? Where they exist, probe on the following: (their clarity and relevance to stroke clinical
care, stroke care professionals familiarity with and confidence in clinical guidelines usage, their
attitudes towards clinical guidelines and the perceived barriers of these guidelines in clinical
decision-making
f. Now let’s discuss the current practical challenges which hinder the delivery of optimal care to
stroke patients? Could you elaborate on some of the barriers you face on daily bases? Probe on
the following: Guideline factors, health staff level barriers, patient factors, incentives and
resources, policy decisions/contexts, national level factors, etc.
g. How do you cope or manage to provide stroke care in the midst of such barriers?
h. What recommendations will you like to make to the hospital authorities on how to improve
acute stroke care in the hospital?
i. Is there anything you will like to share, either audio-recorded or off audio recorded in relation
to the issues we have just discussed?
j. I will be transcribing the recording and if you don’t mind I will be happy to share the interview
transcript with you to cross check to be sure what is transcribed reflects your views?
k. Thank you for your time
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